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Summary
Systemic immunological hyporesponsiveness for humoral and cell
mediated immunity (CMI) after enteral antigen exposure (oral tolerance)
allows most individuals to ingest foods repeatedly without adverse
effects.
Abrogation of this response is considered to be the underlying
mechanism in food related hypersensitivities causing intestinal injury
and malabsorption. The work of this thesis was designed to
investigate, in an animal model, factors which govern the induction and
abrogation of oral tolerance and the concomitant expression of
intestinal CMI. Feeding ovalbumin to adult mice led to systemic
hyporesponsiveness which also prevented the induction of CMI in the
gut.
Modulation of the immune response by cyclophosphamide, N-acetyl-
muramyl-dipeptide, and a graft-versus-host reaction (GvHR) prior to
ovalbumin feeding led to reversal of oral tolerance.
By feeding mice on the first day of life or one day before
parturition (by intraamniotic antigen injection), it was demonstrated
that early antigen exposure without further immunomodulation primes the
with
animal for systemic immune responses. These findings contrast the well
established ease of tolerance induction in the neonatal period and
the fact
underline that the route of antigen exposure is of great importance for
subsequent immune responses.
The role of the gut was investigated by adoptive serum transfer
studies of animals which had been fed ovalbumin. The results show that
circulating antigenic moieties are capable of transferring tolerance for
13.
CMI but not for antibodies. Cyclophosphamide pretreatment and X-
irradiation of donors abrogated transferable tolerance. Studies of
antigen uptake revealed that these effects were not related to
quantitative differences in ovalbumin absorption. Further studies were
performed to investigate the question whether the abrogation of oral
tolerance correlates with the induction of a local CMI on antigen
challenge. By histological and morphometric analysis I was able to
demonstrate that neonatal antigen exposure and pharmacological
immunomodulation prime for local intestinal CMI. In these experiments
intraepithelial lymphocyte infiltration has been shown to be an early
and reliable marker of CMI in the gut.
I have shown that feeding ovalbumin to neonatal mice does not lead to
tolerance but primes for systemic and local immune responses. These animals
exhibit signs of an intestinal CMI when the same antigen is introduced into
their diets at a later developmental stage. I propose that this effect is
due to stimulation of a T-helper/inducer cell population within the gut
associated lymphoid tissues (GALT). This phenomenon may underly
enteropathies associated with food hypersensitivities in infancy.
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Immunological tolerance is defined as a state of specific
immunologic hyporesponsiveness to an antigen which, under normal
circumstances, would induce an active immune response. The most
obvious example is the inability of an organism to be sensitized
(immunised) against its own tissue components, although these
components are highly immunogenic for other organisms.
The need for the understanding of the mechanisms whereby an antigen
can be immunogenic or able to prevent the development of specific cell
mediated and/or humoral responses was first stated by Paul Ehrlich in
1904. He tried to explain this central phenomenon by the term "horror
autotoxicus", a mechanism by which the organism was prevented from
producing antibodies against its own components.
Owen in 1945 observed that dizygotic bovine twins have vascular
anastomoses between the two placentae and he found that these twins
shared blood group antigens. The erythrocytes however were not being
recognised as foreign antigens and those twins possessed a state of
acquired immunological tolerance (chimera). This phenomonen was the
basis for the theory of tolerance to 'self', originally proposed by
Burnet & Fenner (1949). The absence of immune responses to self
antigens led them to postulate the existance of a specialised mechanism
for the acquisition of self tolerance which was termed "clonal deletion"
(Burnet 1959).
A clone is a group of cells all of which are the progeny of a
single cell and this theory predicts that the individual carries a
complement of clones of lymphoid cells that are capable of reacting with
all possible antigenic determinants. During foetal life or in early
stages of their development, clones which react against self antigens
are eliminated or killed on contact with antigen thus rendering the
organisms specifically unresponsive to self antigens. If different
clones came into contact with, for example, soluble or particulate
antigens during foetal life, these animals would then be rendered
specifically unresponsive to these antigens in later life. Following
Burnet's theory, it was shown that dizygotic bovine twins do not reject
skin transplants between each other but reject those of other animals
(Billingham, Brent & Medawar 1953, Medawar 1961). In pursuing this
line, Medawar's group showed that mice of strain A, having been injected
with cells of strain B on the 17th day of gestation, do not reject skin
transplants of B mice in later life, although they were capable of
rejecting skin transplants of other mice. This state of tolerance
could be abrogated by injection of lymphoid cells of normal A mice.
Soon afterwards, tolerance to a protein antigen was induced in
rabbits (Hanan & Oyama 1954) and further investigations demonstrated
that tolerance could be induced to various antigens and that the
induction of a specific immunological unresponsiveness is readily
achieved in neonatal animals.
It seems that the clonal deletion theory is only one mechanism of
central tolerance induction and it is now well recognised that there are
multiple ways of tolerance induction which can be summarized as
peripheral suppression. These two forms of tolerance are not mutually
exclusive and may co-exist. The latter state of tolerance is
maintained by active suppression of immunocompetent cells, for example,
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T-suppressor cells. Their effects are normally detected as a
dampening down of a measurable immune response by regulatory
T-lymphocytes which govern the T-T or T-B cell co-operations. The
cells and mechanisms involved in the induction of peripheral
tolerance will be outlined in the following section.
I. Immune responses and tolerance
The observations of Good & Varco 1955, Miller 1961, Cooper & Ada
1972 and Warner, Szenberg & Burnet 1972, subdividing the immune system
into a thymus derived (T) and bursal or bone marrow (B) compartment has
been a useful and stimulating concept.
Although additional classes of lymphoid cells including natural
killer cells, marrow derived cells, mast cells, dendritic cells and
macrophages are all recognised to have important afferent, efferent and
regulatory roles in the immune response, I will restrict myself to the
discussion of T and B-cells, their ontogeny, interactions, subclasses
and their roles in tolerance induction.
1. Ontogeny of B-lymphocytes
Despite the extensive amount of information that has been
accumulated on mouse embryology, it has not been possible to identify a
tissue equivalent to the bursa in birds and both the gut associated lymphoid
tissue and the bone marrow have been proposed as "bursa equivalents".
The current view is that B-lymphocytes are derived from hematopoietic stem
cells (Wu, Till & Siminovitch 1967) which are themselves orginating from the
embryonic yolk sac (Moore & Owen 1967). The yolk sac and the foetal
liver seem to be the most likely sites of B-cell differentiation (Phillips &
Melchers 1976) during foetal life. A few days after birth the
of
generation B-cells in the liver stops (Melchers, von Boehmer & Phillips
1975) and their generation then shifts to the bone marrow (Owen, Raff &
Cooper 1975). The earliest recognisable cells of the B-cell lineage
are called pre B-cells. They have cytoplasmic IgM, but not surface IgM, and
have been described at 11 and 12 days of gestation in the murine foetal liver
(Raff, Owen, Cooper, Lawton, Megson & Gathings 1975, Raff, Megson, Owen &
Cooper 1976, Melchers 1977). Surface immunoglobulin is first detected at 15
or 16 days of gestation (Nossal & Pike 1973) and at this time is exclusively
of the IgM class. IgG and IgA expression occur a few days later. IgD
bearing cells appear around 9-10 days after birth. The role or function of
surface IgD is not solved and one possible function relates to the regulation
of tolerance-susceptibility of immature B-lymphocytes (Vitetta & Uhr 1975).
These authors hypothesized that binding antigen by surface IgM alone might
deliver a tolerance signal, whereas surface IgD and IgM together might induce
differentiation. In support of this theory it has been shown that cells
depleted of surface IgD by anti-IgD antibodies were more susceptible to
tolerance induction (Scott, Layton & Nossal 1977).
a) Immune responsiveness of murine B-cells
The capacity to mount immune responses against T-dependent and
T-independent antigens has been shown to occur in a programmed manner
(Sherr, Szewczuk, Cusano, Rapaport & Siskind 1979, Siskind 1981). Murine B-
cells are capable of producing an adult like heterogeneous antibody response
around 7-10 days of age (Goidl & Siskind 1974). Whether the change in
immune responsiveness is due to a differentiation event (Goidl, Klass &
Siskind 1976) or under an immunoregulatory influence by T-cells or antigen
presenting macrophages has not been resolved. It has been shown, however,
in all transfer studies using syngeneic adult irradiated recipients
supplied with an excess of adult T-cells, that B-cell precursors already
have acquired the potential to produce IgG antibodies by 14-16 days of
gestation (Goidl et al 1976).
The reason for the poor antibody responsiveness to a T-dependent
antigen of neonatal mice (Fidler, Chiscon & Golub 1972, Spear & Edelman
1974) cannot be solely attributed to a gross deficiency of T-lymphocytes
or immunoglobulin bearing B-cells (Spear, Wang, Rutishauser & Edelman
1973). They demonstrated that adult responsiveness is not achieved
before 4-8 weeks of age. Further studies demonstrated that immune
responsiveness to T-independent antigens precedes the capacity to
respond to T-dependent antigens during ontogeny (Rabinowitz 1976, Hardy
& Mozes 1978).
The suppression of antibody synthesis of neonatal mice was shown by
Mosier and Johnson (1975) to be associated with an excess of endogenous,
non-specific suppressor T-cella which interfered with the function of T-
helper cells. They demonstrated that neonatal thymocytes constitute a
rich source of T-suppressor cells for adult antibody synthesis (Mosier,
Mathieson & Campbell 1977) emphasising the close immunoregulatory links
between and B and T-cells.
2. Ontogeny of T-lymphocytes
The T-cell system has two primary roles. The first is regulation
of the immune response through antigen recognition and co-operation
with other immunocompetent cells.
The second role is the effector function of T-cells. They are
responsible for cytotoxicity and delayed type hypersensitivity reactions
as well as for suppressing the development of autoimmune phenomena.
T-cells orginate from the foetal yolk sac, liver or adult bone marrow-
derived hemotopoietic stem cells which migrate to the thymus (Owen & Raff
1970, Stutman & Good 1971). This migration is an absolute requirement for
further differentiation of T-lymphocytes in vivo (Stutman 1978).
After the demonstration of a subpopulation of immunologically
competent T-cells within the thymus (Raff 1971), the model of T-cell
differentiation was based on the following sequence: hematopoetic stem
cell - (thymus) thymocyte - mature thymus lymphocyte - peripheral T-
lymphocyte (Raff 1971,1973).
Several theories have been proposed to explain the development of
subsets of mature T-cells each of which have different functional
characteristics. The main differences between the different theories
proposed by Raff (1971,1973) and Stutman (1978,1981) are related to the
influence of antigens on T-cell maturation, and to the restriction by
the major histocompatibility complex. T-cells may require antigen
exposure before they differentiate into functionally different
populations (Raff 1971,1973) or they may even be precommitted to a
certain activity before antigen exposure (Stutman 1981).
a) T-lymphocyte cell surface marker
The murine thymus contains thymocyte precursor cells as early as
12-13 days of gestation (Chakavarty 1977) and by 19 days of gestation the
expression of Thy 1+, Lyt 1+, Lyt 2+ antigens reach adult levels
(Kamarck & Gottlieb, 1977).
The expression of several murine membrane antigens is linked with
maturational events within the thymus and with peripheral immunoregulatory
function. Thy 1+ antigen is mainly found on prethymocytes and is reduced in
quantity during development. Lyt antigens are developed during maturation
and cells which undergo further functional differentiation will lose
either the Lyt 1+ or Lyt 2,3+ marker (Cantor & Boyse 1975,1977). When
T-cells are released into the periphery from the thymus they contain
roughly 50% Lyt 1,2,3+, 30% Lyt l+,2- and less than 10% Lyt 1—;2,3+
cells. By using different subsets of specific antisera and complement,
the following functions can be associated with the membrane markers
listed below:
Lyt 1,2,3+ : amplifier cell, nonspecific suppressor cell
Lyt l+;2,3- : helper/inducer cell, probably also DTH effector
cell
Lyt l-;2,3+ : specific suppressor cell; cytotoxic cell
(Gershon 1975, Feldman, Beverley, Dunkley et al 1977, Waksman 1977).
Except for the cytotoxic or natural killer cells, activated T-cells
exert their influence by the production of soluble, antigen specific T-
cell factors, lymphokines. These factors are mediator molecules and
perform the function of those cells in an antigen specific manner and
thus play an important part in immunoregulation (Tada & Okumura 1979,
Germain & Benacerraf 1980). Whereas antigen specific suppressor
factors have been demonstrated in many experimental conditions for
antibodies (Feldman 1974, Tada, Taniguchi & Takemori 1975, Kontiainen,
Howie, Maurer & Feldman 1979) and for delayed type hypersensitivity
reactions (Kojima, Tamura & Egashira 1979, Liew, Sia, Parish & McKenzie
1980), soluble helper factors for delayed type hypersensitivity have so
far not been demonstrated.
The important and crucial role of the T-cell in tolerance
induction, modulation and maintenance will be discussed in the following
section.
II. Mechanisms operative in immunological tolerance
It has become more and more evident that immunological tolerance
cannot only be attributed to one central mechanism (clonal deletion) but
that it is the outcome of a delicate network of different
immunoregulatory control mechanisms. These mechanisms are not mutually
exclusive and can co-exist in the same animal (Waksman 1977). In this
section I shall confine myself mainly to the discussion of tolerance to
protein antigens and describe the mechanisms for parenteral induction of
T and B-cell tolerance.
The mechanisms of tolerance can be broadly distinguished by their
mode of action and described as direct (passive) leading to removal of
B-cell clones from reactivity (reviewed by Nossal & Pike 1980) or as
indirect (active) by activation of specific suppressor T-cells which
then act on T or B-cells (Gershon & Hondo 1970,1971, Waksman 1977).
The mechanisms responsible differ according to the various experimental
systems.
Specific tolerance can be induced by a wide range of antigens and
a variety of experimental in vivo and in vitro conditions and results in
unresponsiveness of all limbs of the immune system.
Reversible receptor blockade or functional deletion of B-cell has
been demonstrated by Aldo-Benson & Borel(1974) in experiments coupling
hapten conjugates to isologous gamma globulin and by Howard & Mitchison
(1975) using pneumococcal polysaccharides. Clonal deletion of B-cells
in vitro by using lipopolysaccharides and antigen antibody complexes
has been demonstrated by Diener & Feldman (1972). Clonal deletion
during perinatal tolerance induction and clonal abortion in adult
animals has been demonstrated also by Nossal and Pike (1975,1980).
The relevance of these mechanisms for tolerance at the T-cell level
is still unproven, although specific T-cell deletion is known to occur
(Cooper & Ada 1972, Godfrey 1976). The balance between tolerance and
sensitisation is delicate depending on antigenic structure, dose, immune
status of the animal and route of antigen presentation. It was shown
that unusually high or low doses are tolerogenic on intravenous
injection (Dresser 1962, Dresser & Mitchison 1968) and experiments by
Chiller, Habicht & Weigle (1971), Weigle (1977) and Parks & Weigle
(1980a) demonstrate that deaggregated human gamma globulin is
tolerogenic whereas aggregated human gamma globulin is an obligate
immunogen. Generally, this phenomenon seems to be dependent on the
epitope density of antigens. Low epitope density renders antigens
rather tolerogenic whereas antigens with a high epitope density are more
likely to immunise.
Antigen presentation to T-cells directly or via macrophages has
been shown to activate a certain population of these cells and to create
a state of tolerance transferable by spleen cells. Tolerance for CMI
in mice seems to be very sensitively controlled by T-suppressor cells as
has been shown in studies by various groups using particulate and skin
sensitising antigens (Basten, Miller, Sprent & Cheers 1974, Claman,
Phanuphak & Moorhead 1974, Kaufman & Hahn 1979, Asherson & Zembala
1980). Whether the tolerant state is maintained by active suppression
appears to be dependent on the experimental system. In this respect
the absence of demonstrable T-suppressor cells in tolerant animals
(Parks, Doyle & Weigle 1978, Parks and Weigle, 1980b, Hanson & Miller
1982) strengthens the possibility that more than one mechanism may be
responsible for maintaining tolerance. On the other hand, a deficiency
of T-helper cells is responsible for immunologic hyporesponsiveness
after intravenous injection of ovalbumin (Endres & Grey 1980a,b).
Furthermore, the hyporesponsive state can also be induced by
immunoregulatory feedback suppression. This immunoregulatory circuit
depends on activation of T-helper inducer cells (Lyt 1+) which are
directly stimulated by antigen to become inducers of T-suppressor cells
(Lyt 2,3+) which will then at the end of the circuit suppress Lyt 1+
helper cells (Eardley, Hugenberger, McVay-Boudreau, Shen, Gershon &
Cantor 1978, Shimamura, Hashimoto & Sasaki 1982, McDonald 1982). This
circuit can also be triggered off by immune B-cells (Shimamura et al
1982).
1. Regulation of cell mediated immunity (CMI)
In general, humoral and cell mediated immune reactions are both
dependent on the balance between systemic sensitisation or suppression
and in this section I will discuss the regulation of CMI or delayed type
hypersensitivity reactions. The term 'cell mediated immunity'
encompasses various forms of immune reactions involving T-cells,
macrophages, basophils, eosinophils or polymorphonuclear cells (Waksman
1979). The classical CMI reaction (tuberculin type) is T-cell mediated.
T-jjth ceHs release lymphokines, for example, a macrophage activation
factor, and produce a macrophage dominated inflammatory lesion.
Suppressor T-cells appear to play a major part in regulating the
induction and expression of CMI (RSllinghoff, Starzinski-Powitz,
Pfizenmaier & Wagner 1977, Gill & Liew 1978, L'age- Stehr & Diamantstein
1978) whereas the existence of soluble helper factors for CMI have still
not convincingly been demonstrated (see review Taussig 1980).
The induction of T-helper and T DTH effector cells show
differences in their dose responses to the same antigen. T-cell
stimulation usually requires antigen presentation on the surface of a
macrophage. T-cell subsets, T-helper or T DTH cells which are Lyt 1+
but not Lyt 2,3+ in mice are triggered only when they recognise I-region
associated (la) antigens of the macrophage surface in close connection
with the antigen; a process which is called 'dual recognition'
(Bretscher & Cohn 1970). The activation of antigen-specific suppressor
T-cells of Lyt 2,3+ phenotype is restricted commonly by K or D region
antigens of the major histocompatibility complex (see review Zinkernagel
& Doherty 1977). Since T-helper and T-^^j cells share the same surface
markers and major histocompatibility complex restricted recognition
pathway (Miller, Vadas, Whitelaw & Gamble 1976) it remains to be proven
whether these are functions of T-cells of different origin rather than
alternative operative or developmental functions of the same cell.
B. STRUCTURE AND DEVELOPMENT OF THE GUT
ASSOCIATED LYMPHOID TISSUES (GALT)
There is now ample evidence that antigen within the lumen of the gut
can trigger off an immune response which may manifest both locally in the
lamina propria and/or systemically throughout the body. Because of
the unique exposure of the gastrointestinal tract to a wide range of
complex antigenic stimuli, a complete range of different defence and
effector mechanisms are found in the epithelium and lamina propria of the
gut mucosa. These include mainly IgA and, possibly, IgM secreting plasma
cells, effector T-cells including suppressor, helper and killer
cells as well as macrophages, monocytes, eosinophils and mast cells (see
review Parrott 1976, Waksman & Ozer 1976, Bienenstock & Befus 1980).
I shall first deal with special features of the gut associated
lymphoid tissue (GALT), migration pathways of T and B blasts and discuss
the heterogeneity of intraepithelial lymphocytes and their possible
relationships to cells of T and/or mast cell lineage.
Since the recognition that IgA is the main secretory immunoglobulin
(Tomasi, Tan, Solomon & Prendergast 1965), it has been shown that the
Peyer's patch is the main source of IgA committed blast cells. The
Peyer's patches are lymphoid aggregates within the intestinal mucosa of
the gut. The nodular area of the lymphoid follicles is a B-cell area
whereas the T-cell area is a small and narrow internodular zone. It
contains also the post-capillary venules with their highly specialised
epithelium which plays an important role in lymphocyte traffic (Parrott &
de Sousa 1971). The epithelium over the dome area is cuboidal instead
of columnar and lacks goblet cells. Work on human Peyer's patches (Owen
& Jones 1974) and in mice (Owen 1977) has shown that there is a
specialised M (microfold) cell which seems to be a major route for
intraluminal antigen access and presentation to immunocompetent cells in
the Peyer's patch (Owen 1977).
In the mouse, Peyer's patches can be identified before birth as
aggregates of reticular cells, and these areas are populated by
lymphocytes as early as three days after birth (Ferguson & Parrott
1972). Primary nodules appear around 3-7 days and germinal centres at
4-5 weeks of age (Ferguson & Parrott 1972, Waksman 1973).
I. Lymphocyte traffic
Gowans and Knight (1964) first demonstrated in rats that thoracic
duct lymphocytes have a selective tendency to 'home' into lymphoid
tissues including the Peyer's patch (small lymphocytes) and that labelled
large lymphocytes migrate from the blood into the gut wall where they
assumed the appearance of plasma cells. This work has been confirmed and
extended (Hall & Smith 1970, Parrott & de Sousa 1971, Guy-Grand,
Griscelli & Vassalli 1974). In the Peyer's patch it has been shown that
thymus cells are confined to T-dependent areas between the nodules.
There is still some debate whether there exists a common mucosal
associated lymphoid system with free cell traffic or whether there is
only a restricted traffic between different mucosal sites, for example,
between the gut associated and the bronchus associated lymphoid tissues.
In a rabbit model, Rudzik, Clancy, Perey & Bienenstock (1975)
demonstrated that IgA containing cells from the gut associated lymphoid
tissue, had a propensity to repopulate the bronchial mucosa. Goldblum,
Ahlsted & Carlsson (1975) and Hanson, Carlsson, Cruz, Dahlgren, Garcia &
Urruttia (1981) demonstrated an enteromammaric axis when they showed
that antigenic exposure of the intestine resulted in secretory antibodies
appearing in breast milk, probably due to the traffic of Peyer's patch
cells to the mammary gland.
Investigations of the traffic/homing pattern demonstrated that
immunoblasts begin to enter the gut within two hours after injection and
reach a maximum after 24 hours (Hall & Smith 1970) and that the
differentiation from blast cells to immunoglobulin producing plasma cells
takes place within the lamina propria (Hall, Parry & Smith 1972, Parrott
& Ferguson 1974, Guy-Grand et al 1974). The factors controlling
lymphoblast localisation in mucosal tissues are still not completely
understood. In experiments in which hypothetical receptors
responsible for the localisation of IgA-lymphoblasts were blocked, it
was shown that their localisation was not dependent on the 'secretory
piece' or immunoglobulin receptors (McWilliams, Phillips-Quagliata &
Lamm 1975). Factors such as antigen exposure (Husband & Gowans 1978),
hormones (Weisz-Carrington, Roux, McWilliams, Phillips-Quagliata & Lamm
1980)
1978) and blood supply (Ottaway & Parrott) all have been shown to
influence the 'homing' pattern of lymphoblasts to secretory sites. T-
blasts from the thoracic duct and mesenteric lymph nodes seem to have
an antigen independent homing pattern as they lodge selectively in the
lamina propria and epithelium of both normal small intestine and of
antigen free foetal gut isografts implanted under the kidney capsule
( Parrott & Ferguson 1974, Guy-Grand et al 1974, Sprent 1976).
Peripheral T-blasts do not localise in the intestine unless the
mucosa is inflammed (Rose, Parrott & Bruce 1976).
1. Memory of gut associated lymphoid tissues
It is well known that further antigen administration after
primary immunisation can lead to an anamnestic, secondary, response
which takes a shorter time to reach the maximum, affects mainly the IgG
system and is usually higher than the primary response. The question
whether the intestinal immune system has a classic immunological memory
is still a matter of some debate and seems to be dependent on the
experimental conditions and antigens.
Experiments in which counts were performed of cells synthesing IgA
in the thoracic duct and lamina propria after a parenteral
immunisation, followed by an oral challenge, demonstrated an anamnestic
response (Pierce and Gowans 1975, Husband and Gowans 1978). However,
measurements of specific antibodies in intestinal secretions did not
show classical memory in dogs (Pierce, Sack & Sircar 1977). Injection
of bacteria into rat Peyer's patches (Andrew & Hall 1982), however,
produced clear evidence of a secondary IgA response in the
bile. Whether this is the case after oral antigen administration
remains to be established.
II. Mucosal and intraepithelial lymphocytes and local cell mediated
immunity
Lymphocytes are found throughout the gastrointestinal tract and
are numerous in the organised lymphoid tissues such as Peyer's patches
and mesenteric lymph nodes. In the mucosa they are found in the
lamina propria and within the epithelium.
An increase of intraepithelial lymphocytes during a local CMI
(Ferguson 1973) or a reduction in antigen deprived small intestine or
in thymectomized mice (Ferguson & Parrott 1972) indicate an
important immunological role of these cells.
Intraepithelial cells were first described almost 100 years ago
(cited by Stenqvist 1934) and studied in more detail by Fichtelius,
Yunis & Good (1968), Ferguson and Murray (1971), Ferguson (1973, 1977)
and Otto (1973). Intraepithelial lymphocytes constitute about 10% of
the epithelial cells in mice. In guinea pigs they have been shown to
respond to cell mitogens and to exhibit antibody dependent cell
mediated cytotoxity in vitro (Arnaud-Battandier, Bundy, O'Neill,
Bienenstock & Nelson 1978). Similar functions have been ascribed to
lamina propria lymphocytes which have been shown to respond to
phytohaemagglutinin (PHA) and concanavalin A (Con A) and in mixed
lymphocyte reactions (Singal, O'Neill, Clancy & Bienenstock 1976,
Arnaud-Battandier et al 1978, Arnaud-Battandier, Wahl & Nelson 1979).
Intraepithelial lymphocytes are not a homogeneous population.
They appear to consist of small and large cells (Fichtelius, Finstad &
Good 1969, Glaister 1973). The number changes appreciably with age in
mice, adult levels being reached three weeks after birth around
weaning. Cell surface marker studies (Selby, Janossy, Goldstein &
Jewell 1981, Lyscom & Brueton 1982, Schrader, Scollay & Battye 1983) of
isolated, intraepithelial and mucosal lymphocytes preparations revealed
that the majority (around 70%) are of the suppressor/cytotoxic
phenotype Lyt 2,3+, whereas the rest are of Lyt 1+ phenotype (helper).
The majority of intraepithelial cells are of lymphoid character by
morphological criteria and several workers have described granules
similar to those of mast cells within the cytoplasm of these cells.
These granules however are smaller and fewer than those found in
connective tissue mast cells (Murray, Miller & Jaffrett 1968, Rudzik &
Bienenstock 1974).
Intestinal mast cells are found in substantial numbers in the
lamina propria of rats. They are situated mainly around the crypts and
differ from connective tissue mast cells in their morphological
(Enerback 1966a) and histochemical staining properties (Enerback
1966b).
Intraepithelial (atypical) mast cell infiltration is part of an
important protective host response against nematode infections. Worm
expulsion in rats actively immunised with Nippostrongylus brasiliensis
is clearly related to an infiltration with atypical mast cells or
globule leucocytes (Miller & Jarrett 1971). This response seems to be
under control of the thymus (Olson & Levy 1976, Ruitenberg & Elgersma
1976). The population of these cells is also expanded during a GvHR
(Guy-Grand et al 1978, Mowat & Ferguson 1982) and thought to be a
measure of gut cell mediated immune responses during the GvHR.
Although T-cell markers have been identified on these cells (Guy-Grand
et al 1978, Schrader et al 1983) a sharp distinction between mucosal
mast cells, intraepithelial granulated cells and intraepithelial
lymphocytes has not yet been drawn. It seems likely that intra¬
epithelial granulated cells and mucosal mast cells are of different
lineage. Recent work (Kitamura, Shimada, Hatanaka & Miyano 1977,
Mayrhofer 1980, Kitamura, Yokoyama, Matsuda, Ohno & Mori 1981) has
shown that mast cells are probably of (hematopoietic) bone marrow
with
origin contrasting the theory of Burnet (1977). The sparsely
granulated cells are not a homogeneous population and may account for
natural killer, suppressor and cytoxic activity seen in gut mucosal and
intraepithelial lymphocyte preparations (Davies & Parrott 1981,
Schrader et al 1983, Parrott, Tait, Mackenzie, Mowat, Davies & Micklem
1983). The T-cell dependency of experimental villus atrophy in the
small intestine of rats during a mematode infection (Ferguson & Jarrett
1975) is evidence of the important immunoregulatory role of the T-cell
system. It could be taken as indirect evidence that mucosal T-cells -
necessary for a local CMI to develop - also have effector functions.
Athymic mice, for example, are deficient in clearing a usually self-
limited giardia infection (Roberts-Thomson & Mitchell 1978).
An increase of intraepithelial lymphocytes during an
immunologically mediated mucosal damage in mice has been demonstrated
during a GvHR (Guy-Grand et al 1978), allograft rejection (MacDonald &
Ferguson 1976) and during a local CMI against ovalbumin in mice (Mowat
& Ferguson 1981). In man, a raised intraepithelial lymphocyte count
is found in cows' milk protein intolerance and coeliac disease
(Ferguson 1974, Mavromichalis, Brueton, McNeish & Anderson 1976,
Phillips, Rice, France & Walker-Smith 1979). Whether these cells
have an effector or mainly an immunoregulatory role or are only
secondarily recruited to the site of tissue damage remains to be
established.
C. IMMUNE RESPONSES AFTER ENTERAL ANTIGEN PRESENTATION
ORAL TOLERANCE
The phenomenon of hyporeactivity after enteral antigen
administration was noted by Dakin (1829) who described the practice of
American Indians of ingesting leaves of the poison ivy plant to prevent
or alleviate symptoms which occurred after a cutaneous encounter.
Orally or parenterally administered poison ivy extracts or a
combination of both have been used to prevent or alleviate symptoms due
to contact allergy for a long time (Stevens 1945).
When the first encounter with an antigen is by the enteral route,
a local secretory IgA antibody response will ensue (Heremans 1974).
Small amounts of protein antigens are absorbed intact (Uhlenhuth 1900,
Lippard, Schloss & Johnson 1936, Swarbrick 1979, Walker 1981) and
thus may induce systemic humoral immune responses (Gruskay & Cooke
1955, Rothberg & Farr 1965, Rothberg, Rieger, Silverman & Peri 1981) or
systemic CMI which has been demonstrated by Perrotto, Hang, Isselbacher
& Warren (1974) after feeding a soluble egg antigen of Schistosoma
mansoni.
It is important to note however that circulating food related
antibodies are not synonomous with disease and are frequently
demonstrated in healthy individuals.
It was shown in the early experiments of Wells and Osborne (1911)
that oral administration of antigen is extremely effective in inducing
systemic tolerance. He demonstrated that the anaphylatic response of
guinea pigs towards egg white or corn protein could be prevented by
prior feeding of the antigen in question. This was confirmed for
contact sensitising agents (Chase 1946, Asherson, Zembala, Perera,
Mayhew & Thomas 1977) heterologous red cells (Andrd, Heremans, Vaerman
& Cambiaso 1975), Kagnoff 1978a,b) and for proteins (Thomas & Parrott
1974, Hanson, Vaz, Maia, Hornbrook, Lynch & Roy 1977, Ngan & Kind
1978, Miller & Hanson 1979).
Under normal conditions, both limbs of the immune response are
rendered unresponsive after an oral feed. Suppressed total serum
antibody responses (Hanson et al 1977, Kagnoff 1978a) specific IgE
responses (Ngan & Kind 1978, Vaz, Maia, Hanson & Lynch 1977) and CMI
responses (Chase 1946, Asherson et al 1977, Kagnoff 1978a, Miller &
Hanson 1979) have been reported to be suppressed after antigen feeding.
The underlying mechanisms for the unresponsive state are still
unclear and both cellular and humoral mechanisms have been implicated.
It was found that serum from orally immunised mice was capable of
suppressing the immune response in vivo and in vitro (Andre et al
1975, Kagnoff 1978a, Chalon, Milne & Vaerman 1979). Mechanisms held
responsible for the suppression of humoral immune responses after
feeding sheep erythrocytes include circulating antigen-antibody immune
complexes (Andrd et al 1975) and - supported by better evidence -
anti-idiotypic antibodies (Kagnoff 1980). T-suppressor cells were
however required to suppress delayed type hypersensitivity reactions
(Kagnoff 1980). These cells have been shown to be generated in rat
Peyer's patches after feeding sheep erythrocytes (Mattingly & Waksman
1978).
To date, no circulating suppressive serum factors could be
demonstrated after feeding soluble antigens and induction of T-
suppressor cells seems to be the prevalent mechanism for inducing
hyporesponsiveness to protein antigens (Thomas & Parrott 1974, Ngan &
Kind 1978, Richman, Chiller, Brown, Hanson & Vaz 1978, Miller & Hanson
1979) and skin sensitising agents (Asherson et al 1977).
The liver plays a role in tolerance induction (Triger, Cynamon &
Wright 1973, Thomas, Ryan, Benjamin, Blumgart & MacSween 1976) by
filtering out antigenic moities as demonstrated by the abrogation of
tolerance after portocaval shunting in dogs (Cantor & Dumont 1967).
Much further work to elucidate the role of the liver is needed; and
whether the abrogation is due to circumvention of specialised liver
macrophages remains to be established (Richman, Klingenstein, Richman,
Strober & Berzofsky 1979).
I. Immunoregulation by class specific regulatory T-lymphocytes
A hypothesis for immunoregulation of systemic or local immune
responses after oral antigen exposure has been proposed recently
(Elson, Reilly & Rosenberg 1977, Strober, Richman & Elson 1981) and
implies a crucial immunoregulatory role for the Peyer's patch.
Antigenic stimulation within the gut associated lymphoid tissues
induces T-helper and T-supressor cells which may account for systemic
unresponsiveness and local mucosal responsiveness following antigen
feeding.
A class specific regulation of mucosal immune responses has been
proposed, local mucosal IgA responses being induced after feeding and
systemic IgG and IgM responses being suppressed. These experiments
and theories still leave many aspects unexplained, for example, how a
mucosal IgM response can be induced by feeding.
D. MODULATION OF IMMUNOLOGICAL TOLERANCE
One of the enigmas in immunology is that the immunological
response obtained depends critically on the route of antigen
administration. This is very well demonstrated in the case of contact
sensitivity where intravenous injection (Claman 1979) and prior feeding
of a contact sensitising agent (Asherson et al 1977) induce a state of
tolerance, whereas topical application leads to contact sensitivity
(Asherson et al 1977, Claman, Miller & Moorhead 1977). In general,
intravenous injections of high and exceptionally low antigen doses lead
to tolerance, whereas intermediate range doses lead to immunisation
(Dresser & Mitchison 1968) . The dose of antigen has also been shown
to be important for induction of T and/or B-cell tolerance (Chiller &
Weigle 1971, Weigle 1977).
Furthermore, the antigenic structure (epitope density) has been
shown to be equally important since deaggregation of human
gamma globulin (Chiller and Weigle, 1971) renders it an obligate
tolerogen, whereas aggregated human gamma globulin is immunogenic.
It was further shown that in vitro digestion (Dosa, Pesce, Ford,
Muckerheide & Michael 1979) generated tolerogenic and immunogenic
fragments. It is assumed that the underlying mechanism depends on the
capacity of the immunoregulatory cells to recognise the antigen as
tolerogenic without macrophage presentation or as immunogenic when
presented by macrophages (Endres & Grey 1980 a,b). In addition, the
immune responsiveness of the animal can be altered by pharmacological
manipulation prior to, during or after antigen administration.
I. Modulation by cyclophosphamide
Cyclophosphamide, an alkylating agent, has been used in a variety
of experimental systems with variable effects.
When it is given shortly after immunisation, the predominant
result is a dose related suppression of the immune response and affects
mainly antibody synthesis (Mitsuoka, Baba & Morikawa 1976, Ramshaw,
Bretscher & Parish 1976). If given before antigen, antibody responses
are mainly unaffected and CMI may be enhanced by the suppressive action
of cyclophosphamide on T-suppressor cells (Lagrange, Mackaness & Miller
1974, Asherson et al 1977, Gill & Liew 1978, Mitsuoka, Morikawa, Baba,
& Harada 1979) Furthermore, cyclophosphamide pretreatment has been
used to induce CMI responses locally in the gut associated lymphoid
tissues (Mowat & Ferguson 1981) by concomitantly abrogating systemic
tolerance which is dependent on T-supressor cells. Thus, cyclo¬
phosphamide is a useful tool for analysis of the immunoregulation of
oral tolerance and will be used in the experiments described in this
thesis.
II. Immunomodulation by immaturity
Although it has been shown that the neonatal period is
exceptionally sensitive to tolerance induction by allogeneic cells
(Billingham, Brent & Medawar 1953, Medawar 1961), by intravenous
injection of human gamma globulin (Waters, Pilarski, Wegmann & Diener
1979, Chiller, Titus & Etlinger 1979), or by transfer of a tolerogenic
form of human gamma globulin via colostrum (Halsey & Benjamin 1976)
there is no report of induction of oral tolerance in neonatal mice
except by Hanson (1981) where he used human gamma globulin. Indeed,
it seems that the physiological route of dietary antigen exposure
during the neonatal period has been neglected and recent reviews on the
development of the immune system and the immunoregulatory capacity of
the rodent foetus and newborn (Murgita & Wigzell 1981) do not mention
any work dealing with the immune responses induced by feeding antigen
during the neonatal period. Modulation of the immune response by
antigen feeding during the neonatal period, however, seems to be of
crucial importance in understanding the underlying mechanisms which tip
the balance from tolerance to sensitisation and which could thus lead
to food allergic diseases in humans.
E. AIM OF THE THESIS
This thesis will focus on experiments on the ways of induction and
modulation of oral tolerance and examine whether abrogation of oral
tolerance leads to local intestinal CMI responses. The experiments
are conducted in inbred mice and ovalbumin was chosen as a dietary
antigen for immunological (not related to self antigens) and practical
reasons (readily available ovalbumin-free mouse diets).
The specific objectives addressed in the thesis are:
1. To test and establish protocols and methods for assessment of
systemic tolerance and induction of local mucosal cell mediated
immunity.




(iii) graft-versus-host reaction, and
(iv) by perinatal ovalbumin feeding
3. To investigate the role of the gut in induction of oral tolerance
by adoptive transfer of serum of fed donor mice.
4. To test whether abrogation of oral tolerance leads to local
intestinal cell mediated immunity on antigen re-exposure in later
life.
The long term aim of the work presented here is to establish an
animal model for human food allergic diseases so that methods for their





Mice of the following inbred strains were used throughout the
experiments:
CBA/Ca (H/2k/k) ancj bALB/c (H/2d//d) originated from the Jackson
Laboratories, USA, and have been bred since 1974 in the Animal Unit of
the Western General Hospital, Edinburgh. (CBA x BALB/c)
(H/2k/d) and (C57BL/6 x DBA/2) ?1 (H/2b/d) were bred on demand
(CBA x BALB/c) F^ or bred continuously (BDF^). New Zealand white
rabbits (NZW) were used to raise the anti-ovalbumin antisera.
The age of the animals was as indicated in the experimental
section. Adult animals were mainly used at 6-8 weeks of age. They
were kept on a 12/12 hour light/dark cycle and experimental procedures
were carried out usually between 9.00 - 11.00 am.
B. DIET
Animals were fed a standard rodent diet (Spratts No.l, Spratts
Patent Limited, Cambridge) and had ad libitum access to tap water.
In experiments in which animals were chronically challenged with
ovalbumin, 2 mg ovalbumin/100 ml was dissolved in their drinking water
equivalent to a daily intake of 0.1 mg/mouse, assuming a 5 ml daily
fluid intake for an adult animal.
C. ANTIGENS
Ovalbumin, human serum albumin and bovine serum albumin, five times
recrystalised, were obtained from Sigma Chemical Company, Poole,
Dorset. Antigens were dissolved in sterile water or 0.15 M saline
before injection or feeding.
D. ANAESTHESIA
Ether anaesthesia was used for procedures such as footpad
immunisation, retro-orbital and axillary bleeding.
Abdominal surgery was carried out under barbital anaesthesia using
SAGATAL 60 mg/ml (May and Baker Ltd) diluted 1:10 in sterile water.
Mice were injected intraperitoneally with 0.01 ml/g body weight which
provided adequate anaesthesia after about 15 minutes, lasting for up to
two hours.
E. INTRAGASTRIC ADMINISTRATION OF ANTIGEN
Experimental animals were not fasted. 100 mg ovalbumin was
usually dissolved in 1 ml of 0.15 M saline thus providing the tolerising
dose of 1 mg ovalbumin/g body weight in 0.01 ml/g body weight.
In experiments where dose dependency of tolerance induction was
examined, the concentration of ovalbumin was increased and the maximal
adminstered volume did not exceed 0.3 ml in adult or 0.05 ml in
neonatal mice (age 1-14 days).
I. Feeding technique and feeding equipment (Figures 2.1 and 2.1a)
Mice aged three weeks and older were intubated with a 19 gauge
stainless steel dosing needle with a spherical shaped blunted end.
Experimental animals aged between two and three weeks were intubated
with a premature infant feeding catheter (Argyle, Sherwood Medical
Industries, 3.5 Charriere) attached to a 19 gauge stainless steel needle
stock.
2.1 Feeding techniques and equipment
Top: A microsyringe (500 pi) and three feeding tubes used
at different ages. The stainless steel tube with a blunted end
was used after three weeks of age. Below, feeding tube used in
early experiments (1-14 days), bottom: definitive feeding tube
with a flexible, soft silicone rubber tip used from 1-14 days of
age (arrow indicates the joining stainless steel needle stock).
Bottom: Feeding technique and position demonstrated on a 14
day old BDF^ mouse.
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2.1a Feeding techniques and equipment
Test feed with Evan's blue of a one day old BDF^ mouse. Note
the clearly visible milk filled stomach on the right which now
exhibits blue colouration ( left) after feeding 0.05 ml Evan's
blue solution. Perforation leads to a diffuse colouration of
the abdomen.
Some of the neonatal mice up to 14 days were intubated with a 00
flex nylon intravenous tubing attached to a 26 gauge needle stock. To
prevent mucosal abrasion and to minimise trauma, the end of the tubing
was blunted by careful heating and checked for smoothness under the
dissecting microscope.
A modified feeding tube with a flexible silicone rubber tip
(No 602-105, Dow Corning, USA) was used in most of the neonatal feeding
experiments. The smooth rubber tip was attached to polyvinyl tubing
(Portex Limited) by connecting the two tubes with a circa 2 mm stainless
steel stock of a 27 gauge needle which was inserted half into each
tubing under the dissecting microscope. The soft tip was cut 1.5 mm
above the joining piece.
All feeding techniques were checked before starting a series of
experiments by feeding Evan's blue (Figure 2.1a). On dissection, the
oesophageal and gastric mucosae were checked for injury and the pharynx,
oesophagus and lungs were checked for reflux, injury, and via falsa
intubation. No signs of injury, reflux or intratracheal intubation
could be found after having established these experimental procedures.
Animals which exhibited signs of regurgitation or bleeding were excluded
from the experiments. The exclusion/mortality rate in mice fed at day
one of life was less than 4%.
F. IMMUNISATION OF ANIMALS
In early studies of systemic immunity, mice were immunised with
2 mg ovalbumin suspended in complete Freund's adjuvant in a volume of
0.2 ml intraperitoneally. In all other experiments 100 pg antigen
suspended in an equal amount of complete Freund's adjuvant was injected
intradermally into one rear footpad (volume 0.05 ml).
NZW rabbits were immunised with 2 mg ovalbumin or human serum
albumin emulsified in complete Freund's adjuvant intramuscularly at
monthly intervals for three months and bled out two weeks after the last
booster injection.
G. BLOOD COLLECTION
Up to 200 pi of blood were obtained routinely from the
retro-orbital plexus under ether anaesthesia using heparinised
hematocrit tubes (Propper Ltd, Long Island, New York). This route was
chosen for survival experiments. Larger quantities of blood were
obtained by either cardiac puncture or bleeding mice from the axillary
vessels. Haematocrit tubes were sealed with CRISTASEAL (Hawskley,
England) and allowed to clot in the upright position. They were spun
in a haematocrit centrifuge (Hawskley, England) for five minutes,
decomplemented for 30 minutes (water bath) at 56°C and stored at
-20°C until assayed.
H. PASSIVE HAEMAGGLUTINATION ASSAY
Sera were tested for antibodies by passive haemagglutination.
Sheep red blood cells were collected and stored in Alsever's solution
(v/v) and washed three times in saline at 1500 x g before use. 100 pi
packed sheep red blood cells were mixed with 0.7 ml saline and 100 pi
protein solution (15 mg/ml ovalbumin or 1 mg/ml human serum albumin) in
saline. 1 ml of 0.01% chromic chloride (Analar, BDH Limited) in saline
at pH 5.0 was added dropwise under continuous agitation. The mixture was
then allowed to stand for 10 minutes at room temperature (around 25°C),
the reaction was stopped by adding 10 ml of phosphate buffered saline
pH 7.2 and the coated cells were then washed twice in phosphate buffered
saline and resuspended at 1% before use.
Decomplemented sera were absorbed with 10% sheep red blood cells
for about one hour before use. 25 pi serum was doubly diluted with
0.15 M saline in round bottom microtitre plates (TITERTEK, Flow
Laboratories) and 25 pi of coated sheep red blood cells were added with
a multi channel (eight) pipette (TITERTEK, Flow Laboratories) to each
well.
After settling for 90 minutes at room temperature, the titres were
taken as the last dilution to show complete agglutination. All sera
were tested with or without the addition of 25 pi of 0.1 M 2-mercapto-
ethanol (Sigma Chemical Co Ltd) to obtain information on both
mercaptoethanol resistant and sensitive (presumably IgM) antibodies.
In some experiments, haemagglutination assays were performed in
collaboration with Mrs H Drummond and Mrs M Gordon.
I. ASSESSMENT OF SYSTEMIC DELAYED TYPE HYPERSENSITIVITY
Mice were tested for delayed type hypersensitivity with
microcalipers (POCOTEST-A, Carobronze Limited, London, United Kingdom) by
measuring the specific footpad thickness increment 24 hours after an
intradermal injection of 100 pg of antigen in 0.05 ml of saline into the
plantar side of a non-immunised rear footpad. Control mice were either
immunised with complete Freund's adjuvant and saline and tested with
antigen, or were immunised with antigen in complete Freund's adjuvant and
were tested with 0.05 ml of saline.
J. SACRIFICE OF ANIMALS
Mice were killed by cervical dislocation.
I. Removal of tissues
Immediately after death, pieces of jejunum (5 mm) were removed
10 cm beyond the pylorus, avoiding Peyer's patches. They were placed
on a card, cut open and immersed into the fixative, villus surface
upwards.
II. Body weights
Body weights were obtained on living animals using an Oertling TD30
single pan balance.
III. Spleen weights
Spleens were dissected free of surrounding tissues after removal of
the intestinal specimens, placed in an airtight container to prevent
drying and were weighed on a torsion balance (White Electrical
Instrument Company).
K. FIXATIVES AND HISTOLOGY
For conventional histology, jejunum and Peyer's patches were fixed
in 10% buffered formalin, embedded in paraffin wax and sections were cut
5 microns thick. They were stained with haematoxyline and eosin. As
preservation of intestinal mast cells or granulated intraepithelial
lymphocytes is dependent on the fixative (Enerback 1966a) pieces of
jejunum were removed as before, fixed in Carnoy's solution and stained
53.
with astra-blue/safranine (BDH Limited) pH 0.3 (Bloom & Kelly 1960).
Specimens were examined under a Leitz EB20 or Leitz Ortholux II microscope.
Histological processing was carried out by Mr Alexander Sutherland
and Mr Frances Donnelly.
I. Intraepithelial lymphocyte counts
Intraepithelial lymphocyte counts are expressed as the number of
intraepithelial lymphocytes/100 villus epithelial cells (Ferguson &
Murray 1971). Sections were examined under x 1000 (oil immersion)
magnification and only well cut sections with a single epithelial cell
layer were counted.
Counts were done by enumerating epithelial and lymphoid cell nuclei
lying unequivocally above the basement membrane and a total of 500 cells were
counted in each specimen. In serially sectioned specimens care was taken to
avoid recurring areas.
II. Counts of astra-blue positive granulated cells
Mucosal mast cells and cells with astra-blue positive granules
within the epithelial layer were included in the total count. The cells
were counted by using a square-grid eyepiece fitted to a Leitz EB20
microscope which was calibrated to give the number of cells per square
millimetre of mucosa. The eyepiece was aligned with the lower edge lying
on the upper surface of the muscularis mucosa close to the bottom of
i
the crypts. The tissue was examined under x 400 and x 1000 magnification
and 10 randomly chosen, well orientated sections were counted and the numbers
2
expressed as cells/mm mucosa. No correction was made for the area which
was covered by the epithelium. Because of the distribution of these cells
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in the lower one-third of the mucosa, there were no significant differences
in counts obtained per square millimetre or per mucosal unit.
L. TISSUE PROCESSING FOR MICRODISSECTION (CLARKE 1970)
Mice were injected with 7.5 mg/kg colchicine (BDH Limited)
intraperitoneally and sacrified at different intervals from 20-120 minutes
after injection. Pieces of jejunum, 10 cm beyond the pylorus were removed,
placed on cards, cut open and fixed in Clarke's fixative for maximum 24
hours. Thereafter they were transferred to 75% ethanol for storage before
microdissection. To allow repeated examination in case of technical
difficulties, only half of the tissues were stained in bulk by the modified
Feulgen reaction. Pieces of gut were immersed in 50% ethanol for
10 minutes, followed by tap water for 10 minutes and 7 minutes hydrolysis in
0.1 N HC1 at 60°C. The tissue was then rinsed three times with tap water
and stained with Schiff reagent (Difco Limited) for 20-30 minutes at room
temperature and then kept in tap water (maximum 48 hours) for
microdissection.
The lamina muscularis mucosa was removed under the dissecting microscope
(x32, Zeiss Stereomicroscope 4B) and a single villus or thin segments of
mucosa containing a few villi and their crypts were then cut out of the non-
traumatised mucosa by dissection with a cataract knife (Weiss Limited). The
mucosal fragments were placed on a slide in a drop of 45% acetic acid,
covered with a coverslip and examined under a microscope with a previously
calibrated eyepiece micrometer.
In each specimen, the lengths of 10-15 complete villi and crypts were
measured and the means taken for group comparisons. The tissue under the
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coverslip was then gently squashed with a wooden stick and the number of
arrested metaphases counted for at least 10-15 complete crypts.
I. Crypt cell production rate
The crypt cell production rate/hour was obtained by correlating the mean
number of metaphases/crypt with the corresponding time interval after
colchicine injection and submitting them to linear regression analysis.
After having established linearity, the crypt cell production rate is
calculated from the gradient of the line of best fit calculated by the method
of least squares. Crypt cell production rates are given per hour with
the correlation coefficient which indicates the relationship between the two
variables; where there is complete correlation the value is 1.0; absence of
correlation is indicated as 0.
M. PREPARATION OF SPLEEN CELL SUSPENSIONS
Spleens were removed immediately after sacrifice, dissected free of
surrounding tissue and cut into little segments in cold RPMI 1640 medium
(Flow Laboratories). The pieces were then passed through a stainless steel
60 gauge wire mesh with a plunger of a 5 ml plastic syringe (BD Limited).
The resultant suspension was passed once gently through a 23 gauge needle to
break up lumps. The cells were then washed three times at 400 g in cold
RPMI 1640 until the supernatant was clear. Cell counts were done in a
haemocytometer (improved Neubauer chamber) with white cell counting fluid.
The cell pellet was made up to the required concentration in RPMI 1640 and
injected into the recipients within 60 minutes after removal of the spleen.
Cell viability as assessed by trypan blue exclusion was generally greater
than 90% (range 82-96%).
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N. INDUCTION OF GRAFT-VERSUS-HOST REACTION
Adult female animals of both F^ hybrid generations (CBA; C57BL/6) were
used for induction of GvHR. Adult animals received 6 x 10^ CBA spleen
cells in 0.2 ml of medium intraperitoneally.
Neonatal BDF^ animals aged 1-2 days received 1 x 10^ C57BL/6 spleen
cells intraperitoneally in 0.05 ml RPMI 1640. Control animals received
either medium alone or equivalent numbers of syngeneic F^ hybrid spleen
cells.
I. Assessment of graft-versus-host reaction
Simonsen's (1962) spleen weight assay was used. Mice were weighed
shortly before sacrifice, the spleen removed, weighed and the relative spleen
weight expressed as mg spleen/lOg of body weight. The Spleen Index is
calculated after the following equation:
relative spleen weight in mice with GvHR _ Spleen Index
relative spleen weight in control mice
0. STATISTICAL EVALUATION AND PRESENTATION OF RESULTS
In general, results are expressed as means (x) + 1 standard
deviation (SD) or + 1 standard error (SEM) of the mean, as stated in the
legends to the figures.
In interexperimental or animal strain comparisons, results are
expressed as percentage change of the experimental group compared to the
appropriate control group.
Students t-test was used to compare differences in most cases. In
experiments including haemagglutination assays, comparison was done on
log!q transformed titres using the t-test and by non-parametric
analysis (Wilcoxon's Rank Sum test). In practice, similar signifance
levels were obtained. Results of the enzyme-linked immunosorbent assay
(ELISA) are expressed as absorbance (A^~*) units and were compared by
Rank Sum analysis as non-parametric distributions could not be ruled
out.
Crypt cell production rates calculated by linear regression were
compared by analysis of co-variance to examine the differences between
the slopes of the best fit curves. All calculations were done on a
Casio fx 180P or on a programmable desk top calculator from Texas
Instruments (TI59C) which was connected to a printer.
P. LIST OF SOLUTIONS AND BUFFERS
Phosphate buffered saline pH 7.2 (1000 ml)
anhydrous Na2HP04 1.50 g
anhydrous KH-^PO^ 0.43 g
NaCl 7.20 g
0.03 M Carbonate buffer pH 9.6 (Northeast Biomedical Ltd) (1000 ml)
Na2 C03 1.59 g
NaH C03 2.93 g
NaN3 0.20 g
diluted 1:1 with distilled water
10% Diethanolamine buffer pH 9.8 (1000 ml)
diethanolamine 100.0 ml
distilled water 840.0 ml
MgCl2 x 6H20 0.102 g
NaN3 0.200 g
adjust to pH 9.8 with 1 M HC1 (approximately 60 ml/litre
of buffer)
Washing solution for ELISA (1000 ml)
0.15 M NaCl 1000.0 ml
Tween 20 0.5 ml
Serum diluent for ELISA (1000 ml)
0.15 M NaCl 1000.0 ml





sodium citrate 8.0 g
dissolve in 1000.0 ml of water, sterilize by membrane
filtration (0.22 pm) and store at room temperature.
RPMI 1640 medium (500 ml)
tissue culture medium without glutamin. Flow Laboratories,
Order No. 12-602-54.
Fixatives:
10% buffered formalin (1000 ml)
formalin (40% formaldehyde) 100.0 ml
distilled water 900.0 ml
NaH2P04 x 2H20 4.0 g
Na2HP04 6.5 g
Clarke's fixative (1000 ml)
ethanol (96%) 750.0 ml
glacial acetic acid 250.0 ml
Carnoy's fixative (1000 ml)
ethanol (96%) 600.0 ml
chloroform 300.0 ml
glacial acetic acid 100.0 ml
(store in a dark, airtight glass container)
Chapter 3
NEW TECHNICAL DEVELOPMENTS
A. ENZYME LINKED IMMUNOSORBENTASSAY FOR DETECTION OF
ANTI-OVALBUMIN-ANTIBODIES IN MOUSE SERUM
Measurements of serum antibodies by passive haemagglutination with
sheep red blood cells, although a relatively simple and specific
immunological method, has several disadvantages.
The test is dependent upon the availability of fresh sheep red
blood cells, requires extensive washing and time-consuming coating
procedures and the coating process is dependent on the age of the sheep
red blood cells. Test sera have to be absorbed to remove heterophilic
antibodies and serially diluted before testing. A further theoretical
disadvantage is that IgM antibodies agglutinate antigen coated sheep red
blood cells better than IgG antibodies which have a different antigen
coating optimum. Furthermore, it seemed that the reproducibility and
sensitivity in the low titre range was not as good as in medium and high
titre (above 1:1280) sera. Thus, a less time consuming, specificity and
sensitivity improved solid phase enzyme linked immunosorbent assay
(ELISA) was developed. Following the general procedures as outlined in
Voller, Bidwell & Bartlett (1979), chequerboard titrations and
incubation studies were performed to determine optimal concentrations of
antigen, antiserum, enzyme conjugates and substrate.
After setting up the ELISA assay, this newly developed test was
then validated against sera which had already been tested by passive
haemagglu tination.
I. Setting up the anti-ovalbumin-antibody ELISA
Preliminary experiments showed that a macro-ELISA system was
workable but its reproducibility was unsatisfactory. Thus a micro-ELISA
system using microtitre plates (LINBRO, Flow Laboratories) was set up
and the following conditions were tested by chequerboard analysis:
Coating conditions: 4°C for 16 hours, 37°C for 2 hours
Coating concentrations: 0.1, 1.0, 5.0, 10.0 mg ovalbumin/ml in
0.03 M carbonate buffer, pH 9.6
1/50 in doubling dilution steps to 1/6400
0.05% Tween 20 (BDH Limited) in 0.15 M NaCl
0.<2% sodium azide
For 5 hours at room temperature
1/500 - 1/2000
For 16 hours at room temperature
Substrate concentration: 1 mg/ml p-nitrophenylphosphate in 10%
diethanolamine buffer
Each incubation step was followed a washing step which consisted of
three washings with 0.05% Tween 20 in 0.15 M NaCl. The definitive















2 hours at 37°C
1 mg ovalbumin/ml
5 hours at room temperature
1/100
16 hours (overnight) at room temperature
1/1000 (antiserum from Northwest Biomedical Limited)
1/2000 (antiserum from Miles Limited)
Each incubation step was followed by a washing step as indicated
above.
Substrate incubation: Under the above conditions the positive
control hyperimmune serum reached 1.0
absorbance after 30-45 minutes at room
temperature. Absorbance was measured
at 405 nm against a reference wavelength
of 630 nm with an automatic microelisa
reader (Dynatech Limited)
1. Variations of antigen binding to the solid phase
It has been noted that there is an apparent variation in the degree
of antigen absorption to the surface of the wells in different sections
of microtitre plates. ,
Absorbance was tested in empty plates and in plates in which all
wells had been treated uniformly so that each well received the same
dilution of antigen, serum, conjugate and substrate. In repeated
experiments, less than 4% of the A^^ readings within one plate were
outwith one standard error of the mean absorbance reading of the whole
plate, indicating a satisfactory uniform binding.
2. Assay controls ■
Each plate contained wells which received only serum diluent
during each step in the assay. These wells received substrate and were
used as blanks to zero the ELISA reader.
Conjugate controls (ie. wells coated with antigen, conjugate and
substrate, but without serum) were included to determine the*non¬
specific binding of the conjugated antiserum to the antigen coated
wells. In addition, each plate was run with appropriate dilutions of
positive and negative reference sera. Each treatment condition was
assayed in triplicate.
3. Testing for linearity of serial anti-serum dilutions
To investigate whether serum antibody concentrations or the
antimouse antibody enzyme-conjugate were the rate-limiting factors
in this test system, positive and negative reference sera were serially
diluted from 1/100 - 1/102400 and assayed. Figure 3.1 shows an
excellent correlation between reciprocal serum dilutions plotted against
absorbance values (r.995, p<0.001) indicating that the concentration of
antibody enzyme-conjugate was not the rate-limiting factor in the assay
and that the linearity of this assay system covered almost three log
units. Diluting the negative serum beyond 1/100 did not change the
readings significantly. In order to investigate whether the
experimental group characteristics remained stable throughout different
dilutions, titration studies with positive and negative reference sera
were performed. Sera from a group of tolerant mice which had been fed
ovalbumin before immunisation, and of a saline fed, non-tolerant, group
were included.
The results demonstrated that there is no crossover and the
positive/negative ratio (ovalbumin fed vs. saline fed animals) remains
stable, indicating maintenance of group characteristics over a wide
range of anti-ovalbumin antibody concentrations.
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3.1 Test for correlation between serum antibody concentrations and
absorbance at 405 nm (ELISA)
Serum containing anti-ovalbumin antibodies and normal mouse serum
were serially diluted from 1/100 to 1/102400 and the absorbance
recorded at 405 nm. Note the good correlation of the slightly
S-shaped curve over a wide range of serum dilutions. Mean
absorbance readings of the normal mouse serum (+ 3SD) are
indicated by the hatched area.
II. Comparison of ELISA with haemagglutination assay
Before changing to a new test system a comparison between groups
tested with ELISA and the haemaggiutination assay was carried out. 65
sera were tested by haemagglutination and by ELISA tests and the
corresponding means of absorbance values and haemagglutination titres
are plotted in Figure 3.2 and show a good correlation (r = 0.930,
p<0.001).
B. ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) FOR THE
DETECTION OF OVALBUMIN IN MOUSE SERUM
The need for a sensitive, reliable assay system became obvious when
published reports (Warshaw, Walker & Isselbacher 1974, Vaz et al 1977,
Swarbrick 1979, Mowat 1981) not only demonstrated highly variable
amounts of ovalbumin after feeding, but that the amounts detected were
also as low as 2 ng ovalbumin/ml serum one hour after feeding (Swarbrick
1979).
A passive haemagglutination Inhibition test commonly used for
detection of immunoreactive antigen was not likely to yield this
sensitivity as was shown by Mowat (1981) working in the same laboratory.
The detection limit was around 1-3 pg ovalbumin/ml serum.
To achieve the above stated objectives, two different approaches
were pursued. One was based on the principle of a competitive
(inhibitory) ELISA and a further on a direct ELISA (Engvall & Pesce
1978, Voller et al 1979) using protein-A purified (Hjelm, Hjelm &
Soquist 1972) specific IgG-anti-ovalbumin antibody bound to the solid
phase.
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Correlation of readings with passive haemaaalutination titres
(x - SEM) n=65
3.2 Comparison of absorbance readings at 405 nm (ELISA) with
passive haemmagglutination titres
65 sera were tested by the two assay systems and the reciprocal
haemmagglutination titres were plotted against absorbance (405
nm) readings (x + SEM). The figures below the bars indicate
the numbers of sera tested in each group.
I. Direct ELISA ('Sandwich') for measurement of circulating
ovalbumin after feeding
The inhibitory ELISA system did not reach the desired sensitivity
(<20 ng ovalbumin/ml serum) and a different approach was used. To
achieve these objectives, a direct (sandwich type) ELISA was set up in
collaboration with Dr Don Hanson using specifically purified anti-
ovalbumin antibodies of the G-class bound to the solid phase.
II. Isolation of IgG antibodies by protein-A sepharose CL4-B
Rabbit anti-ovalbumin antiserum (Miles Yeda Laboratory) was
purified for G-class antibodies by protein-A sepharose (Pharmacia Fine
Chemicals AB, Uppsala) which is the method of choice for isolation of
IgG-type antibodies (Hjelm et al 1972). For the isolation procedure of
G-class antibodies, the manufacturers instructions (Pharmacia Fine
Chemicals AB, Uppsala) were followed and G-class antibodies were
eluted with 0.3 M acetic acid.
III. Purification of specific IgG anti-ovalbumin antibodies by
affinity chromatography
Ovalbumin specific antibodies are only a minor constituent of the
total IgG antibody fraction even in hyperimmune sera and thus affinity
chromatography with ovalbumin bound to sepharose was used to yield a
preparation of IgG anti-ovalbumin antibodies.
Cyanogen bromide (CNBr) activated sepharose 4B (Pharmacia Fine
Chemicals AB, Uppsala) was used to couple ovalbumin covalently to
sepharose following the manufacturers instructions ('Affinity
chromatrography', Pharmacia Fine Chemicals A3, Uppsala 1979). In short:
1 g of gel (3.5 ml final gel volume) is swollen in posphate buffered
saline pH 7.4 and washed for 15 minutes on a glass filter with 0.003 M
HC1 solution. 10 mg ovalbumin are dissolved in 0.1 M NaHCO^
containing 5 ml of 0.5 M NaCl and then mixed with the gel by end over
end rotation at room temperature avoiding magnetic stirrers.
Unbound material was washed away with the coupling buffer and
remaining active groups were blocked with 1.0 M ethanolamine for 1-2
hours. Non-covalently absorbed ovalbumin was removed by three wash
cycles with the coating buffer. Ovalbumin specific IgG class
antibodies were eluted with 0.3 M sodium isothiocyanate (NaSCN). The
buffer was exchanged by sephadex G-25 (Pharmacia Fine Chemicals AB,
Uppsala) chromatography and elution with 0.15 M NaCl; 0.02% sodium
azide was added to prevent bacterial growth. The concentration of IgG
class ovalbumin specific antibody which was used in the ELISA was 10
pg/ml.
IV. Setting up the ELISA system
The following conditions, which were chosen according to my own
experience and published guidelines (Voller et al 1979), were analysed
by chequerboard analysis.
Solid phase: microtitre plates, polystyrene (LINBRO, Flow




100, 125, 150 pi
1, 10 mg/ml IgG anti-ovalbumin-antibody
solution in 0.03 M carbonate buffer pH 9.6
Coating conditions: 16 hours at 4°C, 2 hours at 37°C
Ovalbumin serum standards: range: 0-10 ng ovalbumin in normal
mouse serum






1/2.5, 1/5, 1/10/ 1/100 with serum diluent
according to standard dilutions
IgG anti-ovalbumin specific antibodies
coupled with alkaline phosphatase by the
glutaraldehyde method (performed by
Northeast Biomedical) 1/500, 1/1000,
1/2000, 1/4000
All plates were washed three times with saline and 0.05% Tween 20
between each incubation step and p-nitrophenylphosphate was used as
substrate (1 mg/ml in 10% diethanolamine buffer). For the final test











10 pg/ml IgG anti-ovalbumin-antibody
in 0.03 M carbonate buffer pH 9.6
2 hours at 37°C
1/10
1/10
specifically purified IgG anti-ovalbumin
coupled to alkaline phosphatase was used at
1/500 dilution
16 hours at room temperature
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1. Test sensitivity
A typical standard curve is shown in Figure 3.3 and the sensitivity
was increased more than ten-fold compared to the inhibitory ELISA. The
detection limit was defined by taking two standard deviations above
the mean absorbance reading of non-ovalbumin containing normal mouse
serum as the lower limit of sensitivity. Thus, taking into account
the day to day variation of the absorbance readings of normal mouse
serum, the threshold of detection varied from 0.3 to 3 ng ovalbumin/ml
serum.
The coefficient of variation within the test was 4.6% (n = 8) and
between tests 9.2%.
C. COMMENT AND DISCUSSION ON NEW TECHNICAL DEVELOPMENTS
The haemagglutination test using antigen coated sheep red blood
cells is a standard and well defined immunological test system.
However, the variation from batch to batch of sheep red blood cells, the
time which is needed to perform absorption, the preparation of the
microtitre plates and performing the dilutions and the lower sensitivity
at lower antibody concentrations, make this test unsuitable for testing
large experimental groups under identical conditions. Thus, ELISA
assays for the detection of ovalbumin and of ovalbumin specific antibody
were developed, extensively tested and shown to give a better
distinction between treatment groups.
It is common practice to present the results of the ELISA test as
A^"' readings or as the ratio of positive/negative group readings
(Voller et al 1979). However, this practice may be criticised and the
optimal presentation of ELISA results would be by giving test results in
nanogrammes of specific antibody/ml serum. In a pilot experiment, I
tested and compared serial dilutions of known amounts of specficially
purified anti-ovalbumin antibody with unknown amounts of ovalbumin
antibody of a mouse hyperimmune serum (Figure 3.4). It can be seen
that the absorbance readings of the mouse hyperimmune serum were
comparable to those obtained when purified IgG class anti-ovalbumin
antibody was added to normal mouse serum. In this thesis all ELISA
results will be presented as individual absorbance readings.
10000 3160 1000316 100 31 6 10 3-16 1 0 -316
ng OVA/ml mouse serum
3.3 Typical ovalbumin-ELISA standard curve
Amounts of ovalbumin (in nanograms) added to normal mouse serum
(logarithmic scale) are plotted against absorbance (405 nm)
readings.
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3.4 Comparison of an anti-ovalbumin hyperimmune serum with known
amounts of specifically purified anti-ovalbumin antibodies of the
IgG-class
Reciprocal serum dilutions and concentrations of specifically
purified anti-ovalbumin antibody/well are plotted against A ^
readings.
I : Purified anti-ovalbumin antibody diluted with serum diluent
II : Hyperimmune serum diluted with serum diluent
III: Specifically purified antibody (as in I) diluted 1/10 with
normal mouse serum before further dilution with serum
diluent.
Chapter 4
ORAL TOLERANCE TO OVALBUMIN AND ITS MODULATION
My first experiments were performed to assure that standard oral
tolerance to fed antigen could be produced in the animal strains
available for the experiments (BALB/c, BDF^,CBA) and that this
phenomenon was consistent, the induction reproducible and the systemic
tolerance specific for ovalbumin.
The intitial protocol (Swarbrick 1979) required a 14 day period
between feeding and immunisation and separate sites of immunisation for
assessment of antibody responses and CMI responses. It is shown in
Figure 4.1 and typical results in Figure 4.2. This protocol was
modified in order to reduce the time scale and to reduce the numbers of
animals required while retaining the capacity to measure the suppressed
systemic immune response.
The final experimental protocol used for the investigation of oral
tolerance was changed as follows:
1. Reduction of the time interval between feeding and immunisation to
seven days;
2. By changing the route of immunisation to footpad immunisation,
the same animals could be assessed for antibodies and CMI
responses, thus reducing the numbers of animals and the variability
of the test system.
The modulation treatments were broadly concerned with increasing T-
help or reducing T-suppression and activating macrophages. The
conditions are shown together with the general protocol in Figure 4.3.
By applying antigen via an aboral route (rectal enema), Peyer's patches,
a privileged site of antigen presentation (Owen 1977), and intraluminal
digestion have been avoided. Finally, the modulating effects of a GvHR







H2O a) 2mg OVA/CFA i.p.
b) 100pg OVA/CFA id.
25mgOVA a) 2mg OVA/CFA i.p.
b) 100pg OVA/CFA id.
mice immunised after a): bled weekly for antibodies
(days 21,2835)
mice immunised after b): tested for systemic DTH at day 35
Initial experimental protocol
The initial experimental protocol required a 14 day interval
between feeding and immunisation. Groups of mice were immunised
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Example: Humoral and cell mediated immunity in ovalbumin-fed
and control animals
Haemagglutinating antibody titres are given on a logarithmic
(log^) scale; footpad increments in millimetres (3 weeks after
immunisation).
A. INDUCTION OF ORAL TOLERANCE TO OVALBUMIN IN
DIFFERENT STRAINS OF MICE
I. Suppression of systemic immune responses
To demonstrate that oral tolerance to ovalbumin is not confined to
a certain strain of mice, BALB/c, BDF^ and CBA mice were treated
according to the general experimental protocol (Figure 4.3) and systemic
immune responses assessed three weeks after immunisation. The results
for repeated experiments in adult female mice are listed in Table 4.4.
They show that the suppression of antibody and CMI responses does not
vary significantly between the different strains of mice, with 70-95%
suppression of antibody responses and 78-96% suppression of CMI
responses.
II. Specificity of systemic tolerance induced by ovalbumin
To confirm that the state of tolerance induced by feeding ovalbumin
was immunologically specific to the fed protein, mice were immunised
with 2 mg of human serum albumin in complete Freund's adjuvant two
weeks after feeding 25 mg ovalbumin and tested one and three weeks
later for antibodies and three weeks later for CMI responses.
Figure 4.5 shows that feeding of ovalbumin did not alter the immune
responsiveness against human serum albumin and that ovalbumin fed mice
exhibited similar antibody and footpad responses to their water fed
controls.
III. Persistence of tolerance to ovalbumin




















footpad test for CMI
o indicate the essential steps which form the basis for all
subsequent experimental protocols
IMMUNOMODULATION
GvHR Graft versus host reaction
CY Cyclophosphamide i.p.
MDP N-acetyl-muramyl-Dipeptide
Immaturity OVA feeds during perinatal period
Colon Colonic OVA adminstration
5-89 mice/experimental group
4.3 General experimental protocol
This graph shows the experimental protocol for the investigation
of oral tolerance and for the effects of immunomodulation. The
day of feeding is assigned "day 1" and all other times indicated
are related to this day.
Table4.4








































































































































































































[] H20 fed U 25mg OVA fed
4.5 Specificity of systemic tolerance induced by feeding
ovalbumin
Anti-human serum albumin antibody responses measured one and
three weeks after immunisation with human serum albumin in
Freund's complete adjuvant in mice fed 25 mg ovalbumin before
immunisation (x + SEM). Systemic delayed hypersensitivity
responses three weeks after immunisation with human serum albumin
with Freund's complete adjuvant in mice fed ovalbumin as above.
Bars represent mean (+ SD) specific footpad increments at 24
hours after challenge with 100 jag human serum albumin (i.d.).
Ovalbumin feeding did not suppress immune responses against human
serum albumin.
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Months after OVA feed
4.6 Persistence of orally induced tolerance to ovalbumin
Serum antibody and CMI responses in BDF^ mice which were fed
ovalbumin or saline at six weeks of age and immunised at various
times thereafter. Immune responses were measured three weeks
after immunisation. Stippled bars indicate the absence of
significant suppression.
a) measured with ELISA










9monthsSAL0.683+0.05 OVA0.598+.048 12months 17monthsSAL OVA SAL OVA0.925+.51 0.690+.23 1.1 1.2
+0.08 +0.06
77% 62% 14% 12% 25% +9%
0.01 0.05 NS NS 0.05 NS
CMIresponses (x+SEM) 0.18+.01 0.02+. 1 0.15+.02 0.011+0.008 0.21+.02 0.046+. 01 0.11+013 0.028+. 08 0.13+017 0.02+19 0.11+015 0.018+. 07 0.12+0 016 0.02+0 12
SuppressionP<
0.001
89% 93% 78% 75% 84% 68% 83%
Experimentaldatwhichfor edtbasisforFigure4.6."6.5months"g oupwasalsoestedbyhaemagglutinationassaydthesuppressionw sotsig ificant(23%,pNS).
persistence of the antigen (Dresser & Mitchison 1968, Nossal & Pike
1980). Tolerance after injection of human gamma globulin affects the
T and B-cell systems differently (Chiller & Weigle 1971, Weigle 1977),
lasting 2-3 months for the B-cell system and approximately 5-6 months
for the T-cell compartment.
Persistence of.oral tolerance to protein antigen has not been
systematically studied and in published reports, tolerance for humoral
responses has persisted for around 60 days (Vaz et al 1977, Ngan & Kind
1978, Challacombe & Tomasi 1980) and for six months in delayed type
hypersensitivity responses (Kagnoff 1978a).
1. Experimental protocol
Groups of age matched female mice were fed ovalbumin or saline on
the same day and immunised with ovalbumin in complete Freund's adjuvant,
.5,1,3,6,9,12,17 months thereafter.
The results are depicted in Figure 4.6 and Table 4.7. They
demonstrate clearly that the humoral immune response is significantly
suppressed over three but less than 6.5 months after feeding, whereas
the CMI responses are still signficantly suppressed 17 months after the
initial feed.
IV. Comment
Since all control animals were age matched, the obtained results
are not likely to have been affected by the reduction of the immune
responsiveness of ageing animals and are due to the intitial treatment.
The results show that T and B-cell compartments are differently
affected as has been demonstrated after intraveneous injection of human
gamma globulin (Weigle 1977, Waters et al 1980). My observations also
show that systemic tolerance induced by antigen feeding is a long
lasting event in BDF^ mice.
B. MODULATION OF ORAL TOLERANCE TO OVALBUMIN BY CYCLOPHOSPHAMIDE
AND A LOW DOSE TOLERISING SCHEDULE
Feeding of antigen to rodents is more likely to induce systemic
tolerance than active immunisation. One way to investigate the
underlying mechanisms of oral tolerance is to modulate the induction
phase by specific immunomodulating treatments and then to assess the
effects of this treatment on oral tolerance.
Cyclophosphamide has been shown to increase CMI responses (Turk,
Parker, Poulter 1972, Lagrange et al 1974) and in the following years
it has been demonstrated that when given before antigen, it prevents the
generation of T-suppressor cells from short lived precursors but does
not affect the mature effector Tq^ or cytotoxic T-lymphocytes
(Rollinghoff et al 1977, L'age-Stehr & Diamantstein 1978). T-
suppressor cells have been confirmed to be more susceptible to active
metabolites of cyclophosphamide than B or T-helper cells (Kaufmann, Hahn
& Diamantstein 1980). Cyclophosphamide has also been shown by Mowat
and Ferguson (1981) to be capable to induce a state of CMI to a dietary
protein. Since suppressor T-cells have been implicated in induction
of oral tolerance by feeding ovalbumin (Richman et al 1978, Ngan & Kind
1978, Miller & Hanson 1979), I wanted to investigate whether
cyclophosphamide pretreatment would abrogate systemic tolerance observed
after feeding. This information would be important for the evaluation
of the immunoregulatory role of T-suppressor cells.
Systemic immunity and local CMI may differ in their susceptibility
to intravenous tolerance induction (Silver & Benacerraf 1974) and they
may therefore be controlled by different regulatory mechanisms which
could be activated in a dose dependent manner.
The results of the long term experiments described in the previous
chapter point in the same direction. Thus the following set of
experiments were designed to give information on the regulation of
humoral and cell mediated immunity and to clarify the potential role of
the T-suppressor cell. Cyclophosphamide was used in a dose of 100 mg/
kg and was administered intraperitoneally two days prior to feeding
of antigen.
I. Experimental protocol and results
The experiments were performed in BALB/c mice according to the
experimental protocol shown in Figure 4.3. Control groups received
water intraperitoneally and orally and further control groups received
water intraperitoneally and were fed 2 or 25 mg ovalbumin. A third
group received cyclophosphamide intraperitoneally and was fed 2 or 25 mg
ovalbumin two days later. After 14 days all groups were immuninised
with ovalbumin in complete Freund's adjuvant.
1. Humoral antibody responses
Figure 4.8 shows the antibody responses 7,14 and 21 days after
primary immunisation for animals which were fed 2 mg ovalbumin before
immunisation. No antibodies were detected at seven days and at 14 days
the ovalbumin fed group showed a suppression of 60% of their antibody
responses (p<0.05). This suppression was partially reversed after
cyclophosphamide treatment. The antibody titres were 2-mercaptoethanol
sensitive and thus presumably of the IgM class.




















4.8 Immunomodulation of oral tolerance by pretreatinent with
cyclophosphamide
Humoral antibody responses in mice which were fed 2 mg ovalbumin
two days after injection of 100 mg/kg cyclophosphamide (see 4.2
and 4.3). There was no suppression of the systemic antibody
responses three weeks after immunisation.
Note a transient suppression of 2-mercaptoethanol sensitive
antibody levels (IgM) after 14 days.
In contrast to the results after 14 days, there was no suppression
of antibody titres detectable in either group after three weeks (Figure
4.8) and mercaptoethanol resistant antibodies accounted for the majority
of antibodies detected.
A different picture was obtained when the animals were fed 25 mg
ovalbumin (Figure 4.9). Although there were no differences in
antibody titres after 14 days, the response of ovalbumin fed mice was
suppressed (93% suppression, p<0.005) after three weeks.
Cyclophosphamide pretreatment partly reversed the suppressive effect of
the 25 mg ovalbumin feed (67% suppression, pNS) and these titres were
not different from control but were significantly higher than in
tolerant animals (p<0.05) (Figure 4.9).
As judged by the evaluation of mercaptoethanol sensitive antibody
responses, animals fed 2 mg ovalbumin had their peak response after two
weeks, and at one week when they were fed 25 mg ovalbumin. At these
times, both doses of oral antigen suppressed the subsequent IgM
(mercaptoethanol sensitive) response compared to controls, 93%
suppression in 25 mg ovalbumin fed animals, (p<0.01) and 60% suppression
in 2 mg ovalbumin fed mice (p<0.05).
Since these antibody titres have been obtained by calculating a
ratio between total antibody titres and mercaptoethanol resistant
were
antibody titres and not measured specifically, the pattern of the IgM
response need to be cautiously interpreted.
On the whole, the results indicate that IgM responses of mice may
be tolerised even by low doses of oral protein while larger amounts are
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4.9 Immunomodulation of oral tolerance by pretreatment with
cyclophosphamide
Humoral antibody responses in mice which were fed 25 mg
ovalbumin two days after injection with cyclophosphamide (100
mg/kg). Seven days after immunisation, 2-mercaptoethanol
sensitive (IgM) antibody levels were suppressed (group 2) and
this suppression was abrogated by cyclophosphamide (group 3).
This effect was not detectable after 14 days. After 21 days IgG
antibody responses were suppressed in group 2 (p<0.005 vs. group
1, p<0.05 vs. group 3). Cyclophosphamide treatment partially
reversed the suppression of these antibody responses observed in
group 2.
IgM responses appeared to be more susceptible to abrogation by
cyclophosphamide pretreatment, although there was great variation
between individual groups.
2. Cell mediated immune responses
Figure 4.10 shows the CMI responses in mice fed 2 or 25 mg
ovalbumin which was assessed three weeks after immunisation by measuring
the specific increase in footpad thickness at 24 hours. The results
illustrate that both doses of oral ovalbumin will suppress a subsequent
CMI response, with 88% suppression (p<0.05) in 25 mg ovalbumin fed mice
and 64% suppression in the mice fed 2 mg ovalbumin (p<0.05) compared to
controls. Cyclophosphamide given to mice fed 25 mg ovalbumin returns
their systemic CMI responses to a value which is midway between the
control and tolerant mice and which is not significantly different from
either group. It is important to note, however, that the mice receiving
cyclophosphamide before feeding 2 mg of ovalbumin have completely normal
CMI responses and show no residual tolerance. Similar results were obtained
48 hours later Figure 4.10, confirming the delayed type hypersensitivity
nature of the reactions measured and the consistency of the tolerant state.
Thus, feeding 2 and 25 mg ovalbumin suppress the CMI responses
significantly.
II. Comment
The results presented here confirm that when the first encounter
with an antigen is by the oral route, a range of different effects on
the systemic immune response may be observed.
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4.10 Immunomodulation of oral tolerance by pretreatment with
cyclophosphamide
Delayed type hypersensitivity responses in mice which were fed
2 or 25 mg ovalbumin two days after injection with
cyclophosphamide (100 mg/kg). Abrogation of tolerance for CMI
was complete in mice which received 2 mg ovalbumin (group 2).
The difference in specific footpad increments was maintained
after 48 hours.
feeding 25 mg ovalbumin two weeks before immunisation will reduce
humoral and CMI responses to ovalbumin. Mice which were fed 2 mg
ovalbumin only showed a suppression of their CMI responses and IgM
responses, whereas IgG antibody levels were unaffected.
Cyclophosphamide partially reversed tolerance induced by feeding 25
mg ovalbumin and completely abrogated the tolerance for CMI found after
feeding 2 mg ovalbumin. The results indicate that systemic CMI is readily
tolerized and that it is completely abrogated by cyclophosphamide, a
finding in line with the theory that tolerance to orally presented antigen
is dependent on the induction of a cyclophosphamide sensitive suppressor
cell system.
The dose dependent suppression of systemic CMI and antibody
responses and the differential effects of cyclophosphamide treatment
suggest that oral tolerance is dependent on several immunoregulatory
factors including T-suppressor cells. Whether these effects are strain
dependent or due to the action of this drug on the immune system alone
will be considered in the next section.
C. EFFECTS OF CYCLOPHOSPHAMIDE ON SYSTEMIC TOLERANCE IN
DIFFERENT STRAINS OF MICE
Having demonstrated that cyclophosphamide given intraperitoneally
two days before antigen feeding, partially reverses the tolerance for
humoral immunity and abrogates CMI tolerance (see previous section) it was
of special interest whether the effect of cyclophosphamide is specific to
BALB/c mice only. Since my original experiments were done in BALB/c mice
and most of the relevant work on oral tolerance was conducted in BDF^
mice, I compared the effects of this drug on systemic immune responses in
these two strains before examining the effects of cyclophosphamide on
induction of local intestinal CMI (see below).
I. Experiments and results
The general experimental protocol (Figure 4.3) was followed and
closely age matched females were injected intraperitoneally with saline or
100 mg cyclophosphamide/kg body weight and fed 20 mg ovalbumin two days
later.
1. Antibody responses two and three weeks after immunisation
BALB/c mice injected with saline showed no detectable antibody
production after 14 days compared to a titre of 2.3 + 0.32 (x + SD) in
the cyclophosphamide treated group. This obvious trend of reversing
tolerance by cyclophosphamide was maintained after three weeks where the
tolerant group reached only 33% (antibody titre 2.4 + .17) of the
antibody responses of the cyclophosphamide treated group (antibody titre
2.92 + 0.13, p<0.001). These results confirm that cyclophosphamide
reverses the humoral tolerance seen after ovalbumin feeding (Figure 4.11).
BDF^ mice showed a different pattern which is demonstrated two
and three weeks after immunisation. Two weeks after immunisation, the
saline injected (tolerant) mice developed a titre of 2.45 + .23 compared
with 2.18 + .34 in the cyclophosphamide treated group. This trend was
maintained after three weeks where the saline injected group exhibited a
titre of 3.22 +0.13 and the cyclophosphamide group again showed a
considerable lower antibody titre (2.84 + 0.31, x + SEM p<0.05 (Figure
4.11).
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4.11 Modulation of oral tolerance by pretreatment with
cyclophosphamide: Effects of cyclophosphamide in different mouse
strains
BALB/c and BDF^ mice were injected with cyclophosphamide, fed
ovalbumin and treated according to the general protocol (4.3).
Antibody responses: Cyclophosphamide reversed the
immunosuppression observed after ovalbumin feeding in BALB/c
animals as previously shown in Figure 4.9 (p<0.001), whereas the
immune suppression in BDF^ animals was further increased
(p<0.05).
CMI responses: Both strains exhibited a similar reversal of
immune suppression after cyclophosphamide treatment (p<0.001).
95.
2. Cell mediated immune responses three weeks after immunisation
BALB/c mice: Cyclophosphamide had a profound effect on CMI
reactions and abrogated the suppression of delayed type hypersensitivity
responses seen after ovalbumin feeding (0.03 + 0.007 mm vs. 0.11 + 0.004
mm; x + SEM, p<0.001; Figure 4.11). The results confirmed that
cyclophosphamide abrogates humoral and CMI tolerance in BALB/c mice.
BDFi mice: As seen in Figure 4.11, BDF^ mice responded to
cyclophosphamide treatment in the same way as did BALB/c mice; the drug
abrogated tolerance for CMI (0.06 + 0.01 mm vs. 0.17 + 0.02 mm; x + SEM,
pCO.001).
II. Comment
An unexpected finding was the demonstration of a difference in
susceptibility to cyclophosphamide treatment in the two strains of mice
tested. This difference affected only the humoral immune responses.
The experiments have been repeated with virtually identical results
by myself and independently by M Pickering (personal communication 1982)
and are in line with published reports (Hanson & Miller 1981). The
reason for this different susceptibility to cyclophosphamide treatment
cannot be given and the results presented are not due to the
experimental design. It seems however possible that the differences
in susceptibility to cyclophosphamide are genetically determined and
evidence along these lines will be discussed later (General Discussion).
D. EFFECTS OF CYCLOPHOSPHAMIDE ON SYSTEMIC IMMUNITY
Although cyclophosphamide is rapidly cleared from the circulation
(Tew and Taylor 1977), it has been found to increase the systemic
immune responses at a later date. It was therefore important to
investigate the effects of cyclophosphamide on systemic immunity at the
time of parenteral immunisation.
I. Experimental protocol and results
In line with the time scale of other experiments, BALB/c mice were
given 100 mg of cyclophosphamide 16 and nine days before immunisation,
whereas BDF^ mice received cyclophosphamide nine days before
immunisation.
I. Humoral antibody and cell mediated responses
Serum antibodies in BALB/c animals immunised 16 days after
cyclophosphamide were measured by passive haemagglutination. Figure
4.12 shows that cyclophosphamide given 16 days before immunisation had
no significant effect on either antibody or CMI responses, although the
humoral responses were slightly suppressed. These minor effects were
consistent, but not significant and observed in the BALB/c and BDF^
animals (Figure 4.13) which were immunised nine days after
cyclophosphamide treatment.
It seems, therefore, highly unlikely that the reversal of oral
tolerance by cyclophosphamide could be explained by a stimulatory
action on the immune system.
II. Comment
Systemic immune responses in animals which were injected with
cyclophosphamide 16 or nine days before immunisation with ovalbumin
suggested that the immune enhancement seen after cyclophosphamide
treatment prior to oral antigen is not dependent on stimulatory effects
on systemic immunity. The results obtained in this series of
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4.12 Effects of cyclophosphamide on systemic immunity
Cyclophosphamide had no effect on antibody or CMI responses if
given 16 days before immunisation. Note that systemic responses
were slightly, but not significantly, suppressed.
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4.13 Effects of cyclophosphamide oil systemic immunity ("ELISA^
Cyclophosphamide had no significant effect on serum antibody or
CMI responses when given nine days before immunisation. Note
that there is a slight, but not significant, reduction of
systemic immunity in both strains of mice (BALB/c, BDFp
(Compare Figure 4.12).
experiments confirm that oral tolerance is abrogated by cyclophosphamide
given two days before oral antigen administration. Divergent effects
effects on the humoral antibody production in different inbred strains
of mice strengthen the theory that humoral immunity and CMI are
controlled by different - not necessarily exclusive - homeostatic
mechanisms involving T-suppressor cells. Furthermore, after
demonstration of these effects, it seems important to take care even in
extrapolating results from one inbred mouse system to another without
carefully assessing the properties of the system in use.
The above findings indicate that comparable states of tolerance
to oral antigen may be controlled by different homeostatic mechanisms.
Phenotypically similar degrees of immunological tolerance have been
observed in animals in which the tolerant state was due to clonal
deletion or active suppression by T-suppressor cells (see:
Introduction). It is conceivable that these two strains of mice differ
in certain immunoregulatory circuits but exhibit phenotypically
identical humoral and CMI responses after oral ovalbumin presentation.
The exact nature of these phenomena remains to be established and
is beyond the scope of this thesis.
E. MODULATION OF ORAL TOLERANCE TO OVALBUMIN BY A GRAFT-
VERSUS-HOST-REACTION (GvHR)
Mice experiencing a GvHR develop a depression of systemic humoral
and CMI responses to sheep erythrocytes (Treiber & Lapp 1976).
Although some lymphoid cells are destroyed during a GvHR, those
immunosuppressed mice still possess antigen reactive cells (Treiber &
Lapp 1973) and they can mount a delayed type hypersensitivity reaction
to different antigens in complete Freund's adjuvant without making an
antibody response. The hypothesis for the underlying mechanism implies
that a population of adherent cells and/or their products (monokines)
exerts a regulatory role on T-helper and T-DTH effector cells (Treiber &
Lapp 1976).
It has also been demonstrated that systemic immunity is enhanced
in the early, initial phase of a GvHR (Davis, Cole & Schaffer 1970).
Because of the profound and well documented immunoregulatory
disturbances in these animals and the experience already gathered with
this animal model in the laboratory (Mowat & Ferguson 1982), I decided
to investigate the effects of a low grade GvHR on the induction of
tolerance to ovalbumin.
By using this animal model of a GvHR which does not induce
mucosal damage, it was feasible to modulate and to investigate the
immune responsiveness after an antigen feed. The important question
whether the modulation of systemic immunity to an antigen may also
induce a local CMI on subsequent antigen challenge will be discussed
later (Chapter 7).
In this section I shall state the relevant findings used as
indicators for assessment of a GvHR and shall discuss mainly the effects
of a low grade GvHR on modulation of oral tolerance.
I. Experiments and results
GvHR was induced by intraperitoneal injection of 6 x 10^ CBA
spleen cells suspended in RPMI 1640 into (CBA x BALB/c) F^ males and
females aged 6-8 weeks. Controls were injected with medium alone. On
day 12 after induction of the GvHR, control animals and mice with a GvHR
were fed 25 mg ovalbumin or saline and treated according to the general
experimental protocol (Figure 4.3). To assess morphological parameters
and whether the GvHR induction was successful in these animals, further
groups of mice, which had received spleen cells or medium on the same
day, were sacrificed 12 and 40 days after GvHR. The animals were
weighed, pieces of jejunum taken for histological examination and the
Spleen Index was calculated after Simonsen (1962).
1. Indicators of a graft-versus-host reaction
All animals remained healthy throughout the experiments. Groups
of animals which were sacrificed 12 or 40 days after GvHR induction
showed a Spleen Index of 2.36 (12 days) and 1.59 (40 days) indicating
substantial splenic hypertrophy.
2. Intraepithelial lymphocyte infiltration
Intraepithelial lymphocyte infiltration counts were increased in
animals with a GvHR (18.2 + 1.1 vs. 10.2 + 0.1, p<0.001) after 40 days.
These parameters taken together (see also Chapter 7) were taken as
evidence that a low grade GvHR had been induced in these mice.
II. Effects of graft-versus-host reaction on oral tolerance
Assessment of the parameters described above revealed that the
animals which showed no signs of disease did have a low grade GvHR
and that changes in the immune responsiveness could reasonably be
attributed to the immunoregulatory disturbance induced by a GvHR.
1. Experimental protocol and results
Mice with GvHR and sham injected controls were fed either saline
or 25 mg ovalbumin 12 days after the initial treatment. Systemic
immunoresponses were assessed three weeks after immunisation with
ovalbumin in complete Freund's adjuvant (as outlined in the experimental
protocol (Figure 4.3)).
(a) Humoral antibody responses
Antibody responses were assessed in mice with or without GvHR which
had been fed ovalbumin. Control animals fed ovalbumin showed a marked
suppression of their antibody responses (2.35 + 0.08 vs. 3.08 + 0.15,
x + SD, 80% suppression, p<0.05). Animals with GvHR exhibited only
46% suppression three weeks after immunisation (3.05 + 0.24 vs. 3.32 +
0.16, pNS) indicating a partial reversal of the tolerisability during
the early phase of a GvHR (Figure 4.14). It is notable that animals
with GvHR exhibited a consistently higher humoral response than their
normal counterparts.
(b) Cell mediated immune responses
The CMI responses were affected in a similar way and animals with
GvHR fed ovalbumin showed only 24% reduction of their footpad swelling
24 hours after challenge (0.21 + 0.02 mm vs. 0.16 + 0.03 mm, pNS)
whereas control animals exhibited 85% suppression (0.20 + 0.02 mm vs.
0.03 + 0.01 mm, p<0.001, x + SEM) which was the usual degree of
suppression (Figure 4.14).
III. Effects of a graft-versus-host response on systemic immunity
The above results show that animals fed on day 12 of a GvHR were
not tolerised by the usual feeding regimen. The relevant measurements
were made at 40 days after induction of GvHR. To gain more insight
into the underlying disturbances in immunoregulation in these animals,
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4.14 Effects of a graft-versus-host response on the induction of
oral tolerance
Serum antibody and CMI responses three weeks after immunisation.
Feeding ovalbumin 12 days after induction of GvHR did not lead
to systemic tolerance.
which led to the partial reversal of oral tolerance, the immuno-
responsiveness on the 12th day after GvHR induction was investigated.
1. Experimental protocol and results
Male and female animals with GvHR and control mice injected with
medium alone were immunised on the 12th day of the GvHR with 100 pg
ovalbumin in complete Freund's adjuvant and humoral immunity and CMI
assessed two and three weeks after immunisation.
(a) Effects of a graft-versus-host reaction on humoral immunity
Mice with GvHR all responded with an increased antibody production
two and three weeks after immunisation. The antibody titre in GvHR
animals two and three weeks after immunisation was 2.54 + 0.2 and 3.66 +
0.19 compared to 2.0 + 0.5 and 2.95+0*36 intact animals (two weeks
p<0.02, three weeks p<0.001, n = 17, x + SD) (Figure 4.15).
(b) Effects of a graft-versus-host reaction on cell mediated
immune responses
CMI immunity was enhanced in a similar way. Control animals
showed a footpad swelling of 0.07 + 0.01 mm, whereas the responses were
increased to 0.12 + 0.01 mm (p<0.005, 77% increase, x + SEM) in mice
with GvHR (Figure 4.15) and this difference was maintained after 48
hours (80% increase, p<0.05) proving the delayed type hypersensitivity
nature of this response.
IV. Comment
Injection of parental spleen cells into unirradiated F^ hybrids
led to a low grade GvHR as assessed by the increased Spleen Index and
mucosal infiltration of intraepithelial lymphocytes.
The GvHR did not lead to overt disease and the animals remained
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4.15 Effects of a graft-versus—host response on systemic immunity
Mice with a GvHR were immunised with ovalbumin and systemic
humoral and CMI responses measured two and three weeks later.
Humoral antibody responses were significantly enhanced at two
(p<0.02) and three weeks (p<0.001). Specific footpad increments
at three weeks were also enhanced (p<0.005).
healthy throughout the experiment. The GvHR had, however, pronounced
effects on the host immune system. Tolerance after feeding ovalbumin
was partially reversed. This was most probably due to the immuno-
stimulatory effects of GvHR since animals immunised 12 days after
induction of a GvHR all showed an enhanced systemic immune response.
This could have been initiated by adherent cell dependent activation of
T-helper/amplifier cells during a GvHR as suggested by Treiber and Lapp
(1976), although the present study was not designed to investigate these
mechanisms.
F. MODULATION OF ORAL TOLERANCE TO OVALBUMIN BY MURAMYL-DIPEPTIDE
Immunostimulatory treatment with the synthetic adjuvant N-acetyl
muramyl-dipeptide has been shown to enhance and suppress systemic immune
responses. The timing of antigen administration in relation to the
adjuvant injection seems to be of crucial importance (Leclerc, Juy,
Bourgeois & Chedid 1979). Muramyl-dipeptide is the simplest structural
unit of bacterial peptidoglycans which is capable of replacing whole
killed bacteria in Freund's complete adjuvant (Chedid, Parant, Parant,
Lefrancier, Choay & Lederer 1977). The primary action seems to be on
macrophages and if administered in close temporal association with
antigen it also has a stimulatory effect on T-helper cells (Leclerc et
al 1979). As do many other adjuvants, it stimulates macrophages and
the production and liberation of monokines which activate B and T-cells
(Fevrier, Birrien, Leclerc, Chedid & Liacopoulos 1978, Pabst & Johnston
1980).
Since an adherent cell population seems to have been responsible
for the reversal of tolerance during a GvHR, I decided to use muramyl-
dipeptide as an immunomodulatory agent because its mode of action is
well defined (Lowy, Bona & Chedid 1977, Leclerc et al 1979, Dukor,
Tarcsay & Baschang 1979) and to get additional information on the role
of adherent cells and T-helper cells during the reversal of tolerance
to ovalbumin.
I. Experimental and protocol results
Following the standard experimental designs, animals were injected
saline or 50 pg muramyl-dipeptide immediately before one half of each
group was fed saline or ovalbumin. After this initial treatment, all
mice were immunised and the systemic immunity tested as outlined in the
general experimental protocol. In this way, not only the effects of
muramyl-dipeptide on the induction of oral tolerance were investigated,
but also the effects on systemic immunity.
1. Humoral antibody responses
Animals injected saline and fed either saline or ovalbumin
demonstrated the anticipated pattern; ovalbumin fed animals showed a
significant suppression of their responses (p<0.01) compared to their
controls (Figure 4.16). Injection of muramyl-dipeptide abrogated
systemic tolerance, non-fed and ovalbumin fed animals showing a similar
antibody response. On the other hand, the adjuvant injected on its own
did not increase the antibody responses in the saline fed control group
(Figure 4.16).
2. Cell mediated immune responses
A similar pattern was found for CMI. The saline injected
ovalbumin fed group demonstrated 88% suppression (0.082 + 0.01 vs.
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.16 Effects of muramyl-dipeptide on the induction of oral
tolerance
Mice were injected with muramyl-dipeptide before they were fed
saline or ovalbumin. All groups were immunised seven days later
and treated according to the general protocol (4.3). Muramyl-
dipeptide abrogated the suppression of serum antibody responses.
Tolerance for CMI responses was also reversed.
0.01 + 0.008 mm, p<0.001, x + SEM), whereas the delayed type
hypersensitivity responses of animals injected muramyl-dipeptide before
feeding ovalbumin were not significantly (30%) suppressed (0.097 + 0.012
mm vs. 0.068 + 0.008 mm, pNS, x + SEM) (Figure 4.16).
11. Comment
N-acetyl-muramyl-dipeptide in saline given at the same time as the
antigen abrogates oral tolerance for humoral and cell mediated immunity,
although the abrogation for CMI was not complete. These effects are
likely to be due to macrophage activation and altered antigen
presentation and/or handling by immunoregulatory cells. Local
intestinal or mucosal factors, such as histological damage are not
likely to be of importance in this respect (see Chapter 7).
G. INDUCTION OF "ORAL TOLERANCE" BY COLONIC ADMINISTRATION
OF OVALBUMIN
1. Questions to be answered
These experiments were performed to investigate two main questions:
1. Are Peyer's patches as specialised and organised lymphoid tissues
necessary for the induction of tolerance after oral administration?
2. What is the role of intraluminal digestion in induction of
tolerance to protein antigens?
The aboral route of administering drugs, for example, by
suppositories, is frequently used in the paediatric age group and
pharmacological effects are obvious, although the absorption is
variable. In radiolabelling and antigen-binding studies, it was shown
that rectally administered heterologous gamma globulin is absorbed in
significant amounts and that a sizeable proportion of it retains its
antigen-binding activity (Nagatomi, Ogita, Okudaira & Mitzushima 1980).
Since uptake of immunoreactive ovalbumin after rectal administration
into the circulation was likely to occur, I decided to investigate the
uptake after oral and colonic administration. This would enable me to
discuss any differences in tolerance to ovalbumin in the light of these
findings.
II. Experimental protocol results
Experiments were conducted in BDF^ mice according to the general
experimental protocol (Figure 4.3) and included orally dosed control
groups. Six out of 16 mice in each group were bled out after 60
minutes and the circulating concentrations of ovalbumin measured with a
direct enzyme immunoassay (see Technical developments, Chapter 3).
1. Circulating ovalbumin after oral or colonic administration
The circulating amounts of ovalbumin after one hour varied
considerably in both treatment groups. The mean amount of ovalbumin
detected in the 'colon' group was 288.0 + 134 ng/ml serum (range 6 -
1122 ng/ml, mean = 0.0015%) and in the 'stomach' group 212.0 + 124
ng/ml (range 13 - 795 ng/ml, mean = 0.00085%) (Figure 4.17).
The detection threshhold of the ELISA test system was 3ng/ml
(Figure 4.17). There were no significant differences and the results
indicate that colonic administration was as effective as judged by the
amount of circulating antigen. If there was any leakage of antigen out
of the rectum due to defecation, it was not significant enough to affect
the overall uptake in comparison to the oral administration.
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4.17 Circulating ovalbumin in the serum after intragastric and
colonic administration
The circulating amounts of ovalbumin in the serum 60 minutes
after administration of 25 mg ovalbumin via the 'colon' or
'stomach' are shown on the left hand side of the graph. The
corresponding ovalbumin standard curve (ELISA) is shown on the
right. The detection threshold was 3 ng ovalbumin/ml serum
and the hatched area indicates the mean (+ 2SD) absorbance
readings of normal mouse serum.
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2. Effects of feeding a concentrated ovalbumin solution on systemic
immunity
The concentration of the standard feeding solution was 100 mg/ml
and the following experiment was performed to establish whether a more
concentrated ovalbumin solution would influence the degree of tolerance
induced by feeding. Oral administration of 25 mg ovalbumin applied
in a concentrated ovalbumin solution (400 mg/ml) in 0.065 ml induced the
same degree of suppression for humoral immunity and CMI as observed
when the same dose of ovalbumin was fed in a 100 mg/ml solution.
Suppression of antibody responses was 80% (3.1 + 0.21 vs. 2.42 + 0.21,
p<0.01, x + SD) and of CMI responses, 86% (0.12 + 0.01 mm vs. 0.017 +
0.01 mm, p<0.01, x + SEM) (Figure 4.18, 'Stomach'group)
3. Effects of colonic administration of ovalbumin on systemic immunity
Animals receiving identical amounts of ovalbumin exhibited profound
tolerance for both antibody and CMI responses. The antibody responses
I
showed a 81% suppression compared to animals which received a saline
enema (3.11 + 0.28 vs. 2.38 + 0.27, p<0.01, x + SD). CMI responses
were suppressed by 75% (0.12 + 0.004 mm vs. 0.03 + 0.009 mm, p<0.01,
x + SEM) (Figure 4.18, 'Colon' group).
III. Comment
A solid and profound state of tolerance was induced by colonic
administration of antigen. Surprisingly, the uptake of ovalbumin after
colonic administration was similar to that observed after oral dosing.
The tolerance for CMI was slightly less profound than that observed
after feeding ovalbumin. Oral contact with ovalbumin contaminated
113.
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4.18 Effects of colonic or intragastric administration of ovalbumin
on systemic immunity
Different groups of mice were given saline or ovalbumin via
stomach or colon seven days before they were immunised and
treated according to the general protocol (4.3). Systemic
hyporesponsiveness was induced after ovalbumin administration in
both groups.
faeces after rectal administration cannot be completely excluded.
However, it seems unlikely that this route of antigen exposure could
have accounted for the observed results. These results indicate that
intraluminal digestion or antigen access via Peyer's patches is not
necessary for the induction of systemic tolerance after enteral antigen
administration. Small lymphoid aggregates scattered throughout the
intestinal tract seem to be effective in initiating the hyporesponsive-
ness after antigen feeding. Furthermore presentation of gut processed
antigen via the circulation to the gut associated lymphoid tissues may
be sufficient to create a hyporesponsive state.
Chapter 5
THE ROLE OF THE GUT IN GENERATING IMMUNOLOGICAL HYPORESPONSIVENESS
As demonstrated earlier, oral tolerance to ovalbumin could be
modulated by various means (cyclophosphamide, GvHR, muramyl-dipeptide).
These treatments resulted mainly in total or partial abrogation of
tolerance. In those experiments where cyclophosphamide has been shown
to abrogate oral tolerance, two main features could have been
accountable for the reversal: 1) the action on rapidly dividing T-
suppressor cell precursors or 2) the effects on the gut epithelium.
Effects of cyclophosphamide on the gut have been well documented
(Ecknauer & Lohrs 1976, Mowat 1981). These , although minor, mucosal
changes on one hand could have led to the alteration of antigen uptake
and to a change in antigen processing. Interference with these
important steps may have led to disturb the balance between the amounts
of immunogenic or tolerogenic protein moieties present after feeding.
Possible effects on either T-cells or intestinal mucosa were
investigated by adoptive transfer of serum which was recovered 60
minutes after feeding of ovalbumin.
In a further series of experiments, the impacts of a severe
intestinal damage and subsequent immunosuppression were investigated.
Irradiation (1000 rad) was used as a tool to modulate the
immunoresponsiveness and to induce intestinal damage of the donor mice
before feeding ovalbumin and retrieving the serum for transfer. In
doing so, it was expected to investigate whether the mucosal changes
after irradiation could lead to qualitative and quantitative differences
of circulating antigen. By transfer of serum from irradiated mice,
wall
one would thus gain more insight into the role of the gut in inducing
tolerance to protein antigens.
A. TRANSFER OF TOLERANCE BY SERUM OF OVALBUMIN FED DONORS
AND THE EFFECTS OF CYCLOPHOSPHAMIDE
I reasoned that it should be feasible to examine the effects of
"gut processsing" on the immunogenicity or tolerogenicity of fed antigen
by comparing the in vivo effects of antigen which had been absorbed
across the gut into the serum of mice, with the effects of
administration of similar amounts of native antigen. A serum transfer
protocol was used in which serum collected one hour after feeding mice
ovalbumin was transferred intraperitoneally into syngeneic recipients
(Figure 5.1). The immunological properties (tolerogenic or
immunogenic) of the antigen in the transferred serum were then assessed
by measurements of humoral and CMI responses in the recipients after a
subsequent parenteral injection of ovalbumin. I also investigated the
site of action of cyclophosphamide in modulating oral tolerance by
separately treating donors and recipients of serum with cyclophosphamide
(Figure 5.1). If it acts at the level of the intestine, pretreatment of
donors should alter immune responses in recipients. If cyclo¬
phosphamide exerts its effect by eliminating suppressor cells in
recipients, this treatment should then alter their immune responses.
I. Experimental protocol and results
The basic immunological protocol is illustrated in Figure 5.1 and
the individual treatment groups are listed in Table 5.2.
1. Serum antibodies in recipients before parenteral immunisation
All recipient mice were bled immediately prior to parenteral
immunisation with ovalbumin in complete Freund's adjuvant. None of the
118.
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skin test for DTH
Serum collected
1hour after feeding
5.1 Schematic diagram of serum transfer experiments
Saline or ovalbumin was fed to untreated or pretreated donors as
indicated and their sera were collected one hour after feeding.
0.8 ml of serum were then transferred (i.p.) into untreated or
cyclophosphamide pretreated recipients which were immunised seven
days later.
Table5.2






























































































sera contained detectable antibodies against ovalbumin.
2. Effects of serum transfer on systemic immune responses of
recipients
Analysis of the results in recipients of serum from water fed
donors (Group A) and ovalbumin fed donors (Group B) showed that serum
transfer had no effect on systemic humoral immune responses, the two
groups having identical antibody levels, both total and mercaptoethanol
sensitive, three weeks after immunisation. Results for a typical
experiment are illustrated in Figure 5.3, Groups A and B. In contrast,
the mice receiving serum from ovalbumin fed donors showed significant
suppression of CMI responses (Figure 5.4, Group B) with 67% suppression
(p<0.02) when compared with mice receiving serum from water fed donors.
This experiment was performed three times with identical results.
3. Effects of cyclophosphamide pretreatment of donors on immune
responses of recipients
The serum from cyclophosphamide pretreated and ovalbumin fed
donors induced a similar degree of tolerance for CMI in the recipients
(Figure 5.4, Group D, 87% suppression when compared with Group C,
p<0.01). Serum antibody levels were identical to Groups A and B
(Figure 5.3).
4. Effects of cyclophosphamide on the immune responses of
recipients
Recipient Groups E and F received cyclophosphamide two days before
serum transfer. As shown in Figure 5.4, this pretreatment abrogated
the immunological tolerance for CMI which was induced when similar serum
was transferred to saline pretreated recipients (Group F compared with
Group B). No significant effects on serum antibody responses were
121.
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5.3 Effects of serum transfer and cyclophosphamide pretreatment of
donors and recipients on serum antibody responses
(Groups A to F)
Serum antibody titres were measured three weeks after
immunisation (x + SD).
Open circles: total IgG titres of water fed controls and in
ovalbumin fed mice (black circles).
Open squares: 2-mercaptoethanol-sensitive antibody titres

































5.4 Effects of serum transfer and cyclophosphamide pretreatment of
donors and recipients on delayed type hypersensitivity responses
in recipients (Groups A to F)
Specific footpad increments three weeks after immunisation (mean
+ SD). Transfer of serum from ovalbumin fed donors suppressed
the response (group B, p<0.05) and cyclophosphamide treatment of
donors had no effect on this suppression (group D, p<0.01).
Cyclophosphamide treatment of the recipients abrogated the
suppression induced by transfer of serum (group F).
found. The titres of antibody in Group F, although consistently higher
than in Group E in three separate experiments, never reached statistical
significance.
5. Effects of parenteral ovalbumin on subsequent immune
responses of recipients
Unpublished experiments with radioimmunoassay (Hanson, personal
communication 1982) and enzyme linked immunoassay techniques (see
Chapter 3, Technical developments) indicated that the amount of
ovalbumin present in serum after feeding was very variable but likely to
be in the range 0.001-1% of the ingested dose/ml mouse serum. Doses of
one, 10 and 100 pg native ovalbumin were administered intravenously or
intraperitoneally into recipient mice which were then immunised
parenterally with ovalbumin in complete Freund's adjuvant and then
tested for systemic immunity in the same way as serum recipients
(Table 5.2, Groups H to L). As illustrated in Figure 5.5, native
ovalbumin used in the doses stated above had no significant effects on
the humoral or CMI responses after subsequent parenteral immunisation
with ovalbumin and adjuvant.
II. Comments
Oral tolerance is abrogated by cyclophosphamide pretreatment, and
the mechanism of abrogation could be either via elimination of T-
suppressor cells or via damage to the gut epithelium. A serum transfer
protocol has been used to examine roles of the gut in processing fed
antigen and to investigate the site of action of cyclophosphamide in
relation to oral tolerance for ovalbumin. Serum collected after
feeding was transferred into syngeneic recipients. Delayed type
t
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Effects of parenteral ovalbumin injections on subsequent
systemic immune responses
Systemic immunity was measured after injection (i.p. or i.v.) of
one, 10 and 100 |ig ovalbumin followed by systemic immunisation
(groups G to L, Figure 5.2). Native ovalbumin injected in the
doses stated above had no effect on humoral or CMI responses.
hypersensitivity responses to ovalbumin in recipient mice were
significantly suppressed whereas humoral antibody responses were not
affected by serum transfer. Cyclophosphamide pretreatment of recipients
(but not of donors) abrogated the immunological tolerance for CMI.
Intravenous and intraperitoneal administration of ovalbumin in doses
from one to 100 pg did not induce immunological hyporesponsiveness.
These results show that, after ovalbumin feeding, humoral and cell
mediated limbs of the immune response are likely to be controlled by
different regulatory systems. Absorption across the gut mucosa leads
to generation of tolerogenic moieties. These tolerogens are stable
upon serum transfer and induce hyporesponsiveness for CMI in recipients.
This is probably achieved by cyclophosphamide sensitive T-suppressor
cells since the effect is completely abrogated by cyclophosphamide
treatment of recipients prior to transfer.
B. TRANSFER OF TOLERANCE TO OVALBUMIN BY SERUM
OF IRRADIATED DONORS
The interrelationship between ionizing radiation and various
aspects of the immune response has been extensively investigated
(Taliaferro, Taliaferro & Jaroslow 1964, Anderson & Warner 1975).
Small lymphocytes are characterised by their sensitivity to irradiation
(Taliaferro et al 1964), small B-cells being more susceptable to damage
than small T-cells (Anderson, Sprent & Miller 1974) with cell deaths
occuring in the interphase of the cell proliferation cycle. Activated
T-cells and T-cells with helper activity are considered radioresistant
when irradiated and tested in vivo (Hamaoka, Katz & Benacerraf 1972).
Thus the radiosensitivity of a specific lymphocyte function probably
reflects the extent of cell proliferation which must precede the
expression of such function (Sprent, Anderson & Miller 1974).
Radiation effects on the intestinal epithelium, which have been
reviewed extensively by Quastler and colleagues (1956,1962), are a
function of cell population kinetics in a cell renewal system (reviewed
by Leblond 1981). Irradiation with 1000 rad or more leads to depletion
of the intestinal epithelium mainly by loss of mature cells. Damage
after irradiation in the proliferative compartment of the crypt section
is seen after 30-60 minutes, the extrusion of cells from the tip of
the villus seems to be blocked for the first 12 hours after irradiation.
Mucosal damage and epithelial renewal in lethally irradiated rodents
lead to villus shortening and crypt lenghthening both of which are seen
after a few days. Full histological recovery of the epithelium is
achieved after 5-7 days in non-reconstituted rodents. Functional
recovery of the epithelium may require up to 17 days (Detrick, Latta,
Upham & McCandless 1963) .
In the following experiments I shall use the model of intestinal
radiation damage as a tool to modulate the immunoresponsiveness of serum
donors after ovalbumin feed in a similar adoptive serum transfer system
as used earlier (Figure 5.1). Using this experimental design I should
gain more insight into the importance of mucosal integrity on the
effects of antigen uptake and processing on the subsequent ability to
transfer tolerance for CMI. These objectives were pursued quantitively
by measuring the circulating amounts of ovalbumin 60 minutes after
feeding and qualitatively by a serum transfer protocol measuring
systemic immune responses.
I. Experiments and results
The experimental protocol was similar to the one used in the
cyclophosphamide study (Figure 5.1) and a standard serum transfer
protocol (Table 5.2, group A-D) was incorporated as internal control.
All studies were conducted concomitantly.
1. Irradiation
Male and female animals received 1000 rad from a 250 Mega volt
orthovoltage X-ray source (Siemens Orthovolt). Mice were housed 6-8 in
a perspex cage and were irradiated at a rate of 38 rads/min (the
irradiation was carried out in collaboration with Mrs Barbara Clarke,
Department of Radiation Oncology, Western General Hospital, Edinburgh),
(a) General health and care of animals after irradiation
Mice were housed in groups of 5-6 in clean cages filled with
autoclaved shavings. To prevent weight losses due to dehydration, a bowl
with wet solid food was placed into each cage. No other precautions
were taken and only two out of 200 mice died within five days after
irradiation.
Two days after irradiation: animals were docile, the coat remained
shiny and although fecal pellets were softer there were no overt signs
of diarrhoea.
Five days after irradiation: animals were docile or lethargic,
dehydrated with a ruffled coat and showed signs of overt diarrhoea.
Weights: mice irradiated two days before showed a slight reduction in
their body weight (26.8 + 3.4 g vs. 30.7 + 3.8 g, p<0.1). There was
a significant drop of weights in animals irradiated five days earlier
(24.1 + .96 g p<0.005).
(b) Uptake of ovalbumin after irradiation and after
cyclophosphamide treatment
Ten mice out of each experimental group were fed saline and
ovalbumin and their serum was individually assayed for circulating
immunoreactive ovalbumin 60 minutes after feeding by using a direct
enzyme immunoassay as described (Chapter 3). The results show that
cyclophosphamide pretreatment did not alter the amount of circulating
antigen compared to saline injected controls (Figure 5.6); 63.7 + 50.2
ng/ml vs. 15.4+3.2 ng/ml serum, pNS, x + SEM). On the other hand it
is evident that.irradiation before feeding ovalbumin increases the
amount of antigen detectable in the serum two days after irradiation:
228 + 162 ng/ml, 5 days after irradiation: 235 + 140 ng/ml, x + SEM)
compared to non-irradiated ovalbumin fed mice (63.7 + 50.2 ng/ml,
x + SEM, see Figure 5.6).
(c) Comment
It is obvious that intestinal damage was induced two and five days
after irradiation. Mucosal injury increased the amount of circulating
ovalbumin. The detection of ovalbumin after feeding has been very
variable and a similar degree of variability in the serum after feeding
has been observed and reported by various other authors (Warshaw et al
1974, Swarbrick 1979, Mowat 1981). Although functional changes in
intestinal physiology after irradiation have been described (Detrick
et al 1963), it remains to be established whether the increased
circulating amounts of a protein found in irradiated mice are due to an
enhanced uptake or to a delayed clearance from the circulation caused,
for example, by impaired lymph drainage or impaired renal clearance.
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5.6 Circulating amounts of ovalbumin detected in serum after
administration of a standard dose (1 mg/g) to normal,
irradiated or cyclophosphamide treated mice
Groups of mice which were irradiated two and five days before
feeding ovalbumin exhibited higher serum ovalbumin concentrations
than saline or cyclophosphamide treated groups. Note that
concentrations are given on a logarithmic scale.
II. Assessment of histological changes at the time of feeding
1. Macroscopic examination:
Two days after irradiation:
On dissection the small bowel was filled with fecal fluid and
showed reddening and stiffening of the intestinal walls. The most
striking feature was a major reduction in Peyer's patches which were
reduced to pin point size. Atrophy of other lymphoid organs was
moderate.
Five days after irradiation:
The small bowel of the dehydrated animals was fluid filled, looking
very brittle, the intestinal walls were thickened and were torn easily
at the attempt of taking specimens for histology. Peyer's patches were
no longer visible and lymphoid atrophy was severe.
2. Histological examination:
Two days after irradiation (Figure 5.7, normal histology;
5.8a,-radiation damage)
There is universal mucosal damage. The villus pattern is
irregular, the villi are shortened, the epithelium is stripping off the
basement membrane and some of the epithelial cells are vacuolated.
The crypts are mostly necrotic, shortened and filled with debris.
The Paneth cells are disrupted and the cell nuclei are swollen. The
Peyer's patch is largely reduced in size and the lymphoid cellular
infiltrate has become very sparse.
Five days after irradiation (Figure 5.8b)
The intestinal damage is patchy with an irregular villus and crypt
pattern and a thinned mucosa. There are hyperplastic crypts and areas
























5.7a Normal jejunal histology (BDF^ mouse)
High power view of intraepithelial lymphocytes (magnification
x500) in normal numbers and in typical position (arrow; same
animal as previous page).
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5.8a Mucosal damage two days
after irradiation (1000
rad)
The normal villus pattern
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propria is reduced and focal crypt cell necrosis is present as
demonstrated after two days. Again, there is no polymorph infiltration.
Many epithelial cells exhibit signs of subnuclear vacuolation. Peyer's
patches are grossly reduced in size, have lost their germinal centres,
their lymphoid infiltration and consist mainly of reticular tissue.
3. Intraepithelial lymphocyte counts
Irradiated animals showed a progressive drop in intraepithelial
lymphocytes from 11.3 + 0.9 in controls to 7.0 + 6.8 (p<0.01) two days
and 4.4 + 0.91, (p<0.01) five days after irradiation (Figure 5.9).
4. Mucosal morphology
Mice irradiated two days before sacrifice showed a decreased villus
length (435 + 39 pm vs. 576 + 41 pm in controls) and crypt length
(94.2 + 8.0 pm vs. 156.8 + 7.1 pm in controls). The villus length had
recovered five days after irradiation (536 + 56 pm) and hyperplastic
crypts showed a significant increase in crypt lengths (323.2 + 28.2 pm,
x + SD, p<0.001) (Figure 5.9).
III. Effects of serum transfer from ovalbumin fed irradiated donors
on systemic immune responses in untreated recipients
1. Experimental protocol and results
By analogy with the general serum transfer protocol (Figure 5.1),
serum donors have either been irradiated (1000 rad) or left untreated.
Recipients were not treated except for one internal control group which
had been pretreated with cyclosphamide to reverse the tolerogenic
effects for CMI after serum transfer, as demonstrated earlier
(Figure 5.4).
(a) Humoral antibodies
As in previous experiments, antibody levels are not affected by
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5.9 Effects of whole body irradiation (1000 rad) on mucosal
morphology
Two days after irradiation villus and crypt lengths were
significantly reduced compared to untreated controls (p<0.01).
Five days after irradiation crypt length was significantly
increased (p<0.01), whereas villus length was restored to normal.
Intraepithelial lymphocyte numbers showed a progressive decline
after irradiation.
transfer of serum from ovalbumin fed donor mice and are shown in
Figure 5.10a.
(b) Cell mediated immune responses
Untreated recipients exhibited a marked suppression of their CMI
responses (0.030 + 0.028 mm vs. 0.105 + 0.017 mm, p<0.001).
Suppression was abolished by cyclophosphamide treatment of recipients.
Delayed type hypersensitivity responses in the group of animals which
received serum from donors fed ovalbumin were slightly enhanced (0.096 +
0.017 mm vs. 0.12 + 0.015 mm, x + SEM, p<0.05) (Figure 5.10b).
Irradiation, either two or five days before transfer of serum abolished
suppression of CMI, which is in sharp contrast to the effects seen after
serum transfer from non-irradiated donors.
Similar to the effects seen with cyclophosphamide, transfer of
serum of both irradiated donor groups evoked slight priming effects in
the recipients:
Two days after irradiation: 0.088 + 0.02 mm vs. 0.11 + 0.02 mm
Five days after irradiation: 0.13 + 0.008 mm vs. 0.14 + 0.03 mm,
x + SEM, pNS) (Figure 5.10b).
IV. Comment
Whole body irradiation caused severe intestinal mucosal damage,
led to lymphoid atrophy with progressive decline of Peyer's patch size
and of intraepithelial lymphocyte numbers. Although the animals were
severely compromised both immunologically and intestinally, the
mortality was only 2/200 which is an index of the clean animal housing
conditions and good animal care.
The increased amounts of circulating ovalbumin found in the serum
























donor treatment: - -
feed: SAL OVA
recipient treatment - -
- - irrad-2 irrad-5
SAL OVA SAL OVA SAL OVA
CY CY - - - -
5.10a Systemic immune responses in BDFj recipients after serum
transfer from irradiated donor mice
Humoral antibody responses.
Serum transfer from irradiated donor mice
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.10b Systemic immune responses in BDF. recipients after serum
transfer from irradiated donor mice
Delayed type hypersensivity responses: CMI responses were
suppressed by transfer of serum from ovalbumin fed donors
(p<0.001). The suppression was abrogated by cyclophosphamide
treatment of recipients (see also Figure 5.4). Irradiation two
and five days before serum transfer (donors) abrogated the
transferable tolerance.
of irradiated mice could have been evidence for either increased uptake
or a decreased clearance, for example, due to obstruction of lymphatics
or to renal impairment. The exact mechanism, however, remains to be
established. All of the above mentioned features are likely to have
interfered with the transfer of tolerance for CMI by serum of irradiated
and ovalbumin fed donors. The next step in elucidating this phenonomen
would be to investigate the effects of immediate reconstitution after
irradiation, and to examine qualitatively the serum of irradiated and
ovalbumin fed mice and to find out whether the hypothetical balance
between immunogenic and tolerogenic fragments has been altered.
Chapter 6
EFFECTS OF AGE ON INDUCTION OF ORAL TOLERANCE
Patients with food allergic diseases exhibit active systemic
immunity to food antigens - implying that instead of oral tolerance,
priming or sensitisation has resulted from previous enteral encounter
with the antigen. The induction of a comparable abnormal immune
responses in animals would provide a model for investigation of this
group of important diseases, and since food allergic disease in humans
is a feature of infancy, there is special interest in defining the
mechanisms which regulate immune responses to fed antigens in neonates.
Immunological tolerance is very readily induced in neonatal animals
when antigen is given by routes other than via the gut. This has been
demonstrated with many different forms of antigen, including allogeneic
cells (Billingham et al 1953, Medawar 1961), skin sensitising agents
(Ptak & Skowron-Cendrzak 1977) and aggregated human gamma globulin
(Etlinger & Chiller 1979). In view of this relative ease of tolerance
induction in the neonatal period it might be expected that oral
tolerance would normally be even more profound and complete in neonates
than in adults. However, in the only report of relevant experiments, in
which the antigen ovalbumin was fed to neonatal mice, Hanson found
priming for subsequent humoral responses, and not oral tolerance (Hanson
1981). The effects of neontal feeding on subsequent CMI responses have
not been described. I have therefore undertaken a series of experiments
to examine how the age of an animal influences specific systemic immune
responses to a fed antigen - resulting in either oral tolerance or oral
sensitisation (priming).
A. EXPERIMENTAL DESIGN AND RESULTS
Experiments were designed to investigate the following
immunological consequences of a feed of either antigen or saline in the
neonatal period:
1. Generation of systemic immunity by feeding.
2. Induction of priming (ie. enhancement of the immune response
to a parenterally administered antigen in animals without
antibody responses or CMI before parenteral immunisation).
3. Suppression (tolerance) of the immune response when antigen
fed animals are compared to controls. Suppression was
calculated by using the following formula:
%suppression = 100 - [response of antigen fed mice x 100]
response of saline fed mice
Animals were fed ovalbumin or saline by intragastric intubation or
by intraamniotic injection 24-36 hours before birth (see Materials and
Methods). Four weeks later, serum was tested for antibodies, and skin
tests were performed to detect CMI responses induced by this initial
treatment (these tests were uniformly negative). All animals were then
immunised with ovalbumin in complete Freunds's adjuvant, usually aged 28
days and systemic immunity tested as before (Figure 6.1).
I. Age of the pups
For defining the age of the pups, the breeding pairs were checked
twice per day (9 am, 5 pm) and litters delivered before 9 am were
assigned a birth date corresponding to the preceding day. Animals
which were treated at day one were placed in experiments on the morning
they were discovered and were thus aged between 16-24 hours.
EXPERIMENTAL PROTOCOL
Systemic immune responses
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Experimental protocol for the investigation of age related
effects on induction of oral tolerance
II. Induction of systemic immunity by feeding
Feeding of antigen did not induce systemic immunity when this was
tested in three separate experiments.
III. Age of animals at the time of immunisation
Due to the experimental protocol and necessary adult control
animals, the age of the animals at the time of immunisation ranged from
four weeks (neonatal feeding experiments) to 16 weeks when the long term
effects of a neonatal feed were investigated. Adult animals ( 4 weeks
of age) were immunised seven days after the initial feed. Nevertheless,
a comparable state of systemic immunisation or tolerance was obtained in
all appropriate controls within the age range described.
B. INFLUENCE OF AGE AT FIRST FEED ON TOLERANCE INDUCTION
These experiments were performed to document the time course of
tolerance induction, to test the observed phenomenon in several strains,
and to confirm a previous report (Hanson 1981) that there is transient
reduction in oral tolerance for antibody when mice are fed antigen
around the time of weaning.
I. Intragastric ovalbumin administration to neonatal, immature
and adult mice
Mice were fed ovalbumin in a weight related dose (1 mg/g body
weight) by intragastric intubation at the ages of one, three, seven, 14
■and 42 days. Animals fed ovalbumin between one and seven days after
birth did not develop oral tolerance. Indeed, mice fed one day after
birth exhibited, repeatedly and consistently, signs of priming both for
antibody responses and CMI (Figures 6.2 and 6.3). Extrapolation from
these data suggest that the crossover to significant tolerance induction
occurs around the tenth day after birth.
II. Effects of ovalbumin feeds at day one on systemic immune
responses in different inbred mouse strains
In order to ensure that the observed priming effect by feeding
antigen on the first day of life was not specific for only one strain,
two other strains of mice (CBA and BALB/c) were also tested. Before
these experiments were started, it had been shown that adult mice of
each of these strains were tolerised to a similar degree by a single
weight related dose of ovalbumin (suppression of humoral responses range
from 69-88% and of CMI 74-93%; see Chapter 4). Feeding of ovalbumin on
the first day of life led to qualitatively similar priming effects for
both systemic antibody and CMI responses in repeated experiments
(Table 6.4).
III. Effects of weaning on the induction of tolerance to ovalbumin
By the time mice were aged 14 days, the magnitude of immunological
suppression produced by a feed of ovalbumin was as complete as in adult
animals. However this pattern was disturbed when animals were fed
during the weaning period. In order to separate the effects of age and
those of weaning, animals were fed ovalbumin or saline on the day of
weaning, and three and seven days on either side of this day. In some
groups weaning was delayed for three days so that animals of identical
Effects of OVA feeds at various ages on subsequent immune
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Effects of ovalbumin feeds at various ages on the subsequent
immune responses of BDF^ mice
% suppression or enhancement of humoral antibody responses three
weeks after immunisation compared to age matched and sham treated
controls. Prenatal (intraamniotic) antigen exposure enhanced
the subsequent immune response (p<0.05).
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Effects of ovalbumin feeds at various ages on the subsequent
immune responses of BDF^ mice
% suppression or enhancement of CMI responses three weeks after
immunisation compared to age matched and sham treated controls.
Prenatal (intraamniotic) antigen exposure enhanced the
subsequent immune response (p<0.05).
Table 6.4
Enhancement of Immune responses in different mouse strains






















a) % enhancement of systemic immune responses compared to saline
fed littermate controls
All animals were immunised four weeks after birth
* p<0.01
age differed only in their weaning date. The results are summarised in
Table 6.5. When mice were weaned at age 21 days and given an ovalbumin
feed on that day, they showed no subsequent oral tolerance for antibody
responses, and less than usual suppression of CMI responses. On the
other hand, littermates weaned three days after feeding, or fed
ovalbumin three days after weaning, showed significant oral tolerance
both for humoral and CMI responses. When there was an interval of
seven days between the day of weaning and ovalbumin feed, oral tolerance
analogous to that found in adult animals, was observed. It is
therefore clear that the transient absence of oral tolerance in these
mice aged 21 days was not age related, but the result of weaning.
C. INFLUENCE OF PRENATAL ANTIGEN EXPOSURE
The following experiments were designed to give "oral" and
"parenteral" antigen in utero, by injecting ovalbumin into the amniotic
sack (feeding) and by using intravenous injection of a pregnant female
as a means of exposing the pups, systemically, to antigen. The
experiments were carried out to examine whether the consistent priming,
observed in animals fed antigen on the first day of life, is increased
after prenatal exposure. These experiments would also give useful
information on the capacity of a mouse foetus of 19 days gestation to
mount antigen specific immune responses after in utero antigen
encounter.
I. Effects of prenatal intestinal antigen exposure
The weight of a mouse foetus on the 19th day of gestation is around
1 g. The foetuses were therefore exposed to 1 mg ovalbumin by intra-
151.
Table 6.5
Effects of ovalbumin feeding on tolerance induction in relation
to age and time of weaning
Age Day of feeding
in relation
to weaning
antibody responses cell mediated immunity
% suppression p< % suppression3^ p<
14 -7 8 70 .02 92 .001
21 -3 10 52 .05 97 .001
21 0 7 28 NS 33 .05
24 +3 8 43 .05 75 .001
28 +7 8 82 .01 90 .001
a) % suppression of systemic immune responses after feeding 1 mg/g
ovalbumin compared to saline fed littermate controls
All animals were immunised with 100 pg ovalbumin in Freund's complete
adjuvant 14 days after feeding
n) Animals per group
amniotic injection in 0.05 ml. Results presented in Figure 6.6 show
that by extending the timescale of feeding experiments into uterine
life, priming of the offsprings was further increased when compared with
the day one fed animals. As the amount of ovalbumin which was in fact
taken up by the foetus could not be exactly measured, the results are
not completely comparable with the effect of closely controlled
postnatal feeds. However, they demonstrate clearly that antigen
administration to foetuses through the amniotic fluid does lead to an
active priming of the immune response and that this effect extends into
adult life.
II. Effects of intravenous ovalbumin injections into pregnant females
on their pups' susceptibility to tolerance induction in later life
Pregnant females were injected with 8 mg ovalbumin intravenously,
24-36 hours before delivery. The subsequently born pups were fed
saline or ovalbumin four weeks after birth. All animals were then
immunised and antibody and CMI responses measured as described earlier.
The results of these experiments (Table 6.7) show that intravenous
ovalbumin injection, in amounts similar to those used for intraamniotic
antigen administration, did not enhance immune reactivity in the pups.
Tolerance induction, produced by protein feeding at the age of 28 days,
was identical in the pups of saline or ovalbumin injected mothers, both for
humoral and CMI responses.
III. Specificity of priming by intraamniotic antigen injection
The priming effects described above have been shown to be antigen-
153.
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6.6 Effects of intraamniotic ovalbumin administration on systemic
immunity compared with controls fed postnatally
Mice being exposed to ovalbumin during foetal life by
intraamniotic injection exhibited significantly enhanced antibody
and CMI responses (p<0.05) when tested at four weeks of age.
Animals fed ovalbumin at day one of life showed consistent,
although not significant, enhancement of systemic immunity.
Adult mice developed classical oral tolerance.
Table6.7
Effectsofintraamnioticda ernalintravenousinjection
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specific since intraamniotic administration of bovine serum albumin did
not lead to enhancement of immune responses against ovalbumin.
D. ATTEMPTS TO TOLERISE NEONATALLY PRIMED ANIMALS
A series of experiments were performed, in order to determine
whether it is possible to modulate subsequent immune responses in
animals which had been given a priming dose of ovalbumin in the neonatal
period. Further feeds of ovalbumin were given to the animals, either in
the first few days of life or in young adult life. Theoretically, this
could have led either to an increase in the priming effect or to
subsequent recreation of oral tolerance. It was particularly important
to examine whether primed animals could be retolerised by one or more
feeding regimens which extended into the period of life where young
animals were usually tolerisable (by age 14 days).
I. Effects of age, frequency and total amounts of neonatal ovalbumin
feed on subsequent immune responses
The different feeding schedules and antigen doses are schematically
summarised in Figure 6.8. Animals were fed ovalbumin or saline on the
first day of life and four or 14 days thereafter. Two groups of
animals were fed daily for four and 14 days. The effect of antigen
dose was examined by feeding the total amount which had been given to
these groups of animals over four or 14 days, in a single dose on the
fourth or 14th day of life. Sham fed control groups were incorporated
into these experiments. They were immunised on the same day as the
relevant experimental groups. For simplicity, the groups have been
identified A to G (see Table 6.9). Group A (one feed, day one),
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6.8 Experimental protocol for testing age-dependant effects of
ovalbumin feeding on systemic immunity
Groups of animals were assigned to three different feeding
regimens as indicated.
Table6.9
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demonstrates that the priming effect of a single antigen feed is still
detectable after two weeks, and Group B (two feeds, day one, day 14)
shows that a single refeed does not reverse this effect. However the
group of mice which was fed daily for the first four days of life (Group
C, four daily feeds) showed suppression of their antibody responses
(p<0.001) and reduced, although not significantly suppressed CMI
responses (p<0.1), whereas mice receiving an identical total quantity of
ovalbumin in a single dose on the fourth day of life (Group D, one feed
day four) showed no suppression of their immune responses - ie. were not
tolerant.
In order to investigate the effects of daily feeds in more detail,
littermates were fed 1 mg/g body weight for 14 days (Group E, 14 daily
feeds) or received the same amount of ovalbumin (50 mg) on one occasion
(Group F, one feed day 14). One feed at age 14 days tolerises an animal
as expected, for both antibody and CMI responses (Group F). However
the same quantity of antigen given in divided doses on day 1 and day 14
of life only suppressed subsequent antibody responses (Group G). When
the same quanity of ovalbumin was split into 14 daily doses (Group E),
animals were subsequently tolerant. This implies that multiple daily
feeds of ovalbumin are more effective than a single feed of the same
total amount in suppression of delayed type hypersensitivity responses.
II. Persistence of priming in animals which were fed ovalbumin on the
first day of life and refed ovalbumin at various times thereafter
Animals were fed ovalbumin on the first day of life and attempts
were made to retolerise these mice by an ovalbumin feed two, four, six,
10 and 14 weeks after the initial treatment. The results are
illustrated in Figure 6.10. Primed antibody responses were found to be
partially suppressable by feeding only two weeks after the initial
priming dose and were indistinguishable from those of tolerant animals
when retolerisation was performed four weeks after the initial
treatment. On the other hand, CMI responses exhibited a striking
disparity in that retolerisation was not accomplished before 14 weeks.
III. Persistence of priming in animals which received intraamniotic
ovalbumin and were refed at age 28 days
Ovalbumin or saline were injected intraamniotically 24-36 hours
before birth and the pups were subsequently fed ovalbumin or saline at
age 28 days (Table 6.11). Results of the 'intraamniotic saline' group
show that this manipulation had no effect on the capacity of the pups to
respond in a normal manner (by oral tolerance) when ovalbumin was fed
at age 28 days. On the other hand, animals which had been exposed to
ovalbumin by intraamniotic injection demonstrated oral tolerance for
serum antibody responses when retolerisation was attempted by feeding
antigen four weeks after birth; tolerance for CMI responses, however,
was not present in the same animals (Table 6.11). These experiments
demonstrate that prenatal antigen exposure had similar effects on
subsequent immune responses as did feeding on the first day of life.
E. COMMENT
Substantial priming effects seen after ovalbumin feeds in the
neonatal period and the failure to induce tolerance by an important
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6.10 Effects of an ovalbumin feed to one day old mice followed by
ovalbumin challenge on their subsequent immune responses compared
with tolerant controls
In slight deviation from the general protocol, animals received
ovalbumin or no treatment on the first day of life and were fed
ovalbumin at various times thereafter. The stippled line
indicates the mean humoral immune response at four weeks. The
hatched bars depict the immune responses of tolerant mice and
results are given as a multiplication factor of the responses of
tolerant animals.
Table6,11
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physiological route of antigen exposure is in striking contrast to the
generally recognised pattern - obtained from animal work - that neonatal
mice are very readily tolerised if the antigen is administered via non-
enteral routes, ie. intravenously, intraperitoneally, intradermally
(Billingham et al. 1953, Chiller & Weigle 1971, Etlinger & Chiller
1979).
The crossover from priming or non-tolerance to tolerance is around
the 10th day of life and the increasing ease of tolerance induction was
briefly interrupted around the time of weaning and was related to the
time interval between weaning and feeding and not to the age of the
animals. My attempts to retolerise initially primed animals showed that
daily feeds of a priming dose for 14 days were capable of retolerising
animals, whereas the same dose fed only twice was not. Furthermore, it
is obvious as shown in Figure 6.10 that systemic humoral antibody
responses are more easily retolerised than systemic CMI responses.
These experiments however did not show and were not designed to reveal
whether the abrogation of oral tolerance would, on the same hand, induce
a local mucosal CMI.
The demonstration of such a connection would be the missing link
for using the neonatal feeding experiments as an animal model to
investigate the mechanisms of food related mucosal changes which can
be induced by antigen feeds in human infants.
Experiments designed to investigate how a mucosal CMI can be
induced and investigated will be described in the next chapter.
Chapter 7
INDUCTION OF MUCOSAL CELL MEDIATED IMMUNITY
A. GRAFT-VERSUS-HOST DISEASE AND INTESTINAL MORPHOLOGY
Billingham and Brent (1957) described a runting syndrome in
neonatal mice which received allogeneic lymphocytes to which they were
unresponsive and, unlike organ grafting, in this case the graft was
reacting against the host.
Diarrhoea and wasting are predominant features (Reilly & Kirsner
1965, Slavin & Santos 1973). The small intestine as important target
organ is altered and villus atrophy with crypt hyperplasia and
necrosis of the mucosa may occur (Reilly & Kirsner 1965, Elson et al
1977). However, a GvHR induced by injection of parental cells in to
adult unirradiated mice only leads to infiltration of the mucosa with
lymphocytes, mast cells and other morphonuclear cells (Guy-Grand et al
1978, Mowat & Ferguson 1982).
Although cell mediated cytotoxicity is a conventional explanation
for the tissue damage which occurs (Singh, Sibadini & Sehon 1972) during
a GvHR,'enteropathic' lymphokine production has to be considered as an
alternative way of mediating tissue damage (Elson et al 1977, MacDonald
& Ferguson 1977, Mowat & Ferguson 1982). Local CMI responses in the
intestine, on the one hand, have possibly a protective effect against
pathogenetic organisms and, on the other hand, are also responsible for
intestinal damage (Ferguson & Parrott 1973, Mowat & Ferguson 1982).
B. CYCLOPHOSPHAMIDE AND INDUCTION OF LOCAL CELL MEDIATED
IMMUNE RESPONSES
It has been demonstrated that cyclophosphamide treatment before
feeding ovalbumin induces a local CMI on challenge with the antigen at
a later date (as assessed by intraepithelial lymphocyte infiltration,
increased crypt length and crypt cell production rates (Mowat & Ferguson
1981)). On the other hand, I have demonstrated that cyclophosphamide
treatment abrogates systemic tolerance. In the work discussed in this
chapter, I first demonstrate that I am familiar with the techniques used
in the following experiments and that I can measure parameters of local
mucosal CMI, for example, induced by a GvHR in neonatal mice. In
addition, I have tested the validity of the experimental protocol by
repeating key experiments reported in the literature (Mowat & Ferguson
1981). Based on the demonstration of various ways of abrogation of
oral tolerance (see Chapter 4), I then investigated whether abrogation
of systemic tolerance does subsequently lead to local CMI on intestinal
antigen challenge.
C. INDUCTION OF MUCOSAL CELL MEDIATED IMMUNE RESPONSES BY A
GRAFT-VERSUS-HOST DISEASE IN IMMATURE ANIMALS
I. Experimental protocol and results
Neonatal BDF^ mice of both sexes received 1 x lO'7 parental
C57BL/6 spleen cells intraperitoneally, whereas age matched controls
received 1 x 10^ syngeneic spleen cells in RPMI 1640 (Table 7.1).
1. General health and development
All animals survived the initial handling. All animals were
weighed every other day and showed a normal development until about 10
days after GvHR induction. Animals having received an intraperitoneal
injection of allogeneic cells developed signs of overt disease indicated
by five deaths (Figure 7.2). Surviving animals were lethargic,
developed diarrhoea and failed to gain weight satisfactorily (p<0.001).
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Table 7.1
Induction of graft-versus-host reaction in neonatal and adult mice
EXPERIMENTAL PROTOCOL:
Neonatal animals (BDF^, males and females):
1st day of life: intraperitoneal injection of 1 x 107 C57BL/6
spleen cells or intraperitoneal injection of
1 x 107 BDF^ spleen cells in controls




Adult animals (aged 6 weeks) (CBA x BALB/c)F. (males and females):
1st day of experiment:
1
intraperitoneal injection of 6 x 107 CBA spleen
cells or intraperitoneal injection of 6 x 10
(CBA x BALB/c)F^ spleen cells in controls




All spleen cells injected were of female donor animals.
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Effects of i.e. injection of syngeneic (BDF,q) or semialloaeneic(C57 BL/6*)
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7.2 Effects of intraperitoneal injection of syngeneic (BDF^) or
semi-allogeneic (C57BL/6) spleen cells on the weight gain of
neonatal BDF^ mice
Crosses indicate deaths of animals after induction of GvHD.
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2. Macroscopic examination on sacrifice
Oil sacrifice, the stomachs of the animals with overt GvHD were
severely distended with milk and the remaining intestine was pale, rigid
and fragile and distended with watery, yellowish, faecal material. The
spleens appeared to be enlarged.
Control animals which received syngeneic cells remained normal.
3. Spleen Index
The visual impression of a GvED on clinical grounds and by spleen
enlargement was substantiated by a Spleen Index of 1.64 which indicated
a significant splenic hypertrophy.
4. Histological examination
The histology of a two week old mouse with GvHD is shown in
Figure 7.3b and compared with a littermate control. The striking
features in the diseased intestine are grossly elongated crypts,
shortened villi with some swollen tips and a general oedema. There
is no acute inflammatory infiltration and the lamina propria is only
sparsely populated. The amount of mucus seems to be increased and
there is some epithelial cell extrusion and cell loss via the villus
tips. Contrasting these findings, the normal neonatal intestine shows
a thin mucosa with short crypts and long, rather regular, villi
(Figure 7.3a).
(a) Intraepithelial lymphocyte infiltration
As anticipated, intraepithelial lymphocyte counts of mice injected
with syngeneic cells did not differ from the non-injected age matched
controls and the mean count per 100 epithelial cells of these animals
(n = 10) was 0.55 + 0.18 (Figure 7.4, x + SD). These numbers differ
significantly from those obtained in adult animals which at six weeks
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7.3a Normal jejunal histolog
of a 15 day old BDF^
mouse
Note the long finger-
shaped villi and short
crypts (magnification:
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had a count of 10.4+1.3 per 100 epithelial cells. Neonatal animals
however which received allogeneic cells showed a signficiant increase of
intraepithelial lymphocytes in their mucosa and the count was raised to
3.1 + 0.5 (p<0.01, n = 5, x + SD).
(b) Mucosal mast cells
Very few mucosal mast cells could be detected in the mucosa under
oil immersion (xlOOO). The distribution of these cells in GvHR was
not obviously different from controls. Because of the scarcity of
mucosal mast cells resulting in a wide scatter, no significant
2
differences were found. The overall mean was 39 mast cells/mm
(n = 12).
(c) Mucosal morphology
Control animals which received syngeneic cells showed no changes
in their villus heights or crypt lengths (villus height: 606 + 38 pm,
crypt length 118.2 + 4.5 pm, x + SD) and the villus/crypt ratio was
normal at 5.1. Animals with GvHR had a reduced villus height of
355 + 80 pm and in increase in crypt length of 185 + 30 pm, thus
reducing the villus/crypt ratio to 1.8 (p<0.001) (Figure 7.4).
II. Comment
By injection of parental cells into neonatal animals at the first
day of life, I was able to induce overt GvHD with significant changes in
intraepithelial lymphocyte infiltration and mucosal morphology. These
results complement the findings of Mowat and Ferguson (1982) who
reported a GvHR in neonatal animals which were injected five to seven
days after birth. In their experiments, induction of a GvHR in five to
seven day old mice did not cause villus atrophy or overt GvHD and they
reported a normal weight gain. It has however to be stressed that they
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7.4 Effects of graft-versus-host disease in neonatal mice on
mucosal morphology and intraepithelial lymphocyte infiltration
used a different strain combination (CBA x BALB/c) and injected
the cells at a later date; the differences reported here are likely to
be due to these facts.
D. INDUCTION AND ASSESSMENT OF GRAFT-VERSUS-HOST REACTION
IN ADULT ANIMALS
Adult CBA x BALB/c animals received 6 x 10^ semi-allogeneic
spleen cells according to the experimental protocol and controls were
treated as indicated in Table 7.1.
I. General health and development
All animals remained healthy during the time of the experiment,
they showed a steady weight gain and in particular did not develop any
signs of diarrhoea.
II. Spleen Index
Animals which were sacrificed on the 12th day after induction GvHR
showed a Spleen Index of 2.25 for females and 2.20 for males, indicating
a signficant splenic hypertrophy. Splenic hypertrophy as assessed by
the Spleen Index was still present 50 days after GvHR induction with
1.78 for females and 1.4 for male CBA x BALB/c mice.
III. Histological findings
1. Intraepithelial lymphocyte infiltration
Examination of histological sections revealed no pathological
changes of mucosal architecture 50 days after GvHR. Intraepithelial
lymphocyte infiltration as an additional measure of an ongoing CMI
still showed a significant increase in diseased animals (19.0 + 1.23)
compared to control animals (10.7 + 0.33, p<0.001, x + SD) (Figure 7.5).
2. Mucosal morphology
Mucosal morphology was unchanged (Figure 7.5).
IV. Comment
Whereas injection of parental spleen cells into one day old
neonates led to an overt GvHD disease with marked changes in mucosal
morphology, injection of parental cells into adult F^ animals induced
a signficant increase in intraepithelial lymphocyte infiltration and no
further mucosal abnormalities. These results were comparable to those
obtained by other investigators in the same laboratory (Mowat 1981).
By obtaining these results I demonstrated that I was familiar with the
microdissection and intraepithelial lymphocyte counting techniques which
have been used in the following experiments. Intraepithelial
lymphocyte infiltration and a raised Spleen Index are the only features
found after GvER induction in adult animals of the above stated strain
combination. Although these animals did not exhibit any signs of
disease, splenic hypertrophy and intraepithelial lymphocyte infiltration
can be demonstrated until 50 days after GvHR induction.
E. EFFECT OF CYCLOPHOSPHAMIDE ON INDUCTION OF MUCOSAL CELL
MEDIATED IMMUNITY AFTER CONTINUOUS OVALBUMIN CHALLENGE
Induction of local mucosal CMI to a dietary antigen has been
demonstrated after abrogation of systemic tolerance by cyclophosphamide
(Mowat & Ferguson 1981). Before investigating the effects of a single
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7.5 Effects of a graft-versus-host response induced in adult
(CBA x BALB/c)F. mice on jejunal morphology and intraepithelial
lymphocyte infiltration 50 days after induction
There was a significant increase in numbers (p<0.001) of
intraepithelial lymphocytes in mice with GvHR after 50 days
although mucosal morphology was unchanged.
low and high dose challenge on intestinal CMI I repeated the experiment
in BALB/c and BDF^ animals.
I. The experimental protocol is outlined in Figure 7.6 and was
followed in all subsequent experiments. Female mice of both strains
were injected with cyclophosphamide two days prior to an ovalbumin or
saline feed, rested for 28 days and then challenged with 0.1 mg
ovalbumin/day in their drinking water.
II. Results in BALB/c mice:
All animals remained healthy throughout the experiments.
1. Intraepithelial lymphocytes: Mice fed saline and then challenged
had normal intraepithelial lymphocyte numbers (10.3 + 0.4) whereas
those fed ovalbumin before challenge had an increased lymphocyte count
of 19.6 + 1.8, X + SD, p<0.01) (Figure 7.7).
2. Mucosal mast cells: Mucosal mast cells were not a major part of
intraepithelial or lamina propria cells in these animals. Their
numbers varied from 0-2 per microscopic (x400) field, i.e. from
0-23/mm of mucosa.
3. Mucosal morphology
BALB/c mice usually have long finger shaped villi of rather uniform
length. Experimental animals having received ovalbumin before
challenge displayed unaltered mucosal architecture with a villus length
of 727.3+33.8 pm, a crypt length of 159.1 + 3.9 pm and a crypt cell
production rate of 6.7/hour (r = 0.940) when compared to 756.2 + 44.5
pm, 160.0 +3.8 pm, and a crypt cell production rate of 8.7/hour
(r = 0.987) as seen in control animals (Figure 7.7).
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EXPERIMENTAL PROTOCOL
Local (mucosal) immune responses
Feed Test Challenge Test
SAL mucosal* 0.1 mg OVA mucosal*
OVA CM I CM I




MODULATION OF THE *mucosal CMI tests : IEL counts
IMMUNE RESPONSE crypt length
CCPR/hour
7.6 Experimental protocol for the investigation of local mucosal
"Immune responses
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7.7 Induction of a local mucosal cell mediated immune response to
ovalbumin after cyclophosphamide treatment in adult BALB/c
mice
Mice which were treated with cyclophosphamide and then fed and
challenged with ovalbumin developed a significant increase in
intraepithelial lymphocyte numbers (p<0.01).
III. Results in BDF^ mice:
1. Intraepithelial lymphocyte counts: Mice fed water before ovalbumin
challenge had an intraepithelial lymphocyte count of 10.6+0.5
compared to 18.0+0.6 (p<0.01) found in animals which were fed
ovalbumin before the challenge (Figure 7.8).
2. Mucosal mast cells: There was no change in the usual low mast cell
count of the lamina propria(0-20/mm ). There was no increase in
granulated intraepithelial lymphocytes or 'atypical' intraepithelial
mast cells.
3. Mucosal morphology: The villi of BDF^ mice were generally
shorter and their length more variable than those of BALB/c animals.
Villus length of the control group was 564 + 71 pm compared to mice
which were fed ovalbumin 528 + 56 pm (pNS). There also were no
differences in either crypt lengths (153 + 4.8 pm vs. 158.7 + 5 pm) or
crypt cell production rates which reached 7.2/hour (r = 0.93) compared
to 7.6/hour (r = 0.99) (Figure 7.8).
IV. Comment
A common and consistent feature in all these experiments was the
signficant rise in intraepithelial lymphocytes after cyclophosphamide
pretreatment and oral sensitisation. These results demonstrate that
changes in mucosal architecture such as increased crypt lengths or
decreased villus heights are not the inevitable consequence of a local
CMI as assessed by increased intraepithelial lymphocyte numbers. By
using a recently established protocol for induction of a local CMI
(Mowat & Ferguson 1981), I failed to observe signicant morphological
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7.8 Induction of a local cell mediated immune response to ovalbumin
after cyclophosphamide treatment in adult BDF^ mice
BDF^ mice developed an increase in intraepithelial lymphocyte
numbers after ovalbumin challenge (p<0.01) similar to that
observed in BALB/c mice (7.7).
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changes, for example, in crypt length and in crypt cell production
rates.
These experiments have been repeated several times with virtual
identical results; a significant rise in intraepithelial lymphocytes
proving a reliable marker of a local CMI. The reasons for the
inability to demonstrate significant morphological changes remain
speculative. Genetic differences in the immune responsiveness cannot
be ruled out and a genetic difference, for example, in immune exclusion,
has been recently demonstrated (Stokes, Swarbrick & Soothill 1983).
Furthermore, a change in the adjuvanticity of the gastrointestinal flora
of the animal stock could have caused these different responses. In
support of this hypothesis, it has recently been reported that
lipopolysaccharides play an important regulatory role during induction
of oral tolerance to sheep erythrocytes (Michalek, Kiyono, Wannemuehler,
Hosteller & McGhee 1982, Wannemuehler, Kiyono, Babb, Michalek & McGhee
1982) and further studies are needed to resolve these interesting
hypotheses.
F. EFFECTS OF CYCLOPHOSPHAMIDE PRETREATMENT AND A SINGLE
OVALBUMIN CHALLENGE ON INDUCTION OF LOCAL CELL MEDIATED IMMUNITY
A continuous 10 day challenge has been shown to increase
intraepithelial lymphocyte numbers in previously sensitised animals.
The following experiments were designed to investigate whether the
responses of the intraepithelial lymphocytes and those concerning
intestinal morphology were qualitatively and quantitively dependent on
the amount of ovalbumin used for a single challenge and on the time
lapse between ovalbumin administration and sacrifice.
I. Experimental protocol and results:
The general experimental protocol (Figure 7.6) was followed and the
challenge was l/10th of the long term challenge dose (100 pg ovalbumin)
or a repeat of the initial sensitising dose of 25 mg ovalbumin.
1. Intraepithelial lymphocytes
The individual results are depicted in Figures 7.9 and 7.10 and
show that even as little as 100 pg ovalbumin and as much as 25 mg
ovalbumin intragastrically administered are sufficient in sensitised
animals to lead to an increase of intraepithelial lymphocyte numbers
24-30 hours after challenge (17.8 + 1-0 and 17.5 + 1.2) compared to a
mean count of 10.8 + 0.5/100 epithelial cells of four non-sensitised
control groups (p<.01).
2. Mucosal mast cells
Mast cell infiltration was sparse and no changes in mucosal mast
cells or atypical intraepithelial mast cells were observed.
3. Mucosal morphology
The results of all groups are shown in Figures 7.9 and 7.10.
There were no significant changes in villus or crypt lengths or crypt
cell production rates.
II. Comment
A consistent feature in this experiment was an increase in
intraepithelial lymphocytes and this seems to be the most reliable,
early marker of a local CMI. A rapid and significant increase in
intraepithelial lymphocytes after ovalbumin challenge was observed even
after 24 hours. The lymphocytic response could be elicited by feeding
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Induction of mucosal CMI to OVA after CY treatment and a
single challenge of 100uq OVA
IEL/100 epithelial cells
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7.9 Induction of mucosal cell mediated immunity to ovalbumin after
cyclophosphamide treatment followed by a single challenge of
100 pg ovalbumin
Those conditions which gave rise to a significant infiltration
of intraepithelial lymphocytes (p<0.01) are outlined. It can
be seen that other mucosal parameters were not affected
(N.D. = not done).
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7.10 Induction of mucosal cell mediated immunity to ovalbumin after
cyclophosphamide treatment followed by a single challenge of
25 mg ovalbumin
Those conditions which gave rise to a significant intraepithelial
lymphocyte infiltration (p<0.01) are outlined.
100 pg or 25 mg of ovalbumin. A similar rapid rise in intraepithelial
lymphocytes within 24 hours has been observed by Mowat and Ferguson
(1982) when they induced a GvHR in one week old mice. My experiments
however show that, following an established protocol for induction of
local CMI by cyclophosphamide, additional characteristic features of a
local CMI such as an increase in crypt length and in cell turnover
and/or a reduction in villus lengths are not always part of this
intestinal immune response. These results further indicate that the
gut associated lymphoid tissue exerts a substantial immunoregulatory
control in preventing morphological changes and that the intestinal
damage seen in local CMI reactions is not an 'all or nothing' phenomenon
but can proceed step by step, a rise in intraepithelial lymphocytes
being the first visible histological change.
G. EFFECTS OF GRAFT-VERSUS-HOST RESPONSE ON INDUCTION OF
LOCAL CELL MEDIATED IMMUNITY TO OVALBUMIN
It was demonstrated earlier (Chapter 4) that a low grade GvHR
partially reversed systemic tolerance when the antigen was fed during
the early (proliferative) phase. The following experiments were
designed to investigate whether induction of an additional local CMI to
a new antigen (ovalbumin) would amplify the histological changes
demonstrated at the beginning of this chapter.
I. Experimental protocol and results
The general protocol (Figure 7.6) was followed; (CBAxBALB/c) F^
mice were fed ovalbumin 12 days after induction of a GvHR, rested for 28
days and then challenged with ovalbumin in their drinking water.
1. The general health of all animals was unaffected throughout the
entire experiment.
2. Spleen Index
The mean Spleen Index was 1.6 (female mice 1.78, male mice 1.4), 50
days after the injection of semi-allogeneic cells and indicated an
effective induction of a GvHR.
3. Histology
(a) Intraepithelial lymphocyte numbers
The results of these counts are depicted in Figure 7.11a. All
experimental groups with GvHR had increased counts regardless of whether
they consisted of water fed and water challenged controls (19.0 + 1.23)
of water fed and ovalbumin challenged (18.9+2.3) or of ovalbumin
sensitised and challenged animals (18.4 + 0.7, intraepithelial
lymphocytes/100 epithelial cells, x + SD).
Control animals had significantly lower (p<0.01) counts of
intraepithelial lymphocytes (10.9 + 0.24; 9.1 + 0.43, x + SD). A
striking feature was the finding of a high proportion of intraepithelial
cells being granulated, the percentage of which was unrelated to the
initial treatment.
(b) Mucosal mast cells and atypical granulated cells
A striking feature of all (CBA x BALB/c) animals was the
abundance of lamina propria and intraepithelial granulated cells, which
comprised normal mucosal mast cells, atypical intraepithelial mast cells
and intraepithelial granulated lymphocytes. Nearly all intraepithelial
lymphocytes were found to be granulated and the mean ratio of non-
granulated/granulated lymphocytes in animals with GvHR was 1.14:1
compared to 1.02:1 (Table 7.12). None or negligible numbers of
187.

















day-12 RPMI RPMI GvHR GvHR GvHR
day 1 H20 OVA H^O H20 OVA
day28-37 OVA OVA H20 OVA OVA
7.11a Effects of a graft-versus-host response on the induction of
a local cell mediated immune reaction to ovalbumin
A GvHR led to a rise in intraepithelial lymphocyte numbers
(p<0.01) and this response was not increased by oral
immunisations with ovalbumin.
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7.11b Effects of a graft-versus-host response on the induction of
local cell mediated immunity to ovalbumin
There were no differences in mucosal morphology or crypt cell
production rates.
Table7.12










































granulated intraepithelial lymphocytes were seen in the parental
strains (CBA females: 0.2 - 0.02/100 epithelial cells; BALB/c
males: 0). Counting the numbers of all astra blue positive cells/mm
mucosa, GvHR animals showed 330 + 11.3/mm compared 338 + 35.4 in
control animals (x + SD) (Table 7.12). Cell numbers in the parental
strains were considerably lower (CBA females 10.3 + 3.6; BALB/c males
17.3 + 0.95/mm^ mucosa).
(c) Mucosal morphology
Villus and crypt lengths as well as crypt cell production rates did
not differ in experimental and control groups as is illustrated in
Figure 7.11b. Villus lengths in the GvHR group were 666 +28.5 pm
(n = 20) compared to 670 + 26.9 pm (n = 11). The crypt length was 153.8
+4.1 pm in the GvHR group vs. 157.4 +7.6 pm in control animals. The
range of crypt cell production rates was 4.1 - 6.2/hour in animals with
GvHR compared to 4.4 - 7.6/hour in control mice. They did not differ
significantly.
II. Comment
Induction of GvHR in adult mice led to an increase in the Spleen
Index and to a rise of intraepithelial lymphocytes without altering the
mucosal architecture as assesed by light microscopy. Attempts to
further sensitise animals for a local CMI to ovalbumin during an ongoing
CMI response did not lead to a further increase of intraepithelial
lymphocytes or to induction of additional mucosal changes in (CBA x
BALB/c) animals. A striking feature of this hybrid generation was
the detection of a high proportion of intraepithelial lymphocytes
demonstrating astra blue positive granules which were well above the
numbers found in both parental strains. This feature was not seen in
the (C57BL/6 x DBA2) generation. Thus in the experiments
described above, a high number of granulated cells was not positively
correlated with a GvHR but rather with the strain of mice investigated.
H. EFFECTS OF MURAMYL-DIPEPTIDE ON THE INDUCTION OF LOCAL
INTESTINAL CELL MEDIATED IMMUNITY TO 0VAL3UMIN
It has been demonstrated in Chapter 4 that the systemic immune responses
to a feed of ovalbumin could be altered by intraperitoneal
administration of muramyl-dipeptide at the time of antigen feeding and
that oral tolerance was abrogated by this treatment. In the following
experiments, I wanted to investigate whether the reversal of systemic
tolerance for CMI could have led - at the same time - to a sensitisation
of the gut associated local immune system.
I. Experimental protocol and results
The general experimental protocol (Figure 7.6) was followed and 50
pg muramyl-dipeptide in saline were injected intraperitoneally
immediately before feeding ovalbumin or saline to the animals. After a
rest of 28 days all animals were challenged with 0.1 mg ovalbumin/day
for 10 days.
1. Intraepithelial lymphcytes
All animals which had been injected saline and fed saline or
ovalbumin (10.7 + 1.6; 10.1 + 0.5, x + SD) or injected muramyl-dipeptide
and fed saline (10.5+1.0, x + SD) had normal counts. However, mice
which were injected with the adjuvant and later fed ovalbumin
demonstrated a much increased number of intraepithelial lymphocytes,
18.7 + 1.6 (x + SD, p<0.001, Figure 7.13.).
2. Mucosal mast cells
There was no change in mucosal mast cell infiltration (0-23/mm
mucosa).
3. Mucosal morphology
Since changes in mucosal morphology were never observed in saline
fed and ovalbumin challenged mice, mucosal morphology was only
investigated in direct comparison of adjuvant injected groups fed either
saline or ovalbumin. There were no difference in these parameters,
villus lengths were 689.3 + 30.4 urn vs. 693.8 + 21 pm, crypt lengths
(134.4 + 3.3 pm vs. 135.2 + 4.0 pm) or crypt cell production rates
(4.7/hour vs. 5.7/hour) (Figure 7.13).
II. Comment
A significant increase of intraepithelial lymphocytes after
muramyl-dipeptide injection and ovalbumin sensitisation indicates an
induction of a local CMI response. The adjuvant on its own did not
raise the number of intraepithelial lymphocytes. It can be assumed that
these effects are due to the immunostimulatory properties of muramyl-
dipeptide (Leclerc et al 1979). The exact mechanisms and whether these
effects are due to the action on macrophages or on a T-helper cell
population (Lowy et al 1977) remains to be established and further
investigation of the still hypothetical modes of action is beyond the


































7.13 Effects of immunomodulation by muramyl-dipeptide on the
induction of mucosal cell mediated immunity to ovalbumin
Immunomodulation by muramyl-dipeptide and oral immunisations with
ovalbumin led to a rise in intraepithelial lymphocytes (p<0.01)
while mucosal morphology remained unchanged.
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I. EFFECTS OF A NEONATAL OVALBUMIN FEED ON LOCAL INTESTINAL
CELL MEDIATED IMMUNE RESPONSES AFTER CHALLENGE
Digestive and/or immunological immaturity in the neonatal period
have been implicated in explaining the mechanism which may sensitise
mice for humoral antibody and CMI responses.
Clinical observations in humans and published direct or indirect
evidence (Firer, Hosking & Hill 1981, Van Asperen, Kemp & Mellis 1983)
indicate that introduction of a new dietary antigen in early life can
lead to an intolerance to these antigens in later life. The following
experiments were designed to address the question whether a neonatal
sensitising feed of ovalbumin would also lead to induction of a local
intestinal CMI on antigen re-exposure in later life. In doing so, this
experimental protocol could serve as a pertinent model for the investigation
of the mechanisms which govern the induction and expression of food related
hypersensitivity diseases.
I. Experimental protocol and results
The experiments were conducted in two inbred mouse strains (CBA and
BALB/c) and the general protocol (Figure 7.6) was followed:
1. CBA strain:
Because of the availability of this inbred strain in the Animal Unit of
the Western General Hospital, Edinburgh, CBA mice were used for the first
experiment of this series.
The control group consisted of age matched, non-saline fed mice under
normal stock keeping conditions.
(a) Intraepithelial lymphocytes
There were no differences found in intraepithelial lymphocyte
195.
infiltration in these two groups (11.7 + 1.2 vs. 9.84 + 0.7)
(Figure 7.14).
(b) Mucosal mast cells
The lamina propria was sparsely infiltrated with mucosal mast cells
(12.7 + 3.6 vs. 10.3 + 3.6 mm^, x + SD, pNS) and granulated cells were
almost entirely confined to this site.
(c) Mucosal morphology
Despite unchanged numbers of intraepithelial lymphocytes, there was a
clear increase in crypt length in the group which was challenged with
ovalbumin (148.4 + 10.8 pm vs. 170.4 + 4.02 pm; p<0.001) with a slight
reduction in villus height (647.5 + 61 pm vs. 558 + 67 pm, p = 0.05). The




Animals which were fed ovalbumin on the first day of life and then
challenged showed a striking increase of intraepithelial lymphocytes (9.3 +
0.7 vs. 14.6 + 2.5, x + SD, p<0.005) (Figure 7.15). These experiments have
been repeated with virtually identical results (11.2 + 1.0 vs. 15.7 +2.1,
x + SD, p<0.01)
(b) Mucosal mast cells
2Mucosal mast cells were found in a range between 10-40 cells/mm
mucosa without sizeable numbers of granulated intraepithelial cells in
any of the experimental groups.
(c) Mucosal morphology
Assessment of morphological features in these groups did not show
significant differences and is summarised below:
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7.14 Effects of a neonatal ovalbumin feed followed by an ovalbumin
challenge in CBA mice
An ovalbumin feed to one day old mice with a subsequent ovalbumin
challenge led to a reduction in villus height (p<0.01), an
increase in crypt length (p<0.01) and in the crypt cell
production rate (p<0.05). There was no change in the numbers of
intraepithelial lymphocytes.
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7.15 Effects of a neonatal ovalbumin feed followed by an ovalbumin
challenge in BALB/c mice
Feeding ovalbumin to one day old mice with a later ovalbumin
challenge led to a significant increase of intraepithelial
lymphocytes (p<0.005).
Day 1 saline fed: villus height 688.3 +46.3 pm
crypt length 148.0 + 2.3 pm
crypt cell production rate 9.4/hr (r = 0.985)
Day 1 ovalbumin fed: villus height 697.2 + 64 pm
crypt length 150.1 +1.6 pm
crypt cell production rate 9.9/hr (r = 0.940)
II. Comment
Both inbred mouse strains tested showed an effect of a sensitising
feed of ovalbumin on the first day of life and responded with
morphological (CBA) or cellular changes (BALB/c) on challenge with the
antigen. CBA mice showed, however, no increase in intraepithelial
lymphocyte numbers, a feature which was uniformly seen in BALB/c
animals. The reason for this discrepancy cannot be satisfactorily
explained by the results presented. The pilot experiments performed
in the CBA strain however could be criticised on the grounds that the
control animals were not sham fed on the first day of life and not
challenged with ovalbumin in their drinking water, as had been done in
all subsequent experiments (see Figure 7.6). It seems however unlikely
that the effect of a sham feed in the neonatal period are still
detectable in adult animals and that ovalbumin incorporated in the
drinking water could have affected the mucosal architecture.
The experiments were repeated in BALB/c animals and an increase in
intraepithelial lymphocytes was a consistent feature. Taking the
presented results together, there is no doubt that an ovalbumin feed in
the neonatal period sensitises for later local intestinal CMI responses.
The expression of the CMI however varies as discussed earlier and may be
dependent on genetically different strains of mice, different
gastrointestinal bacterial flora and may also depend on the timing of




The work of this thesis was designed to investigate factors which
govern the induction and abrogation of orally induced tolerance and to
investigate whether abrogation of systemic tolerance would lead to
concomitant induction of local intestinal CMI. This overall objective
has been achieved. I have been able to abrogate oral tolerance in mice
by pharmacological means, such as Injection of cyclophosphamide and
muramyl-dipeptide prior to enteral antigen exposure. In addition, in
these circumstances a local CMI could be induced on intestinal challenge
with a protein antigen. Ovalbumin feeds during the proliferative phase
of a GvHR did not induce oral tolerance. The role of the gut was
investigated by transfer of serum from recently ovalbumin fed animals,
by colonic administration, and by feeding ovalbumin to neonatal mice.
The results of these experiments lend support to the hypothesis that
antigen processing properties of the gut play a crucial role in the
generation of oral tolerance and that humoral and CMI responses are
controlled by different mechanisms.
A most important finding was that feeding a dietary antigen
perinatally without further immunomodulation primed the animals both for
systemic immunity and local intestinal CMI as measured by lymphocytic
infiltration of the epithelium. I shall first discuss the work
relating to the modulation of oral tolerance and to the role of the gut
in generating systemic hyporesponsiveness. Special emphasis will be
laid on the effects of age on oral tolerance induction. The induction
of mucosal CMI after abrogation of oral tolerance will be discussed with
reference to human pathophysiology and disease.
B. INDUCTION OF TOLERANCE BY FEEDING OVALBUMIN
AND ITS MODULATION
After an initial exposure to a protein antigen by the oral route,
specific secretory antibodies of the IgA class are produced in the gut
mucosa. On the other hand, it is well documented that feeding of
antigen also leads to a state of specific systemic hyporesponsiveness
(oral tolerance) (Thomas & Parrott 1974, Andre et al 1975, Hanson et al
1977, Swarbrick, Stokes & Soothill 1979) and it has been demonstrated
that a secretory antibody response and systemic tolerance may co-exist
(Challacombe & Tomasi 1980). The immunoregulatory mechanisms responsible
for this tolerant state remain controversial and the experiments were
designed to gain more insight into the basic mechanisms in vivo.
Immune suppression may be mediated by antibodies after sheep
erythrocytes administration (Kagnoff 1978 a,b) or by circulating,
presumably IgA immune complexes which are produced after oral
immunisation (Andre et al 1975). Hanson, Vaz, Maia & Lynch (1979),
however, have not been able to demonstrate immune suppression after
transfer of serum of animals tolerised by ovalbumin feeds. In
particular, cellular suppressor mechanisms appear to be important for
maintaining the unresponsiveness after feeding ovalbumin (Miller &
Hanson 1979, Challacombe & Tomasi 1980, Titus & Chiller 1981) or after
feeding sheep erythrocytes (Kagnoff 1978b). Using sheep erythrocytes
and feeding the lysed cells over 4-5 weeks in the drinking water, it was
recently shown that there is evidence for induction of a feedback
suppressor pathway in the spleens of these mice (McDonald 1982) . In
these experiments, antigen feeding appeared to activate a system in
which Lyt 1+ cells can suppress immune responses by causing
normal T-cells to become T-suppressor/effector cells. Furthermore,
this author failed to demonstrate the common, antigen-specific Lyt 2,3+
suppressor cells in the spleen after feeding. Suppressor cells in the
Peyer's patches, generated after oral antigen encounter, have been
demonstrated by Miller and Hanson (1979), by Ngan and Kind (1978) and
Mattingly and Waksman (1978). The latter authors also described
antigen specific helper and suppressor factors produced by spleen cells
of rats fed sheep erythrocytes (Mattingly & Waksman 1980). It is too
early to decide whether these discrepancies are due to experimental
differences (soluble vs. particulate antigens, animal strains, feeding
schedules) or whether the Lyt 2,3+ population in the Peyer's patch
represents a non-circulating T-suppressor cell pool.
Induction of oral tolerance to ovalbumin in different inbred
strains of mice
Induction of oral tolerance by feeding a single dose of ovalbumin
to BALB/c, BDF^ and CBA mice is a stable and antigen-specific
phenomenon as demonstrated in Chapter 4 although one group of
investigators reported the CBA strain to be more difficult to tolerise
than other strains (Swarbrick 1979, Stokes et al 1983).
In trying to reduce animal numbers and costs as well as
experimental time, I decided to immunise animals intradermally into
the footpad. By choosing this route I was able to measure systemic
humoral immunity and CMI in the same animal. The time interval from
feeding to immunisation was reduced from 14 to seven days (Hanson &
Miller 1979). By adapting the experimental protocol as outlined in
Figure 4.3, I achieved the same degree of systemic hyporesponsiveness
and was able to reduce the required animal numbers by half.
Persistence of tolerance
Monitoring the persistence of tolerance for both limbs of the
immune response, I could demonstrate that the T and B-cell systems are
affected differently. A similar observation has been made previously
after intravenous injection of human gamma globulin (Chiller & Weigle
1971, Weigle, 1977). There were no reports of persistence of tolerance
for delayed type hypersensitivity to ovalbumin in an in vivo system.
Tolerance for humoral immune responses has been shown to last for
about 60 days (Vaz et al 1977, Ngan & Kind 1978, Challacombe & Tomasi
1980) and for over six months for CMI responses (antigen: sheep
erythrocytes) (Kagnoff 1978 b). Measuring CMI responses in vivo, I
showed that they were significantly suppressed for more than 17 months
after the initial feed. Since most of the published reports did not
investigate CMI responses in vivo it is not clear whether this
phenomenon reflects differences in the assay systems (in vitro assays
vs. in vivo footpad testing) or indicates a possible existence of a long
lived immunoregulatory circuit for suppression of Tq^ effector cells.
Cell transfer experiments would be an adequate way to answer these
questions.
Modulation of oral tolerance:
Cyc1opho sphamide
It has been argued (Mowat & Ferguson 1981) that an important gut
associated suppressor cell system exists to prevent the induction of
local immune responses in the gut and gut associated lymphoid tissues in
addition to producing systemic tolerance in response to oral antigen.
In the mouse, suppressor T-cells are sensitive to certain doses of
cyclophosphamide (Askenase, Hayden & Gershon 1975, Gill & Liew 1978) and
so cyclophosphamide may be expected to interfere with the generation of
such cells following enteral antigen administration. The experiments
using this drug were designed to investigate whether it might prevent
the state of oral tolerance induced by a single feed. There is only a
single report on the humoral antibody and CMI response in vivo after an
ovalbumin feed to mice (Miller & Hanson 1979) and it is possible that
the two limbs of the immune response may be dissociated. Evidence for
this assumption has also been reported by Neveu and Borduas (1974) after
parenteral antigen administration.
Parallel experiments were performed using 25 and 2 mg ovalbumin as
tolerising procedures, the latter dose being close to the reported lower
limit of tolerogenicity (Vaz et al 1977). Cyclophosphamide treatment
prior to a feed of ovalbumin was used to investigate the role of
suppressor cells and I have chosen a dose of cyclophosphamide within the
range known to inhibit suppressor cells in the mouse when given two or
three days before feeding. The two limbs of the immune response were
affected differently by the two ovalbumin doses fed. CMI responses were
more readily suppressed than humoral antibody responses (Figures 4.8 and
4.10). Furthermore, it is apparent from the work of others that
differences exist even within the humoral reponse itself. There is
evidence to suggest that IgE responses may be more readily suppressed
than IgG responses (Ngan & Kind 1978). No such evidence exists at
present on the relative susceptibilities of the IgM and IgG systems
after orally induced hyporesponsiveness.
Careful interpretation of the antibody results obtained with and
without addition of 2-mercaptoethanol (Figures 4.8 and 4.9) suggest that
IgM production may be more readily suppressed by oral antigen
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administration. In support of this observation, Kagnoff (1978b) has
reported that IgM plaque forming cells are more susceptible to
suppression by repeated feeding of sheep erythrocytes.
The results presented in Chapter 4 indicate a dissociation
between CMI and the antibody responses in their susceptibility to
induction of oral tolerance. CMI was markedly reduced by both doses of
oral ovalbumin, despite unsuppressed antibody levels found in the same
mice (2 mg ovalbumin). In this context the consequences of
cyclophosphamide treatment in ovalbumin fed mice are also relevant. In
mice fed 25 mg ovalbumin, cyclophosphamide treatment returned humoral
and CMI responses to a level midway between control and tolerant mice.
A different pattern however was seen in mice fed 2 mg ovalbumin. In
this case, the markedly suppressed CMI responses were returned to
control levels by the immunomodulating treatment. It has been suggested
previously that oral tolerance may have multiple control mechanisms
(Titus & Chiller 1981, Hanson et al 1979) and the findings support a
system of oral tolerance dependent on several "suppressor" mechanisms
activated by protein feeding. These may include induction of
suppressor cells, functional deletion of helper T-cells and B-cell
inhibition, the activation of these immunoregulatory circuits being
dependent on the dose and quality of antigen presented to gut associated
immune system.
While both suppressor cells or their products (Mattingly & Waksman
1978, Mattingly & Waksman 1980, Mattingly, Kaplan & Janeway 1980) and
serum factors (Andre et al 1975, Kagnoff 1978a, Kagnoff 1980) have been
reported in the unresponsive state following feeding of particulate
antigens, it is likely that suppressor T-cells induced in the spleen
and gut associated lymphoid tissues are responsible for tolerance to
protein antigens (Ngan & Kind 1978, Richman et al 1978, Miller & Hanson
1979, Titus & Chiller 1981). In addition, the induction of tolerance by
feeding contact-sensitising agents to guinea pigs is related to the
appearance of suppressor cells (Asherson et al.. 1977) and is abrogated by
cyclophosphamide treatment (Polak, Geleick & Turk 1975). Thus the
tolerance of CMI responses after a low dose of ovalbumin which was fully
sensitive to abrogation by cyclophosphamide in my experiments suggests
that a suppressor cell mechanism is sufficient to account for the
tolerance of CMI responses induced after small doses of oral protein.
Although, as indicated, there is ample evidence to support the view
that this regime of cyclophosphamide treatment is acting by its effect
on suppressor lymphocytes, it is important to consider the effects that
this drug may have on the ability of the gut to process proteins.
Experiments to address this question will be discussed later.
Effects of cyclophosphamide on oral tolerance in different strains of mice
Having demonstrated that phenotypically the systemic tolerance
observed after feeding ovalbumin was similar in CBA, BALB/c and BDF^
mice, the effects after cyclophosphamide treatment could still have been
different. A report of Hanson and Miller (1982) pointed towards this
possibility. By examining humoral antibody responses, they showed that
cyclophosphamide pretreatment in BDF^ mice did not lead to abrogation
of oral tolerance but rather to an increase in suppression of antibody
responses.
Since the only obvious difference in these two experimental systems
was the strain of mice used, I directly compared the effects of
cyclophosphamide in these two strains. In repeated experiments, it was
shown that tolerance for CHI was reversed in cyclophosphamide treated
animals which had been fed ovalbumin (Figure 4.11). Humoral antibody
responses in BDF^ animals however were lower after cyclophosphamide
treatment, whereas BALB/c mice demonstrated the abrogation of systemic
tolerance as described before. The reason for this consistent disparity
in susceptibility to cyclophosphamide in these two strains of mice is
not clear. One possible explanation is a genetic difference in
cyclophosphamide induced immune suppression and evidence in support of
this possibility has been published by Hurme, Bang & Sihvola (1980).
Effects of cyclophosphamide on systemic immunity
In studying the effects of cyclophosphamide prior to immunisation
(Figures 4.12 and 4.13) it was shown that this treatment did not
significantly influence either antibody or CMI responses and that it
affected both strains in the same way. Thus, the different
immunomodulation observed in BALB/c and BDF^ mice cannot be attributed
per se to a general effect of cyclophosphamide on the immune
responsiveness.
Modulation of oral tolerance by graft-versus-host response
Small intestinal damage is one of the major pathological
consequences of a GvHR in experimental animals and man (Reilly & Kirsner
1965, Slavin & Santos 1973). Mucosal injury may be caused by direct
attack of cytotoxic cells (Singh et al 1972) or by release of
enteropathogenic lymphokines (Mowat & Ferguson 1981) produced by
activated T-cells.
An early sign of a local CMI is an increase in intraepithelial
lymphocytes (McDonald & Ferguson 1976,1977, Guy-Grand et al 1978).
These intraepithelial cells have been shown to be a heterogeneous
population. It consists probably of cytotoxic T-cells (Arnaud-
Battandier et al 1978, Davies & Parrott 1981) NK-cells (Parrott et al
1983) and of cells which carry conventional T-helper and T-suppressor
lymphocyte markers (Selby et al 1981, Lyscom & Brueton 1982). It is
conceivable that these intraepithelial cells, because of their proximity
to the gut associated lymphoid tissues and specialised antigen
presenting structures may also be responsible for modulating the immune
response to fed antigens.
The results demonstrated (Chapter 4) reveal that induction of a
GvHR in adult non-irradiated mice led to a signifant increase of the
Spleen Index and of intraepithelial lymphocytes without affecting
mucosal morphology. In these animals tolerance to ovalbumin was
partially reversed for both limbs of the immune response (Figure 4.14).
In animals undergoing a GvHR, the immune responsiveness after
immunisation with ovalbumin in adjuvant was enhanced, complementing the
findings of Treiber & Lapp (1976). Examining the immune responses after
injection of sheep erythrocytes during a GvHR, they suggest that the
immunological enhancement may be caused by an adherent cell dependent
activation of T-helper/amplifier cells. This activation could have
altered the mode of antigen presentation and/or processing within the
gut associated lymphoid tissues. Whether intraepithelial lymphocytes
play a regulatory role in the immune responses discussed above remains
to be established. In view of the recent findings regarding nature and
immunological functions of the intraepithelial lymphocyte populations
found in rodents (Davies & Parrott 1981, Parrott et al 1983, Lyscom &
Brueton 1983), the exact immunological "raison d'etre" of a raised
intraepithelial lymphocyte count is still a matter of current debate.
Modulation of oral tolerance by muramyl-dipeptide
Investigating further the role of adherent cell populations on the
induction or modulation of oral tolerance to a protein antigen, muramyl-
dipeptide was used as an immunomodulatory agent. It has been shown to
be the simplest structural unit to replace whole killed bacteria in
Freund's complete adjuvant (Chedid et al 1977) and to act mainly on
macrophages by liberation of monokines (Pabst & Johnston 1980).
Reversal of tolerance to ovalbumin after administration of
muramyl-dipeptide supports the hypothesis that macrophage activation and
altered antigen presentation can be responsible for this effect. Since
my interest was mainly focused on the immunomodulatory effects of this
adjuvant, its effects on intestinal morphology have not been
investigated. The rapid clearance of muramyl-dipeptide from the
circulation (Lederer 1980) and the simultaneous application of antigen
and adjuvant make it highly unlikely that morphological alterations
could have caused the observed effects.
Modulation of oral tolerance by colonic administration of antigen
Peyer's patches have generally been regarded as important
immunological sites within the gut associated lymphoid tissues in
regulating the immune responses to ingested antigens (reviewed by Tomasi
1980, Bienenstock & Befus 1980, Walker 1981). Peyer's patches have
been shown to generate T-helper cells for local IgA response and T-
suppressor cells for systemic IgG responses after a single feed of
antigen (Richman, Graeff, Yarchoan & Strober 1981). After continuous
feeding for three weeks, Ngan & Kind (1978) demonstrated T-suppressor
cells for IgG and IgE anti-ovalbumin antibody responses within the
specialised lyphoid tissues of the Peyer's patch. By feeding lysed
sheep erythrocytes for four to five weeks, it was shown that adoptively
transferred Peyer's patch cells suppressed IgA and IgG responses in
vitro leaving IgM responses rather unaffected (McDonald 1982). The
unifying theme of these different reports seems to be that Peyer's
patches are important organs in the generation of local and systemic
immune responses to orally ingested antigen.
Circumvention of Peyer's patches by excision prior to antigen
feeds has not been reported in mice. Operative excision would create
great technical difficulties and also cause physiological disturbances
of the small bowel, for example, due to scarring and altered lymph flow.
Thus I decided to use the rectal/colonic route to avoid these problems.
The results presented in Chapter 4 demonstrate that colonic
administration of ovalbumin induces a profound state of systemic
tolerance similar to the tolerance observed after oral feeding. These
findings suggest that organised lymphoid follicles (Peyer's patches) are
not necessary for the induction of oral tolerance and indicate that
intraluminal digestion in the small intestine is not necessary either.
There are however small lymphoid follicles in the colon (Kealey 1976)
and the presentation of antigen to this part of the gut associated
lymphoid tissue is sufficient to induce "oral tolerance". It is
theoretically conceivable that the tolerising effects could have been
due to ingestion of ovalbumin contaminated faeces after the enema.
There was however only unsignifleant leakage and mice were carefully
monitored for the first hour and faeces were immediately removed to
avoid any oral contact. Thus it seems unlikely that the reported
effects are due to the intake of ovalbumin contaminated faeces.
C. ROLE OF THE GUT IN GENERATING ORAL TOLERANCE
As demonstrated in experiments reported in Chapter 4, oral
tolerance was abrogated in mice pretreated with cyclophosphamide. It
was postulated that this modulation was related to the effects on T-
suppressor cells (Rollinghoff et al 1977). However, since
cyclophosphamide also acts on rapidly dividing enterocytes it is equally
possible that the modulation of oral tolerance by cyclophosphamide was
due to alteration in digestion or processing of protein antigens by the
gut. Experiments to transfer tolerance by serum of fed donors were
designed to investigate these possibilities.
The transfer of tolerance by serum from protein fed mice has not
previously been reported. In mice fed repeated doses of sheep
erythrocytes, the tolerogenic factors described in serum, all appear to
reflect immune responses of the animal to the fed antigen (Andre et al
1975, Kagnoff 1978b, Kagnoff 1980).
In the interpretation of their experiments on the induction of
tolerance to oxazolone, Asherson, Perera and Thomas (1979) suggested
that differences in the quantity of systemically available antigen could
account for the contrasting effects of oral and parenteral
administration of antigen. However it is unlikely that results in my
experiments are due to the amount of ovalbumin absorbed since parenteral
administration of over a wide range of antigen doses had no tolerising
effect on the immune responses of recipients. It is more likely that the
tolerogenic properties of the serum from protein fed mice are related to
physico-chemical alterations of the protein occurring in the intestine.
After feeding ovalbumin, large amounts of highly deaggregated antigen
are found in the serum (Swarbrick 1979) and deaggregated proteins are
known to be extremely effective in inducing both oral and parenteral
tolerance (Vives, Parks & Weigle 1980, Parks & Weigle 1980b). It has
also been shown, using bovine serum albumin, that in vitro proteolytic
digestion produces protein fragments which are tolerogenic in vivo,
possibly via suppressor cell activation (Dosa et al 1979, Muckerheide,
Pesce & Michael 1981, Ferguson, Peters, Reid, Pesce & Michael 1983).
Although I have not yet elucidated the nature of circulating
immunoreactive ovalbumin after feeding, the results of the experiments
are consistent with the hypothesis that tolerogenic forms of protein are
produced in vivo after digestion and absorption of protein antigens in
the gut, and that these are important in the induction of tolerance.
A striking finding in these experiments has been that transfer of
serum from ovalbumin fed donors into naive recipients had no suppressive
effect on subsequent systemic humoral immunity of recipients, but did
lead to tolerance for CMI. I have found that these two limbs of the
immune response differ in their susceptibility to tolerance induction
(Chapter 4) by feeding different doses ovalbumin; a low dose of
ovalbumin suppressed CMI but not antibody responses. These experiments
confirm that there are likely to be more than one regulatory factor
involved in modulation of systemic immunity after feeding protein
antigens. The tolerance for systemic CMI after feeding ovalbumin was
abrogated by cyclophosphamide so was the tolerance for CMI which was
observed in recipients of serum from ovalbumin fed mice. The
unequivocal observation that cyclophosphamide pretreatment of donors did
not alter the tolerogenic properties of serum obtained after feeding is
strong evidence to support the hypothesis that the effects of
cyclophosphamide on immune responses to fed ovalbumin are not due to
associated changes in the intestinal mucosa but that the induction oi
oral tolerance for CMI in mice fed ovalbumin is due to a population of
cyclophosphamide-sensitive suppressor T-cells which are activated by
protein moieties generated within the mucosa of the gastrointestinal
tract. In the intact animal, dietary antigens will presumably interact
primarily with the suppressor T-cells which other workers have
identified within the gut associated lymphoid tissue (Mattingly &
Waksman 1978, Richman et al 1978). Parenteral administration of
intestinally processed protein produced a state of tolerance for CMI
which was identical to the suppression observed after enteral encounter.
For this response, it seems to be not essential for the antigen to
meet the regulatory cells of the gut associated lymphoid tissues via the
intestinal epithelium. The latter route of antigen access and
availability within these structures may be of importance for
suppression of systemic humoral response. The results underline the
close association of absorptive and immunological functions of the
intestinal tract, in regulating immune responses to dietary proteins.
Transfer of tolerance by serum of irradiated donors
In a further attempt to investigate the role of the gut in
generating systemic hyporesponsiveness, lethal (1000 rad) whole body
irradiation was used as a tool to alter the mucosal integrity and
immunological responsiveness by modulating the antigen processing and
handling abilities of the gut.
The histological changes after irradiation are shown in
Figures 5.8 and 5.9 and show profound crypt hyperplasia, villus atrophy
and loss of intraepithelial lymphocytes confirming earlier reports
(Quastler 1962).
An unexpected finding was the abrogation of transferable tolerance
for CMI by irradiation of the serum donors. These findings are novel
and experiments are under way to investigate the effect of immediate
spleen cell reconstitution on transferable tolerance in this system.
Hanson and Morimoto (1982, personal communication) were unable in a
different experimental system, however, to induce tolerance in lethally
irradiated BDF^ animals which were reconstituted and fed within two
days after reconstitution. They hypothesise that this might have been
due to insufficient interaction between transferred cells and absorbed
ovalbumin.
In the adoptive transfer system I used, absence or reduced
availability of tolerogens could be due to the effects of irradiation on
the antigen processing capacity of the gut. Although Bennet, Chastani,
Decker & Mead (1951), using radioiodinated human serum albumin,
demonstrated that whole body irradiation (600 rad) of mice did not
change the rate of protein absorption from the small intestine, I could
demonstrate the circulating amounts of antigen in the serum of
irradiated animals were higher than the levels detected in non-
irradiated controls. It seems that the overall availability of antigen
is not the key factor in transferring tolerance for CMI but rather the
balance of circulating tolerogens and immunogens. Again, as in the
serum transfer experiments, humoral antibody responses were not
suppressed but rather primed stressing the fact that CMI and humoral
antibody responses are under different immunoregulatory control.
Further experiments investigating the the effects of irradiation
with or without reconstitution prior to feeding are necessary to
elucidate the intriguing underlying mechanisms which tilt the
immunoregulatory balance from tolerance to sensitisation and to answer
the question why antibody responses are not suppressed by this
treatment.
D. EFFECTS OF AGE ON INDUCTION OF ORAL TOLERANCE
Feeding of a weight related dose of ovalbumin to adult mice
consistently produces tolerance. I have, however, demonstrated that
when an equivalent dose is fed to neonatal mice within the first week of
life, oral tolerance does not occur (Chapter 6). Furthermore, animals
fed on day one of life were primed, and when foetuses were exposed to
antigen via intraamniotic administration, an even greater priming of
subsequent systemic immune responses occurred. These results confirm
and extend one previous report (Hanson 1981) that a single feed of
ovalbumin to mice on the first day of life primes for subsequent
antibody responses. I attempted to modulate this priming phenomenon in
two ways - by a retolerisation feed and by varying the antigen dose and
frequency of administration. The priming effects persisted for several
weeks but it proved possible to create a state of tolerance for systemic
antibody responses by another tolerising feed four weeks after the
neonatal feed; for CMI, however, the state of non-tolerance persisted
for 14 weeks (Figure 6.10). In addition, I demonstrated that several
daily doses of antigen (starting on day one) induced tolerance whereas
the same total dose fed on a single occasion did not (Table 6.9).
Failure to induce tolerance by an important physiological route of
antigen exposure is in striking contrast to the generally recognised
pattern that neonatal mice are very readily tolerised by antigen given
by other routes (Billingham et al 1953, Chiller & Weigle 1971, Titus et
al 1981). It has been reported that a feed of human gamma globulin
tolerises neonatal mice, which contrasts the priming effect observed
after feeding ovalbumin (Hanson 1981) and this was interpreted to be a
dose related phenomen. Human gamma globulin is however an atypical
substance to use as an antigen for investigating immune responses to
dietary antigens, in view of its preferential absorption and handling by
the neonatal gut (Brambell 1966, Morris 1968). The development of the
small intestine in baby mice occurs in stages with a rapid series of
changes around the time of weaning in the third week of life. The
immunological effects of fed antigen also follows an age related pattern
with the change from non-tolerance to tolerance at about 10 days. This
is before closure (Morris 1968, Walker 1979), brush border enzyme
development (Ferguson, Gerskovitch & Russell 1973), intraepithelial
lymphocyte and plasma cell infiltration of villi (Ferguson & Parrott
1972). On the other hand, the organised lymphoepithelial organs
including Peyer's patches are already populated by T-cells three to four
days after birth (Joel, Hess & Cottier 1971, 1972). Thus there are no
clear connections between changes in in vivo immune effects and the well
established patterns of enterocyte and lymphoid maturation of the gut.
The general pattern of increasing ease of tolerance induction after 10
days of age was briefly interrupted around the time of weaning. This
was related to the weaning and feeding interval and not to age. At
weaning there is not only exposure to many new dietary antigens, but
also withdrawal of maternal milk and changes in gut flora. All of
these are candidate mechanisms for the temporary reduction of tolerance
I observed. The factors responsible for neonatal priming may be the
same as those operative around weaning, or there may be entirely
different mechanisms involved in the specific perinatal patterns of
immune responsiveness of mice.
Experiments in adult mice have shown that several different
immunological mechanisms are involved in oral tolerance as discussed
earlier. Immaturity of any of these immunological functions could
explain the absence of oral tolerance, and the priming effect produced
by feeding neonates and foetuses. Nevertheless, it is known that the
foetus responds to antigenic stimuli, can be immunised prior to birth
(Cramer, Kunz & Gill 1974), and that foetal or neonatal cells can act as
adult cells when they are transferred into an adult environment
(Dixon & Weigle 1959). It has been established that there exists in
neonatal, but not in adult mice, a population of nonspecific suppressor
cells (review: Murgita & Wigzell 1981; Stephenson, Dorsch, Roser, Godden
& Herbert 1983). It seems unlikely that these have a role in perinatal
priming but this is still conceivable in view of the complex T-T cell
interactions involved in an orderly immune response. Hanson (1981)
produced evidence that priming for antibody responses in the neonate is
due to direct effects of antigen on B-cells. However since I have
shown effects on systemic CMI too, there must also be direct or indirect
T-cell involvement.
The immunological effects of feeding in the neonatal period may,
however, be unrelated to the state of maturity of the lymphoid system.
It is equally possible that immaturity of the neonatal digestive and
absorptive functions is the key factor (Clark 1959). The permeability
of the neonatal gut to macromolecules is increased, as, for example,
demonstrated by high concentrations of serum antigen after feeding
(Warshaw, Walker & Isselbacher 1974, Eastham, Lichauco, Grady & Walker
1978). Although the quantity of a circulating antigen may be important,
immunochemical properties and characteristics of absorbed antigen may
be equally relevant. Deficiency in the digestive functions of the gut
may yield antigenic moieties which are more immunogenic than normal,
instead of generating tolerogenic fragments (see above). It has also
been shown that in vitro digestion of bovine serum albumin leads to
generation of both tolerogenic and immunogenic fragments (Dosa et al
1979), and so it is conceivable that disturbances in the digestion of
ovalbumin are an explanation for the unusual immune responses observed
after feeding this antigen to the newborn rodent.
A working hypothesis to explain the findings of these series of
experiments has to take into account digestive and immunological
functions, and the fact that there are differences in the pattern of
retolerisation for antibody and CMI responses. Based on published
reports and my own experiments, I suggest that an area of intestine
generates antigenic moieties which stimulate a T-inducer/helper cell
population rather than T-suppressor cells. The differences between
antibody and CMI responses can be explained if memory cells for antibody
responses have a shorter lifespan than T-effector or memory cells for
delayed type hypersensitivity responses. In support of this hypothesis,
it has been shown, although in a different experimental system, that
Tdth effector cells may be long lived (Shiho, Takaoki, Nakagawa,
Arakawa & Takeuchi 1982). Much further work will be required to
investigate the role of the gut as a regulator of immune responses to
fed antigens and to examine the subsequent systemic immune responses at
the cellular level. This should be directed towards the documentation
of development of the mucosal immune system, both with respect to
immunoregulatory and effector functions. It will also be essential to
examine the immunochemical properties of immunogenic materials which
are found in blood after enteral administration. My experiments have
addressed only humoral antibody responses of the IgG and IgM class (by
passive haemagglutination and ELISA techniques) and CMI responses by
measuring delayed type hypersensitivity with a skin test. Subsequent
work should also concern the effects of neonatal antigen exposure on IgE
and mucosal IgA antibody responses.
E. INDUCTION OF MUCOSAL CELL MEDIATED IMMUNITY
Mucosal CMI is a common feature in GvHD and the intestine is a
primary target organ (Slavin & Santos 1973). Using morphometry and
stathmokinetic techniques (Mowat & Ferguson 1981,1982), it was
demonstrated that induction of GvHR in one week old neonatal mice led to
significant changes in intraepithelial lymphocytes and infiltration of
mast cells in the lamina propria. In addition, they observed an
increase in crypt cell production rates and in crypt lengths.
Induction of GvHR in adult mice led to similar changes of intestinal
morphology. The general health of these animals was unaffected and
all groups showed a normal weight gain (Mowat 1981). If, however, as
in my experiments, a GvHR was induced in one day old animals, they
developed overt GvHD with diarrhoea, wasting and death occuring between
the 10th and 14th day after injection of parental spleen cells. This
was mirrored by increases in intraepithelial lymphocytes, increases in
crypt lengths, shortening of villi and a concomitant splenomegaly.
Shortening of villi is considered a late event in the intestinal
epithelial damage (Mowat & Ferguson 1982), presumably being the
consequence of a maximally stimulated cell turnover ("hyperplastic
villus atrophy").
My results confirm the role of the gut as a target organ in
neonatal GvHD and prove the validity of the techniques used to assess
local intestinal CMI.
Nature of cellular infiltration during a local cell mediated immune
reaction: intraepithelial lymphocytes
The T-cell lineage of intraepithelial lymphocytes has been
demonstrated by various groups (Ferguson & Parrott 1972, Guy-Grand
et al 1974,1978, Selby et al 1981), their exact role and nature however
remain unresolved to date.
In humans, the majority of intraepithelial lymphocytes are reported
to bear the suppressor phenotypic marker (Janossy et al 1980) which has
also been demonstrated for rats (Lyscom & Brueton 1982) whereas the T-
helper phenotype is frequently found in the lamina propria. There is
further more - still conflicting - evidence of natural killer cells and
cytotoxic activity detectable in small intestinal intraepithelial
lymphocytes. In guinea pigs, both natural killer and killer cell
activities are detectable among intraepithelial lymphocytes (Arnaud-
Battandier et al 1978). In mice, cytotoxic T-cell activity (Davies &
Parrott 1981) and natural killer cell activity has been shown in
analysing almost pure intraepithelial lymphocyte preparations (Parrott
et al 1983). These reports and studies identifying human natural
killer effector cells as granulated lymphocytes (Timonen, Ortaldo &
Herberman 1981) support the concept that the intraepithelial lymphocytes
are a heterogeneous population of cells. It seems feasible that these
cells play an important role in mucosal defence and immune
surveillance.
Further studies using monoclonal antibodies against cell surface
markers as well as functional studies are needed to elucidate which
population of intraepithelial cells may be responsible for the rise in
numbers during a local intestinal CMI.
Mucosal mast cells
The origin of mucosal mast cells is still a matter of conflicting
reports and a T-cell origin (Guy-Grand et al 1978) of mucosal mast cells
and a bone marrow origin of connective tissue type mast cells have been
proposed (Kitamura et al 1977,1981). Recent studies support the latter
findings and suggest that mucosal mast cell precursors are also of bone
marrow origin (Haig, MacKee, Jarrett, Woodbury & Miller 1982). It is
now becoming obvious that neither population of mast cells is derived
directly from T-lymphocytes (Mayrhofer & Bazin 1981) but that mucosal
mast cells require under certain conditions, for example, during
parasite infection (Ruitenberg & Elgersma 1976) an inductive influence
provided by T-lymphocytes. Mucosal mast cells are involved in delayed
type hypersensitivity responses (Askenase 1980) and have been shown to
be part of the cellular infiltration during a GvHR (Guy-Grand et al
1978, Mowat & Ferguson 1982).
Mucosal mast cell counts and counts of granulated intraepithelial
lymphocytes were performed in the experiments presented in this thesis
to find out whether an increase of granulated cells within the lamina
propria and epithelium would be an essential part of a local intestinal
CMI. Preservation of mucosal mast cells is dependent on the
appropriate fixative (Enerback 1966qi and the results presented in this
thesis were obtained by using Carnoy's fluid, a fixative which is known
to preserve mucosal mast cells.
In my studies I did not observe a significant change in mucosal
mast cell infiltration during a local CMI. This finding, however, does
not imply that these cells do not play a role in CMI responses. Mucosal
mast cells can discharge their mediators without total disruption of
their cell membrane and could thus be still recognisable as intact cells
under the light microscope.
A striking and unexpected finding was that nearly 100% of
intraepithelial lymphocytes of the (CBA x BALB/c)F^ hybrid generation
were granulated. This is in sharp contrast to the numbers found in
both parental strains, where granulated cells contributed to less than
1% of the total intraepithelial lymphocyte population. Parrott et al
(1983) reported that up to 60% of intraepithelial lymphocytes are
granulated and stain positively with astra blue or Giemsa stain.
Further experiments are needed to clarify the exact nature of the
granulated cell populations and to examine the mode of inheritance and
whether, for example, a high number of granulated intraepithelial
lymphocytes may represent a selective advantage.
Abrogation of oral tolerance and induction of local mucosal cell
mediated immunity: cyclophosphamide
Feeding ovalbumin to adult rodents leads to systemic tolerance.
Systemic immunisation, however, has also been shown to occur after oral
antigen administration (Perrotto et al 1974). A local intestinal CMI
has been shown in pigs (Huntley, Newby & Bourne 1979) after feeding
sheep erythrocytes. In these reports the CMI was only short lived and
disappeared within one week. In a different system, intestinal CMI
has been demonstrated in mice after the immune responsiveness has been
modulated by cyclophosphamide prior to feeding (Mowat & Ferguson 1981).
As I have shown earlier, cyclophosphamide also abrogated the induction
of oral tolerance and these results were the rationale for investigating
whether the abrogation of oral tolerance would lead to a local CMI on
re-exposure to the same antigen.
In repeating published work (Mowat & Ferguson 1981), I confirmed
that immunomodulation with cyclophosphamide abrogates oral tolerance and
does lead to an infiltration of the mucosa with intraepithelial
lymphocytes, whereas oral immunisation without cyclophosphamide
treatment was ineffective. Crypt changes and changes in the crypt cell
production rates however were variable and never reached significant
levels. The reasons for this discrepancy remain unclear; among the
candidates mechanisms responsible for this difference could be a change
in the intestinal flora of these animals and in this way altering the
adjuvanticity of the bacterial gut flora (Wannemuehler et al 1981).
It is also conceivable that the duration of the antigen challenge may
have been inappriopriately long and has rather led to induction of
tolerance (see Chapter 6).
To investigate this possibility, single feeds rather than
continuous challenges have been examined. A single challenge of
cyclophosphamide pretreated animals with 25 mg or as little as 100 pg
ovalbumin produced a significant rise in intraepithelial lymphocytes
after only 24 hours. This demonstrates the sensitivity of the
intraepithelial lymphocytes response on one hand and that their numbers,
on the other hand, stay on an elevated level during the period of
challenge. Although I investigated only two time-points, the first
day and last day of the challenge period, it is unlikely that the
intraepithelial lymphocyte infiltration would fluctuate during the time
of continuous antigen presentation. Based on the results of these
experiments it is obvious that feeding for 10 days does not induce oral
tolerance in previously sensitised adult animals. Taking published
reports (McDonald & Ferguson 1976, Guy-Grand et al 1978, Mowat 1981,
Mowat & Ferguson 1982) and here presented evidence together, it is
obvious that the intraepithelial lymphocyte response within the gut is a
reliable marker of a mucosal GMI response. The observations discussed
here demonstrate that an increase in intraepithelial lymphocytes can be
the only sign of a local CMI; an elevated crypt cell production rate
and morphological changes are not inevitably consequences of a local
intestinal CMI.
Graft-versus-host reaction
Induction of GvHR leads to an intestinal CMI and mice being fed
ovalbumin during the proliferative phase of a GvHR failed to develop
systemic hyporesponsiveness. In an attempt to recreate villus and
crypt abnormalities similar to those observed in human food related
diseases (for example, coeliac disease, cows' milk protein intolerance),
I tried to augment the intestinal changes by inducing an additional
delayed hypersensitivity reaction to a different antigen. It was
assumed that abrogation of oral tolerance, at the same time, would prime
the animals for intestinal delayed hypersensitivity reactions as seen
after treatment with cyclophosphamide and muramyl-dipeptide.
Following the general protocol for the induction of mucosal CMI,
a similar infiltration with intraepithelial lymphocytes was observed in
both experimental groups without other morphological changes (Figure
7.11). The failure to demonstrate augmented changes due to an
additional CMI response to ovalbumin proved this hypothesis to be
incorrect. The possibility, however, that the assay system was not
sensitive enough to measure additional effects cannot be ruled out.
Another way to explain these findings would be that oral tolerance is
maintained by different immunoregulatory mechanisms and modulation or
abrogation of only one part of this network (systemic tolerance) does
not necessarily allow a local cell mediated immune response to take
place.
Muramyl-dipeptide
Like other adjuvants, injection of muramyl-dipeptide can lead to
immunostimulation or immunosuppression depending on the time of
application in relation to the antigen (Leclerc et al 1979).
In the experiments described to examine the effects of muramyl-
dipeptide on the systemic immune responses after oral antigen
administration, it was given concomitantly but via different routes.
Having demonstrated the abrogation of systemic tolerance to ovalbumin
by this treatment, I decided then to find out whether the gut associated
lymphoid tissues may have been primed for cell mediated immunity by this
procedure. Figure 7.13 clearly shows that this was the case and the
combination of muramyl-dipeptide and ovalbumin induced a local cell
mediated immune reponse when the animals were challenged with the
antigen for 10 days. Muramyl-dipeptide has complex effects on the
immune system and has been shown to enhance antibody dependent cell
mediated cytotoxicity by activation of macrophages (Lowy et al 1977,
Fevrier et al 1978). Furthermore, induction of T-helper cells has been
demonstrated and with it the need of T-cell co-operation for muramyl-
dipeptide to exert its effects on the immune system (Lowy et al 1977).
T-helper cells have also been postulated to be more readily activated
(Morris & Johnston 1978). The observation that muramyl-dipeptide
injected, ovalbumin fed and immunised mice responded with higher
antibody titres compared to their saline fed controls (Hanson 1982,
personal communication) tends to support the hypothesis that antigen
specific T-helper cells may have been primed.
Following these lines of evidence, it is conceivable that the net
gain in T-help (through macrophage activation or through an increase in
T-help for other reasons) leads to the sensitisation of the gut
associated lymphoid tissues and finally to intestinal CMI. This
interpretation, however, is still speculative and cell culture
experiments with identification of functional T-cell subsets and cell
transfer experiments should be performed in future to answer these
important questions.
The effects of age at first feed on induction of local CMI
Priming of the systemic immune system observed in mice which had
been fed ovalbumin on the first day of life was a complete novel finding
and the possible underlying mechanisms have been discussed earlier.
These findings prompted further investigations to find out whether the
systemic effects could be identified at the mucosal level too.
I demonstrated in repeated experiments that BALB/c mice fed
ovalbumin on the first day of life responded to a later challenge with a
significant rise in intraepithelial lymphocytes. This is suggestive of a
local CMI, although no other morphological changes were observed. It
is not clear why CBA mice treated and tested in the same way developed
intestinal mucosal changes (Figure 7.14) but no rise in intraepithelial
lymphocytes. Both strains of mice differ genetically in the major
histocompatibility complex and presumably in their immune responsiveness
to ovalbumin (Levine & Vaz 1970, Swarbrick 1979, Stokes et al 1983).
Furthermore, there is some speculative evidence that differences in the
activity of a regulatory contrasuppressor circuit to sheep erythrocytes
within the Peyer's patch (Green, Gold, St Martin, Gershon & Gershon
1982) may be closely linked to specific haplotypes of the major
histocompatibility complex and could account for a different
immunoregulation within the micro-environment of the Peyer's patch.
Much further work however is needed to explore these findings in depth
and to substantiate this attractive hypothesis of Green et al (1982).
It seems that a net gain in T-help has been induced by feeding
ovalbumin to neonatal mice. This immune response overrides the usually
observed dampening of the immune responsiveness of the gut associated
lymphoid tissues by "traditional" T-suppressor cells (Richman et al
1981) and/or by induction of an inhibitory feedback pathway by Lyt 1+
suppressor inducer cells in the Peyer's patch (McDonald 1982).
F. CONCLUSION AND CLINICAL SIGNIFICANCE
Immune responses to fed antigen are extremely complex and enteral
exposure to antigens may produce systemic tolerance or less freqently
immunisation and/or local immunity in the intestinal mucosa. After an
antigen feed, various responses at the cellular level are responsible
for the induction and maintenance of oral tolerance which involves T-
helper, T-suppressor cells, B-cells, macrophages and several, still
hypothetical and possibly complementary immunoregulatory circuits
(Richman et al 1981, Green et al 1982, McDonald 1982). Modulation of
these responses by cyclophosphamide, muramyl-dipeptide and a GvHR leads
to abrogation of oral tolerance by elimination of T-suppressor cells and
presumably by activation of macrophages and/or a T-helper inducer cell
circuit.
Immunosuppressive or immunoenhancement therapy is widely used in
treatment of malignant disease and since gastrointestinal side effects
are frequently encountered, it will be important to investigate whether
these are consequences of direct mucosal cell injury or due to the
breakdown of the homeostatic mechanisms controlling oral tolerance.
The quantity of antigenic material taken up by the intestine has been
proposed to be an important regulator of intestinal immune responses
(Walker 1981). However, abrogation of transferable tolerance after
irradiation of serum donors and concomitant demonstration of an
increased quantity of circuiting ovalbumin would suggest a different
explanation. It is not merely the quantity but the immunological
quality of absorbed antigen which regulates the ensuing immune response.
Demonstration of priming of the immune responses by feeding neonatal
mice would point in a similar direction. In the context of these
studies, observation of an even more pronounced priming effect after
intraamniotic antigen exposure ("feeding") suggest a crucial role of the
gut in regulating immune responses to fed antigen.
Several diseases of infancy which cause enteropathy and
malabsorption are closely associated with hypersensitivity to food
antigens. Although cows' milk protein intolerance and persistent
intolerance to wheat (coeliac disease) are frequently found in infancy,
theoretically each antigen introduced during a vulnerable period can
cause a malabsorption syndrome and recent reports confirm this theory
(Vitoria, Camarero, Sajo, Ruiz & Rodriguez-Soriano 1982). Intestinal
lesions consist of crypt hyperplasia, villus atrophy and lymphocytic
infiltration of the epithelium (Kuitunen et al 1974, Mavromichalis et
al 1976, Ferguson 1977, Phillips et al 1979) and it seems likely that
those changes reflect an intestinal CMI response to dietary antigens.
The work described in this thesis indicates that oral tolerance
is induced and maintained by a complex immunoregulatory circuit
including T-suppressor, T-helper/inducer cells and that antigen
presenting cells play an important role in these circuits. Feeding
ovalbumin to mice during the perinatal period and after immunomodulation
by drugs abrogates the protective effects of oral tolerance and induces
a local intestinal CMI response on antigen re-exposure in later life.
These findings bear obvious resemblances to clinical observations
made in. gastroentropathies which have been caused, for example, by cows'
milk protein intolerance. In these cases, a single postnatal feed of
cows' milk to breast fed babies is a sufficient antigenic stimulus to
lead to early sensitisation and priming for immediate and delayed type
hypersensitivity responses in later life.
The experimental work described within this thesis provides a
structured basis for investigation of an important clinical problem:
that feeding of protein antigens to human neonates - at a time when both
digestive and immune systems are immature - sometimes sensitises the
infant for potentially harmful immune responses to foods, and thereby to
food allergic diseases.
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Immunological responses to fed protein antigens in mice
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Summary. Mice fed ovalbumin develop specific sys¬
temic hyporesponsiveness. This oral tolerance is abro¬
gated by cyclophosphamide pretreatment, and the
mechanism of abrogation could be either via T
suppressor cells or via damage to the gut epithelium. A
serum transfer protocol was used to examine the site of
action ofcyclophosphamide in this system. Serum was
collected from ovalbumin-fed mice and transferred
into recipients which were then parenterally im¬
munized with ovalbumin in Freund's complete adju¬
vant. Serum transfer suppressed the delayed-type
hypersensitivity (DTH) responses but not the anti¬
body responses of the recipients. Cyclophosphamide
pretreatment (100 mg/kg) of recipients (but not of
donors) abrogated this suppressor effect. Parenteral
administration of ovalbumin in a range of doses did
not induce immunological hyporesponsiveness. It is
suggested that absorption across the gut mucosa leads
to generation of fragments of ovalbumin that induce
suppressor cells selective for DTH.
Correspondence: Dr Stephan Strobel, Gastro-Intestinal
Unit, University of Edinburgh, Western General Hospital,
Crewe Road, Edinburgh.
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INTRODUCTION
Induction of systemic tolerance by feeding protein
antigens was first described 70 years ago (Wells &
Osborne, 1911) and has been confirmed in many recent
experiments. The mechanisms responsible for this oral
tolerance involving both humoral and cell-mediated
immunity, remain controversial. Thus, in different
systems, there is evidence implicating immune com¬
plexes (Andre et al., 1975) anti-idiotypic antibody
(Kagnoff, 1980) and specific suppressor T cells (Ngan
& Kind, 1978; Miller & Hanson, 1979). We have
reported abrogation of oral tolerance in mice pre-
treated with cyclophosphamide before being fed the
protein antigen ovalbumin (Mowat et al., 1982), and
we postulated that this modulation of tolerance was
related to the effect of cyclophosphamide on suppres¬
sor T cells (Rollinghoff et al., 1977; Schwartz,
Askenase & Gershon, 1978). However since cyclo¬
phosphamide also acts on rapidly dividing cells such as
intestinal enterocytes, it is equally possible that the
modulation of oral tolerance by cyclophosphamide
was due to alterations in the digestion or processing of
protein antigen by the gut.
We reasoned that it should be feasible to examine
the effects of 'gut processing' on the immunogenicity
or tolerogenicity of fed antigen by comparing the
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in-vivo effects of antigen which had been absorbed
across the gut into the serum ofmice, with the effects of
administration ofsimilar amounts of native antigen. A
serum transfer protocol was used, in which serum was
collected 1 h after mice had been fed the protein
antigen ovalbumin, and then transferred intraperi-
toneally into syngeneic recipients. The immunological
properties (tolerogenic or immunogenic) of the
antigen in the transferred serum were then assessed by
measurement of humoral and cell-mediated immunity
in the recipients after a subsequent parenteral injection
ofovalbumin. We also investigated the site ofaction of
cyclophosphamide in modulating oral tolerance by
separately treating donors and recipients of serum
with cyclophosphamide. If cyclophosphamide acts at
the level of the intestine, pretreatment of ovalbumin
fed donors should alter any immunological effects
which the transferred serum has, whereas ifcyclophos¬
phamide exerts its effect by inhibiting suppressor cells,
then cyclophosphamide treatment of serum recipients
should alter their immune responses.
MATERIALS AND METHODS
Animals
Male and female BALB/c mice, aged 6-8 weeks were
used as donors of serum. Female BALB/c mice of the
same age were used as recipients. Details of the various
experimental groups are given in Table 1.
Antigens
Ovalbumin (Sigma Fraction V) was dissolved in
distilled water for use.
Cyclophosphamide
Cyclophosphamide (Endoxana WB Pharmaceuticals)
was dissolved in distilled water for use and mice were
given 100 mg/kg by intraperitoneal injection, 2 days
before ovalbumin feeding or serum transfer.
Collection and transfer of serum
20 donor mice per group were fed either 25 mg
ovalbumin in 0-2 ml of water or 0-2 ml water, by
intragastric tube and were bled out from the axillary
vein 1 hr later. Sera from each group were pooled and
0-8 ml transferred intraperitoneally into each of six
recipient mice. All recipients were immunized 1 week
later with 100 pg ovalbumin in Freund's complete
adjuvant (FCA; H37Ra, Difco Ltd) injected into one
footpad.
Serum antibody levels
Mice were bled from the retro-orbital plexus, 14 and
21 days after immunization, and the sera tested for
haemagglutinating antibodies to ovalbumin as de-
Table 1. Details of experimental protocol and treatment groups
Treatment of serum donors Treatment of recipients
Recipient Day 0 Days 7-28
mice groups Day—2 (feed) Day —2 Day 0 (All groups)
A h2o h2o h2o serum i.p.
b h2o OVA h2o serum i.p.
C CY h2o h2o serum i.p. Day 7—100 pg OVA i.d. via footpad.
D CY OVA h2o serum i.p.
e h2o h2o CY serum i.p.
F h2o OVA CY serum i.p. Day 21 and Day 27—bleed
G — — — saline i.v. for antibodies.
H — — — 1 pg OVA i.v.
I — — — 10 pg OVA i.v. Day 28—skin test for DTH.
J — — — 100 p.g OVA i.v.
K — — — 10 pg OVA i.p.
l — — — 100 pg OVA i.p.
Abbreviations: OVA, ovalbumin; CY, cyclophosphamide; i.p., intraperitoneal; i.v., intravenous; i.d., intradermal; DTH,
delayed-type hypersensitivity.
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scribed previously (Mowat & Ferguson, 1981). Results
were expressed as the mean logio antibody titre.
Delayed-type hypersensitivity responses
Three weeks after immunization, recipients were
tested for systemic delayed-type hypersensitivity
(DTH) by an intradermal footpad test. Footpad
thicknesses were measured by skin calipers immedia¬
tely before, and 24 hr after, an intradermal injection of
100 pg ovalbumin in saline. Ovalbumin-specific incre¬
ments in footpad thickness were obtained by subtract¬
ing the response of immunized animals to saline alone.
Pretreatment of mice with parenteral injections of
ovalbumin
For these experiments eight mice/group were given 1,
10 or 100 jug ovalbumin in 0-2 ml saline either
intravenously or intraperitoneally, 1 week before
immunization with ovalbumin in FCA as above.
Control mice received 0-2 ml saline alone.
Statistics
Results are expressed as means ± one standard devia¬
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Figure I. Effects of cyclophosphamide pretreatment of
donors and recipients on serum antibody responses in
recipients (Groups A to F), 3 weeks after parenteral immuni¬
zation with ovalbumin in Freund's complete adjuvant;
mean + 1 standard deviation. Circles represent total Ig-titres,
squares represent IgM ( = 2-mercaptoethanol-sensitive) anti¬
body titres.
RESULTS
Serum antibodies in recipients before parenteral im¬
munization
All recipient mice were bled immediately prior to
parenteral immunization with ovalbumin in FCA.
None of the sera contained detectable ovalbumin-spe¬
cific antibodies.
Effects of serum transfer on systemic immune responses
of recipients
Analysis of the results in recipients of serum from
water-fed donors (Group A) and ovalbumin-fed
donors (Group B) showed that serum transfer had no
effect on systemic humoral immune responses, the two
groups having identical antibody levels, both total and
IgM, at 2 and 3 weeks after immunization. Results for
a typical experiment are illustrated in Fig. 1, Groups A
and B. In contrast, the mice receiving serum from
ovalbumin-fed donors had significant suppression of
cell-mediated immunity (CMI) responses (Fig. 2,
Group B) with 67% suppression (/><0 02) when
compared with mice receiving serum from water-fed
donors. This experiment was performed three times
with identical results.
Effects of cyclophosphamide pretreatment of donors on
immune responses of recipients
The serum from cyclosphosphamide-pretreated, oval¬
bumin-fed donors induced a similar degree of toler¬
ance for CMI in the recipients (Group D, Fig. 2, 87%
suppression when compared with Group C, P < 0 01).
Serum antibody levels were identical to Groups A and
B (Fig. 1).
Effects of cyclophosphamide pretreatment of recipients
on their immune responses
Recipient groups E and F received cyclophosphamide
2 days before serum transfer. As shown in Fig. 2,
cyclophosphamide pretreatment abrogated the im¬
munological tolerance for CMI which occurred when
similar serum was transferred to saline-pretreated
recipients (Group F compared with Group B). No
significant effects on serum antibody responses were
found. Although the titres of antibody in Group F
were consistently higher than in Group E in three






















Figure 2. Effects of cyclophosphamide pretreatment of
donors and recipients on DTH responses in recipients
(Groups A to F), 3 weeks after parenteral immunization with
ovalbumin in Freund's complete adjuvant; mean + 1 stan¬
dard deviation. (*P<0-05, **P<0 01).
separate experiments, this difference never reached
statistical significance.
Effects of parenteral ovalbumin on subsequent immune
responses of recipients
Unpublished experiments with radioimmunoassay
(Hanson, personal communication) and enzyme-
linked immunoassay techniques (Strobel, unpub¬
lished) indicated that the amount of ovalbumin pre¬
sent in serum after feeding was likely to be in the range
0 01-1% of the ingested dose/ml mouse serum. There¬
fore, doses of 1, 10 and 100 ng native ovalbumin were
administered intravenously or intraperitoneally into
recipient mice which were then immunized parenter-
ally with ovalbumin in Freund's complete adjuvant,
and tested for systemic immunity in the same way as
serum recipients (Groups H to L). As illustrated in
Table 2, native ovalbumin in the doses used had no
significant effects on the humoral or CMI responses to
a subsequent parenteral immunization with ovalbu-
DISCUSSION
The transfer of tolerance by serum from protein-fed
mice has not previously been reported. In mice fed
repeated doses of sheep red blood cells, the tolerogenic
factors described in serum appear to reflect immune
responses by the animal to the fed antigen, for
transferred sera used in experiments with sheep red
blood cell contain antibodies (Kagnoff, 1978), im¬
mune complexes (Andre et al., 1975) and a serum
factor which may be anti-idiotypic antibody (Kagnoff,
1980).
In the interpretation of their experiments on the
induction of tolerance to oxazolone, Asherson, Perera
& Thomas (1979) suggested that differences in the
quantity of systemically available antigen could
account for the contrasting effects of oral and paren¬
teral administration of antigen. However it is unlikely
that results in our experiments are due to the amount
of ovalbumin absorbed, since parenteral administra¬
tion of ovalbumin over a hundred-fold range of doses
had no tolerizing effect on the immune responses of
recipients. It is more likely that the tolerogenic
properties of the serum from protein-fed mice are
related to physico-chemical alterations in the protein
Table 2. Effects of parenteral ovalbumin injections on subsequent systemic immune responses, 3
weeks after parenteral immunization with ovalbumin in Freund's complete adjuvant
Ovalbumin Logio antibody Specific 24 hr footpad
Group dose Route n* titres (mean + 1 SD) n* increment in mm (mean + 1 SD)
G Saline I.V. 6 2-84 + 0-22 5 0-17 + 0-02
H i n I.V. 6 3-14 + 0-20 5 0-19 + 0-02
I 10 fig I.V. 6 2-96 + 0-18 5 0-20 + 0-04
J 100 fig I.V. 7 3-11+0-25 6 0-17 + 0-02
K 10 fig I.P. 6 2-96 + 0-15 5 0-15 + 0-03
L 100 fig I.P. 6 3-01+0-23 5 0-16 + 0-02
* Experimental animals/group.
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occurring in the intestine. After the feeding of ovalbu¬
min, large amounts of antigen free of aggregates are
found in the serum (Swarbrick, 1979) and such
deaggregated proteins are known to be extremely
effective in inducing both oral and parenteral toler¬
ance (Vives, Parks & Weigle, 1980; Parks & Weigle,
1980). It has also been shown, using the antigen bovine
serum albumin, that in-vitro proteolytic digestion
produces protein fragments which are tolerogenic in
vivo, possibly via suppressor cell activation (Dosa et
al., 1979). Although we have not yet elucidated the
nature of circulating immunoreactive ovalbumin after
feeding, the results of our experiments are consistent
with the hypothesis that tolerogenic forms of protein
are produced in vivo after digestion and absorption of
protein antigens in the gut, and that these are impor¬
tant in the induction of oral tolerance.
A striking finding in these experiments has been that
transfer of serum from ovalbumin fed donors into
naive recipients had no suppressive effect on sub¬
sequent systemic humoral immunity of recipients, but
did lead to tolerance for CMI. We have found that
these two limbs of the immune response differ in their
susceptibility to tolerance induction by feeding differ¬
ent doses of ovalbumin, with a low dose of fed
ovalbumin suppressing CMI but not antibody re¬
sponses (Mowat et al., 1982). These experiments
confirm and extend our earlier suggestion that there is
likely to be more than one regulatory factor involved
in modulation of systemic immunity after the feeding
of protein antigens.
In our previous experiments, the tolerance of sys¬
temic CMI after the feeding of ovalbumin was abro¬
gated by cyclophosphamide, as was the CMI tolerance
which occurred in recipients of ovalbumin-fed serum
in the present report. The unequivocal observation
that cyclophosphamide pretreatment of donors did
not alter the tolerogenic properties of serum obtained
after the feeding of ovalbumin is strong evidence to
support our previous suggestion that the effects of
cyclophosphamide on immune responses to fed oval¬
bumin are not due to associated changes in the
intestinal epithelium. Rather we propose that the
induction of oral tolerance for CMI in mice fed
ovalbumin is due to a population of cyclophospha-
mide-sensitive suppressor T cells, which are activated
by protein moieties generated from ovalbumin within
the mucosa of the gastrointestinal tract. In the intact
animal, dietary antigens will presumably interact
primarily with the suppressor T cells which other
workers have identified within gut-associated lym¬
phoid tissues (Mattingly & Waksman, 1980; Richman
et al., 1978). Since parenteral administration of intes-
tinally processed protein produced a state identical to
oral tolerance, it is obviously not essential for the
antigen meeting these cells to be reaching the gut-asso¬
ciated lymphoid tissues via the intestinal epithelium.
Nevertheless, our results underline the close associ¬
ation between absorptive and immune functions of the
intestine, and regulation of immune responses to
dietary proteins.
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Immunological responses to fed protein antigens in mice.
I. Reversal of oral tolerance to ovalbumin by cyclophosphamide
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Summary. Feeding ovalbumin over a wide range of
doses is known to reduce subsequent systemic immune
responses to parenteral immunization. In the present
study, we have fed mice 2 mg and 25 mg ovalbumin
(OVA) 2 weeks before systemic immunization and
followed the resulting humoral antibody and cell-
mediated immune (CMI) responses. The results indi¬
cate that while 25 mg OVA will reduce subsequent
IgM, IgG and CMI responses to OVA, feeding 2 mg
OVA will only suppress CMI responses and to a lesser
extent the IgM response. Furthermore, the tolerant
state induced by feeding 25 mg OVA was only partially
prevented by 100 mg/kg cyclophosphamide (CY)
while the suppressed CMI after feeding 2 mg OVA was
completely blocked by CY pretreatment. These find¬
ings suggest that the humoral and cell-mediated limbs
of the immune response may be controlled by different
regulatory systems after feeding antigen, and that
activation of these systems is dependent on the dose of
oral antigen used. In addition, the results are in
Abbreviations: GALT, gut-associated lymphoid tissues;
CMI, cell-mediated immunity; OVA, ovalbumin; SRBC,
sheep red blood cells; CY, cyclophosphamide; DTH,
delayed-type hypersensitivity; FCA, Freund's complete adju¬
vant; HSA, human serum albumin; PBS, phosphate-buffered
saline.
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agreement with our previous finding that CY pretreat¬
ment will allow the development ofCMI in the gut and
gut-associated lymphoid tissue (GALT) after oral
OVA and suggest that this phenomenon is related to
breakdown of oral tolerance induction.
INTRODUCTION
After an initial exposure to a protein antigen by the
oral route, specific secretory antibodies of the IgA
class are produced in the gut mucosa (Crabbe, Nash,
Bazin, Eyssen & Heremans, 1969; Heremans, 1974).
On the other hand, it is also well documented' that
feeding antigens leads to a state of specific unresponsi¬
veness when the same antigen is met by a parenteral
route (Chase, 1946; Thomas & Parrott, 1974; Andre,
Heremans, Vaerman & Cambiaso, 1975; Hanson,
Vaz, Maia, Hornbrook, Lynch & Roy, 1977; Swar-
brick, Stokes & Soothill, 1979). The mechanisms
responsible for this tolerant state remain controversial
and may include immune suppression mediated by
antibody (Kagnoff, 1978a; Kagnoff, 1980), immune
complexes (Andre et al., 1975) or induction of specific
suppressor T cells in the GALT (Mattingly & Waks-
man, 1978; Ngan & Kind, 1978; Miller & Hanson,
1979). In particular, cellular suppressor mechanisms
appear to be responsible for the unresponsiveness of
CMI responses after feeding OVA (Miller & Hanson,
1979; Challacombe & Tomasi, 1980; Titus & Chiller,
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1981, SRBC (KagnofT, 1978b) and contact sensitizing
agents (Asherson, Zembala, Perera, Mayhew &
Thomas, 1977). We have previously argued that an
important gut-associated suppressor cell system exists
to prevent the induction of local immune responses in
the gut and gut-associated lymphoid tissue (GALT) in
addition to producing systemic tolerance in response
to oral antigen. Abrogation or modulation of this
homeostatic system may lead to the development of
potentially harmful cell-mediated immunity (CMI) in
the mucosa and GALT in response to dietary antigens
and may be the mechanism underlying food allergic
disease (Mowat & Ferguson, 1981).
In the mouse, suppressor T cells are sensitive to
certain doses of cyclophosphamide (Askenase,
Hayden & Gershon, 1975; Ferguson & Simmons,
1978; Gill & Liew, 1978) and so CY may be expected to
interfere with the generation of 'normal' suppressor
cells following oral antigen. In this case, it should be
possible to detect the induction ofCMI in the gut and
its lymphoid tissues as well as to block the induction of
systemic tolerance after antigen feeding. We have
already shown that pretreatment with cyclophospha¬
mide (CY) will indeed allow the induction of local
CMI in the mucosa and GALT after oral sensitization
and challenge with OVA (Mowat & Ferguson, 1981).
The present experiments were designed to investigate
whether a similar regime of CY treatment might also
prevent the state of oral tolerance induced by a single
feed of OVA.
Furthermore, we have examined both the humoral
antibody response and CMI response in OVA fed
mice, since it is possible that the two limbs of the
immune response may be dissociated in their suscepti¬
bility to oral tolerance induction. Thus parallel experi¬
ments were performed using two different doses oforal
protein as the tolerizing procedure to investigate their
effects on the subsequent immune responses.
MATERIALS AND METHODS
Animals
Male and female BALB/c mice were first used at 6-8
weeks of age. These were bred in the Animal Unit,
Western General Hospital and maintained on an
ovalbumin-free diet throughout life.
Protocol of experiments
This is shown in Fig. 1 and the following groups of
animals were used in each experiment. Group 1
received HiO intraperitoneal^ on day —2 and HjO
orally on day 1. Group 2 received H:0 intraperi¬
toneal^ on day —2 and 2 mg or 25 mg OVA (Sigma
Fraction V) orally on day 1 as a tolerizing procedure.
Group 3 received CY intraperitoneal^ on day— 2 and
2 mg or 25 mg OVA on day 1. All mice were
immunized 14 days after feeding, bled weekly for
antibody levels and tested for DTH three weeks after
immunization. Where appropriate, results of Groups
2 and 3 are expressed as a percentage suppression of
the control response, given by: suppression
(%) = [(control value—value in tolerant or CY treated
mice)/(control value)] x 100.
Immunization
To assess the antibody response, animals were im¬
munized with 2 mg OVA in Freund's complete
adjuvant (FCA. Bacto-H37Ra Difco Ltd) intraperi-
toneally and bled at weekly intervals. In preliminary
experiments, this regime was found to be ineffective in
producing CMI. Therefore, for assessment of DTH
separate groups of mice were immunized with 100 pg
OVA in 0 05 ml FCA intradermally into one rear
footpad and tested for delayed hypersensitivity 3
weeks later.
Antigen specificity
To determine the specificity of the tolerance induced
by feeding OVA. mice were immunized with either 2
mg HSA (Sigma Fraction V) in FCA intraperitoneally
or 100 pg human serum albumin (HSA) in FCA
intradermally 2 weeks after feeding 25 mg OVA.
Cyclophosphamide
Cyclophosphamide (Endoxana—WB Pharmaceuti¬
cals) was given 100 mg/kg in distilled water intraperi¬
toneally. Control animals were injected with 0-2 ml
distilled water only.
Group Day —2 Day 1 Day 14
1 Control HjO i.p. H2O orally 2 mg OVA/FCA i.p. Bled weekly for Ab (8 mice/group)
2 OVA Fed H2O i.p. 2 mg or 25 mg OVA orally or
3 CY/OVA Fed 100 mg/kg CY i.p. 2 mg or 25 mg OVA orally 100 pg OVA/FCA Tested for systemic DTH day 35
i.d. (8 mice/group)
Figure 1. Protocol ofexperiments designed to investigate the effect ofCY pretreatment on the induction oforal tolerance by 2mg
or 25 mg ovalbumin.
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Bleeding ofmice
Mice were bled routinely from the retro-orbital plexus
under light ether anaesthesia. Approximately 200 p\
blood was removed from each mouse into heparinized
hematocrit tubes (Propper Ltd), the tubes centrifuged
and the sera stored at —20°, after inactivation at 56°
for 30 min.
Haemagglutination assay
Sera were tested for antibodies to OVA or HSA by
passive haemagglutination of coated sheep red blood
cells (SRBC). SRBC in Alsever's solution were washed
three times in saline at room temperature and 200 p\ of
packed cells were then mixed with 1-4 ml saline and
200 pi of protein solution (15 mg/ml OVA or 1 mg/ml
HSA in saline). Two millilitres of 0-01% chromic
chloride (Analar-BDH Ltd) in saline at pH5 was
added dropwise with continuous agitation and the
mixture allowed to stand at room temperature for 10
min. After the reaction had been stopped by addition
of PBS pH 7-2, the coated cells were washed twice in
PBS and finally resuspended at 1%.
All sera were absorbed with 10% SRBC before use.
Serum (25 pi) was doubly diluted in round-bottomed,
microtitre plates (Titertek Ltd) and 25 pi of coated
SRBC added to each well. The plates were allowed to
settle for 90 min at room temperature and the titre
taken as the last dilution to show complete agglutina¬
tion. All sera were tested with or without the presence
of 25 ^1 0-1 m 2-mercaptoethanol (Sigma Ltd) per well
to obtain IgM and IgG antibody levels for each serum.
Antibody titres were converted to logio units for
statistical analysis.
Footpad testing for delayed-type hypersensitivity
Three weeks after immunization, mice were tested for
delayed-type hypersensitivity (DTH) by the increment
in footpad thickness 24 and 48 hr after an intradermal
injection of 100 pg of the appropriate antigen (OVA or
HSA) in 0 05 ml H2O. Footpad thickness was mea¬
sured by skinfold calipers (Carbobronze) immediately
before and 24 and 48 hr after injection of antigen, and
expressed in millimetres. Control animals were in¬
jected with 0-05 ml H2O only, to assess the non-specific
response.
Statistics
Groups of results ± standard errors were compared by
Student's t test.
RESULTS
Effects of OVA prefeeding on serum antibody responses
to parenteral OVA
IgM levels
Figures 2 and 3 show the mercaptoethanol-sensitive
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Figure 2. Serum haemagglutinating antibody responses (IgM and IgG) 1, 2 and 3 weeks after immunization with 2 mg OVA in
FCA intraperitoneal^ in mice fed 2 mg OVA 14 days before immunization.
































Group I and 3
0.8 2.4 3.2
Mean log10 Ab ti+re
Figure 3. Serum haemagglutinating antibody responses (IgM and IgG) 1, 2 and 3 weeks after immunization with 2 mg OVA in
FCA intraperitoneally in mice fed 25 mg OVA 14 days before immunization. Bars represent mean logio titre + 1 standard error.
toneally with 2 mg OVA in FCA, 2 weeks after feeding
2 mg or 25 mg OVA, respectively. The peak of the IgM
response occurred 2 weeks after immunization in
animals fed 2 mg OVA and at 1 week in mice fed 25 mg
OVA, at which times virtually all antibody was of the
IgM class. It is seen that at these times, both doses of
oral antigen have suppressed the subsequent IgM
response compared with controls, with 93% suppres¬
sion (P < 0-01) in 25 mg OVA fed animals (Fig. 3a) and
60% suppression in 2 mg OVA fed mice (P < 0 05, Fig
2a). The groups of mice pretreated with CY, before
OVA feeding, have IgM levels which are identical to
controls after feeding 25 mg OVA and are not
significantly different from controls in the 2 mg OVA
fed group (36% suppression).
IgG levels
In contrast to the results with the IgM responses in
OVA fed mice where both doses of OVA suppressed
the response, there was a marked discordance in the
effect of 2 mg or 25 mg OVA on subsequent IgG
responses (Figs 2 and 3). Mercaptoethanol-resistant
antibody accounted for the majority of the antibody 3
weeks after immunization and it can be seen that at
this time, feeding 25 mg OVA has markedly sup¬
pressed the IgG response of fed mice compared with
controls (93% suppression P< 0-005) (Fig. 3f). Mice
fed 2 mg OVA on the other hand have IgG responses
which are identical to controls. CY pretreatment of
mice fed 25 mg OVA returns their IgG response
towards normal (77% suppression) although this is not
significantly different from either tolerant or control
animals. CY pretreated, 2 mg OVA fed mice, have IgG
levels which are the same as both other groups in this
experiment.
Time course of antibody responses in mice fed 25 mg
OVA
It was of interest to know if the maturation of the
antibody response was also altered in the mice ren¬
dered tolerant by oral protein. In the three groups of
mice fed 25 mg OVA, serum IgM and IgG levels could
be followed from 1-3 weeks after immunization and
these can be seen in Fig. 3a-e. All groups show the
characteristic early peak of IgM production at one
week (Fig. 3a) with higher levels of IgG later in the
experiment (Fig. 3d-f). However, it is notable that
after the marked suppression of IgM levels early in the
response of the OVA fed mice, there is in addition a
late rise in IgM antibody in these animals (Fig. 3c).
This secondary rise in IgM 3 weeks after immunization
is mirrored by a decline in IgG at this time (Fig. 3f) and
is in marked contrast to the responses of control
animals in whom IgM levels are very low by then.
CY-pretreated mice, after an early IgM response
similar to controls (Fig. 3a) have at later times a
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pattern of IgG and IgM responses which is midway
between the control and tolerant animals (Fig. 3c and
3f). When the results at 2 weeks are compared, the
pattern of this response in the three groups is already
emerging and is clearly associated with the switch from
IgM to IgG production in the controls (Fig. 3b and
3e).
Thus, the results in Figs 2 and 3 indicate that the
IgM responses of mice may be tolerized by even low
doses oforal protein while larger amounts are required
to achieve suppression of the IgG response. Also the
tolerance of IgM responses appears more susceptible
to abrogation by CY pretreatment. Variation between
individual groups at each time in this experiment was
quite large; however, the overall trend of the results in
Fig. 3 indicates that the larger dose of oral OVA
interferes with the maturation of the primary antibody
response as well as suppressing absolute levels of
antibody.
DTH responses in OVA fed mice
Figure 4 shows the DTH responses in mice fed 2 or 25
mg OVA, assessed 3 weeks after immunization by
measuring the specific increase in footpad thickness 24
hr after an intradermal injection of 100 pg OVA in
HjO. The results in this figure illustrate that both doses
of oral OVA will suppress a subsequent DTH re¬
sponse, with 88% suppression in 25 mg OVA fed mice
(/>= 0 05) and 64% suppression in the mice fed 2 mg
OVA (/>= 0 05) compared to controls. CY given to
mice fed 25 mg OVA returns their systemic DTH
responses to a value which is midway between the
control and tolerant mice and which is not signifi¬
cantly different from either. It is important to note,
however, that the mice receiving CY before feeding 2
mg OVA have completely normal DTH responses,
and show no residual tolerance. Similar results were
obtained 48 hr after testing (Fig. 4), confirming the
DTH nature of the reactions measured, and the
consistency of the tolerant state. Thus, feeding 25 mg
OVA suppresses the humoral IgM, IgG and CMI
responses while 2 mg OVA orally is effective only in
reducing CMI and to a lesser extent the IgM antibody
response. Furthermore, while both doses of oral OVA
used produced significant suppression of subsequent
DTH responses, the tolerance after feeding 25 mg
OVA is only partially susceptible to CY pretreatment.
Tolerance found after 2 mg OVA orally on the other
hand is completely abrogated by CY.
Antigen specificity of oral tolerance induced by feeding
OVA
To confirm that the state of tolerance induced by
feeding OVA was specific to the fed protein, mice were
Group
1 Control
24 hr Increments 2 OVA fed
3 CY+OVA fed
1 Control
















Specific increment in footpad thickness (mm)
Figure 4. Systemic delayed hypersensitivity responses 3 weeks after immunization with 100 fig OVA in FCA intradermally in
mice fed 2 mg or 25 mgOVA 14 days before immunization. Bars representmean specific increments in footpad thickness (mm) 24
and 48 hr after 100 pg OVA in saline + 1 standard error.
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also immunized with 2 mg HSA in FCA 2 weeks after
feeding 25 mg OVA. Figure 5 shows the haemagglu-
tinating anti-HSA responses 1 week and 3 weeks after
immunization, and the OVA fed mice exhibit antibody
responses to the unrelated protein which are the same
as those of the H20 fed controls.
Similarly, Figure 6 indicates that 3 weeks after
intradermal immunization with 100 pg F1SA in FCA,
mice fed 25 mg OVA have normal DTH responses to
HSA, assessed as the specific increase in footpad
thickness 24 hr after 100 /rg HSA in H20 intrader-
mally.
Control
25 mg OVA fed
Control
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Figure 5. Serum haemagglutinating anti-HSA responses
(IgM and IgG) 1 and 3 weeks after immunization with 2 mg
HSA in FCA intraperitoneally in mice fed 25 mg OVA 14
days before immunization. Bars represent mean logio titre
+1 standard error. IgG (□) and IgM (H) 3 weeks after
immunization.
Control
25 mg OVA fed
0.1 0.2 0.3
Specific increment in footpad thickness !mm)
Figure 6. Systemic delayed hypersensitivity response 3 weeks
after immunization with 100 ng HSA in FCA intradermally
in mice fed 25 mg OVA 14 days before immunization. Bars
representmean specific increments in foodpad thickness 24 hr
after 100 /ig HSA in saline + 1 standard error.
DISCUSSION
The results presented here confirm that when the first
encounter with a protein antigen is by the oral route, a
range of different effects on the systemic immune
response may be observed. Thus, we have shown that
depending on the dose of oral protein used, both
humoral and cell-mediated immunity may be reduced;
or alternatively, CMI alone may be reliably sup¬
pressed. In addition, our study indicates that unres¬
ponsiveness of the systemic antibody and CMI re¬
sponses also differs in its susceptibility to abrogation
by CY pretreatment.
A number of different experimental schedules have
been used in the investigation of oral tolerance to
protein antigens, and it is therefore necessary to
emphasize that our results on the induction of oral
tolerance to OVA are compatible with those of
previous workers (Hanson et al., 1977; Swarbrick et
al., 1979; Miller & Hanson, 1979; Challacombe &
Tomasi, 1980; Titus & Chiller, 1981; Hanson, Vaz,
Rawlings & Lynch, 1979; Vaz, Maia, Hanson &
Lynch, 1977; Richman, Chiller, Brown, Hanson &
Vaz, 1978). Thus we have used a single dose of oral
OVA known to induce oral tolerance (25 mg) and a
smaller dose (2 mg) which is nearer the lower limit of
tolerogenicity (Hanson et al., 1977; Challacombe &
Tomasi, 1980; Vaz etal., 1977). Similarly, although the
optimum interval between feeding and immunization
with OVA for the demonstration of systemic tolerance
has been shown to be 7 days, similar unresponsiveness
is found when a 14 day interval is employed as here
(Challacombe & Tomasi, 1980; Vaz etal., 1977). Inthe
present study, it was hoped that differences in the
susceptibility of the various components of the sys¬
temic immune response to oral tolerance might be
observed. This was studied partly by the use of the
high and low doses of oral OVA and by investigating
the role of suppressor cells in the resulting states of
unresponsiveness. Thus we have employed a dose
ofCY within the range known to inhibit some types of
suppressor cells in the mouse when given shortly
before the first encounter with antigen.
In addition to the discrepancy between the suscepti¬
bility of the antibody response and CMI response to
reduction by prior feeding, it is apparent that differ¬
ences exist within the humoral response itself.
Although it has been reported that feeding OVA
inhibits subsequent total serum antibody responses
(Hanson et al., 1977; Ngan & Kind, 1978; Hanson et
al., 1979) and serum IgE responses (Ngan & Kind,
1978; Vaz et al., 1977), there is evidence to suggest that
IgE may be more readily tolerized than IgG responses
(Ngan & Kind, 1978). No such evidence exists at
present on the relative susceptibilities of the IgM and
IgG phases of the humoral response. In the present
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study, we have shown that while both 2 mg OVA and
25 mg OVA feeding suppressed the subsequent peak
IgM response to OVA (60% and 93% suppression,
respectively), only the higher dose was effective in
reducing IgG levels (98% suppression). Furthermore,
mice receiving 2 mg OVA subsequently developed
normal IgG levels despite a previously reduced IgM
response, and it is clear that IgM production may be
more readily tolerized by oral antigen. In support of
this observation Kagnoff has reported that IgM
plaque-forming cells are more susceptible to modula¬
tion by repeated feeding of SRBC (Kagnoff, 1978a).
Similarly, while systemic CMI responses are readily
tolerized by OVA feeding (Miller & Hanson, 1979;
Challacombe & Tomasi 1980), our study also indicates
a dissociation between CMI and the IgG antibody
response in their susceptibility to oral tolerance. Thus,
CMI was markedly reduced by both doses of oral
OVA, despite normal IgG levels in mice fed 2 mg
OVA.
In the context of the different effects of oral OVA on
systemic immune responses, the consequences of CY
pretreatment in OVA fed mice are also relevant. In
mice fed 25 mg OVA, similar degrees of suppression of
IgM, IgG amd CMI responses were observed in each
case and CY pretreatment returned these responses to
a level midway between control and tolerant mice. A
different pattern was seen in the mice fed 2 mg OVA
however. In this case, the markedly suppressed CMI
responses were returned to control levels by CY
pretreatment. The reduced IgM responses however
were not completely restored to normal by this
treatment.
The induction of tolerance by parenteral antigen
has been shown to have discordant effects on sub¬
sequent CMI and antibody responses (Neveu &
Borduas, 1974; Silver & Benacerraf, 1974) and may
involve suppressor cells (Basten, Miller, Sprent &
Cheers, 1974), depletion of helper cells (Endres &
Grey, 1980; Parks & Weigle, 1980) and B-cell inhibi¬
tion (Parks & Weigle, 1980). It has been suggested
previously that oral tolerance may have multiple
control mechanisms (Titus & Chiller, 1981; Hanson et
at., 1979) and we propose that our findings support a
system of oral tolerance dependent on two or more
'suppressor' mechanisms activated by protein feeding.
These may include induction of suppressor cells,
functional deletion of helper T cells and B-cell inhibi¬
tion, their activation being dependent on the dose of
antigen presented to the GALT.
While both suppressor cells or their products
(Mattingly & Waksman. 1978; Mattingly & Waks-
man, 1980; Mattingly, Kaplan & Janeway, 1980) and
serum factors (Andre et al., 1975; Kagnoff, 1978a;
Kagnoff, 1980) have been reported in the unresponsive
state following feeding of particulate antigens, it is
likely that suppressor T cells induced in the spleen and
GALT are responsible for oral tolerance to protein
antigens (Ngan & Kind. 1978; Miller & Hanson, 1979;
Titus & Chiller, 1981; Richman et al., 1978a). In
particular, suppressor T cells are important in the
reduction ofCMI responses after feeding OVA (Miller
& Hanson, 1979; Challacombe & Tomasi, 1980; Titus
& Chiller, 1981). Furthermore the induction of toler¬
ance by feeding contact-sensitizing agents to guinea-
pigs is related to the appearance of suppressor cells
(Asherson et al., 1977) and is abrogated by CY (Polak,
Geleick & Turk, 1975). Thus the tolerance of CMI
response after a low dose of OVA which was fully
sensitive to CY in our experiments suggests that a
suppressor cell mechanism is entirely responsible for
the tolerance of CMI responses after small doses of
oral protein.
Although there is ample evidence to support the
view that our regime of CY pretreatment is acting by
its effect on suppressor lymphocytes, it is important to
consider the effects that this drug may have on the
ability of the gut to process proteins. However, this
dose ofCY has minimal effects on the integrity of the
gut mucosa (Ecknauer & Lohrs. 1976; Hartwich,
Weisshaar & Domschke, 1978), and we have found
recently that the uptake of immunologically active
OVA by the gut is not altered by CY pretreatment
(Mowat, Strobel, Drummond, Pickering & Ferguson,
unpublished observation). Further support for an
immunological effect of CY has come from work
showing that the development of suppressor T cells
induced by OVA feeding to mice is inhibited by 100
mg/kg CY (D.G. Hanson, personal communication).
It is unlikely therefore that intestinal damage can
account for the results presented here.
The tolerance of antibody and CMI responses
induced by feeding 25 mg OVA was however only
partially reversible by CY pretreatment. This may
reflect the induction by larger doses of oral protein of
tolerogenic mechanisms additional to suppressor cells.
Thus, feeding OVA to mice has been shown to induce
defective helper T-cell function in addition to the
simultaneous activation of suppressor T cells (Titus &
Chiller, 1981). A defect in T-helper activity may
therefore be produced in response to larger doses of
oral protein. A defect of this nature is consistent with
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the finding of an apparent disturbance in the switch
from IgM to IgG synthesis in animals tolerized with 25
mg OVA (Fig. 3). A similar defect in an accessory T
cell required for DTH expression may also account for
the partial CY sensitivity of the CMI tolerance after
feeding 25 mg OVA.
A further level ofcontrol may be responsible for the
peculiar sensitivity of IgM production to oral toler¬
ance. It is possible that a direct transient, inhibitory
effect on B cells may be manifest as a defect in IgM
synthesis. Indeed, although in certain circumstances
B-cell priming may occur (Titus & Chiller, 1981), a
defect of this type has been described after feeding
proteins (Vives, Parks & Weigle, 1980). In the presence
of helper T cells this may be overcome and a mature
antibody response eventually mounted as seen in the 2
mg OVA fed mice. After feeding 25 mg OVA,
functional deletion of helper T cells would not allow a
full IgG response to occur, and if B-cell recovery were
to take place, a delayed IgM response would ensue, as
we have observed.
In conclusion, the results described here support the
presence of several regulatory mechanisms governing
systemic immune responses after feeding protein
antigens. In particular, systemic CMI responses are
more easily modulated by antigen feeding and a
CY-sensitive suppressor mechanism may be respon¬
sible for this phenomenon. These findings concur with
our previous report that a similar regime of CY
pretreatment and OVA feeding allows the develop¬
ment of CMI in the GALT and intestinal mucosa
(Mowat & Ferguson, 1981). Thus, mice rendered
deficient in suppressor cells by CY show a loss of
tolerance for CMI in addition to the induction of local
CMI in the gut and its lymphoid tissues. These
findings are consistent with the hypothesis that a
homeostatically important suppressor cell system in
the GALT normally protects the animal (and its gut)
against deleterious CMI reactions to dietary antigen
(Mowat & Ferguson, 1981).
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ABROGATION OF TOLERANCE TO FED ANTIGEN
AND INDUCTION OF CELL-MEDIATED IMMUNITY IN
THE GUT-ASSOCIATED LYMPHORETICULAR TISSUES*





There are many T-lymphocytes not only within the organized lymphoid
tissues of the gastrointestinal tract, but also scattered within the mucosa b"
intraepithelial and lamina propria lymphocytes. Specific immunologic
responses to the feeding of protein antigen are multiple, and include a range of
systemic humoral and cell-mediated immune responses, together with mucus-'
immunity (Figure 1). There is an increasing weight of evidence, from work >•
rodents, that the specific immunological responses to fed antigen are regulated K
immunoregulatory T-cells in the organized lymphoid tissues of the gut. Uru 1
recently, our research program has concerned the effector limb of intestir
T-cell-mediuted immunity (CMI). By using the animal models of alloy.'
rejection of intestine, and graft-versus-host reaction, we have produced evident*
that when a CMI reaction occurs in the small intestine mucosa, there is villoui
atrophy, crypt hyperplasia, and lymphocyte infiltrate—lesions associated war
malabsorption.' 5 Intestinal mucosal immune responses to food antigens are likCi
to be implicated in celiac disease and in other malabsorption syndromes w*
food protein intolerance.6 Allergy to foods is an important component of atom,
disease in infants. In these and similar diseases, the primary pathology must >„
accepted as an abrogation of the normal, usually harmless immune response u
dietary antigens, and so there is a need for the study of the mechanis-!S
underlying induction of the various types of immune response to fed antigt-n»,
particularly induction of mucosal cell-mediated immunity.
Induction of systemic tolerance by feeding antigen is well documented'
although the mechanisms responsible remain controversial. There is, howe\>.
persuasive evidence that cellular suppressor mechanisms are related to system*
tolerance for CMI after the feeding of ovalbumin..12 H We therefore, empirical}^
decided to perform a series of experiments in which we would attempt to indue*
intestinal CMI to ovalbumin in mice that were orally immunized after pretrt-a;
men! with cyclophosphamide (CYj, because administration of CY in the dose KK>
mg/kg enhances CMI reactions without an appreciable effect on antiixyi
synthesis, by way of suppressor-cell inhibition.15 These experiments also alloy,,
us to develop an in vitro method for detection of CMI in the lymphoid tissues if
*This work has been supported by a grant from the Medical Research Council of • >.
United Kingdom. Dr. A. Mowat was a recipient of the Allan Fellowship of the Universe-, ,j
Edinburgh; Dr. S. Stobel was the recipient of a grant from the Deutsche Forschungsgerr.t -
schaft, Str 210/2-3.
/Present address: Registrar in Bacteriology and Immunology. Department of Bacleriof-m,
and Immunology, Western infirmary, Glasgow. Scotland.
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BALB/c mice aged 6 to 10 weeks were used throughout. These mice were bred
, (he Animal Unit, Western General Hospital, Edinburgh, and maintained under















pjCURE 1. Diagrammatic representation of the range of systemic and mucosal immune
^jponses to a fed protein antigen. On present evidence, there is a mucosal antibody
^jponse, but induction of mucosal CMI occurs only under experimental conditions or in
disease.
Cyclophosphamide Treatment
Cyclophosphamide (Endoxana, WB Pharmaceuticals) was dissolved in saline
j,~,i mice were given 100 mg/kg intraperitoneal^ two days before primary oral
;-nrnunization with ovalbumin.
Oral Immunization
For primary immunization, mice were fed a single dose of either 2 mg or 25 mg
valbumin (OVA) (Sigma Fraction V) in saline by intragastric tube. In some
-•iperiments a repeat feeding was performed in the following way. Twenty-eight
fjvs after the primary immunization, OVA, 2 mg/100 ml, was dissolved in the
animals' drinking water so that each mouse ingested approximately 0.1 nig 0*> *
daily. This feeding was continued for 10 days.
Skin Testing for Delayed Hypersensitivity
The presence of systemic delayed type hypersensitivity (DTH) was assessed
the various groups of immunized mice by intradermal skin tests using either fu "1
or footpad skin. Mice were injected with 100 ng OVA in 0.05 ml salir*
intradermally on both shaven flanks, and double skinfold thickness was nv ' •
sured with calipers immediately before and 24 hours after injection, results 1»
expressed as mean increment in skin thickness in millimetres at 24 hours. In otM'
experiments, mice were tested by the increment in footpad thickness 24
after an intradermal injection of 100 /xg OVA in 0.05 ml water. Control animal
were injected with 0.05 ml saline only to assess the nonspecific response.
Lymphocyte Migration Inhibition Test
Mesenteric lymph nodes (MLN) from three to four mice were remove,
washed in RPMI 1640 medium (Flow Laboratories) and trimmed of surround''^
material before being gently cut up and passed through a fine wire mesh fiit'-'
After one passage through a 25 gauge needle, the cells were washed three times y
RPMI 1640 and finally adjusted to 100 x 108 cells/ml in RPMI 1640. The
were supplemented with 2 mmol/1 glutamine, 100 ng/ml penicillin G, and 1
Mg/ml streptomycin and buffered with 10 mmol/1 hepes buffer. A standJ"-
migration inhibition test was then performed using 10 /xl capacity glass capih
tubes in macrophage migration inhibition test plates (Sterilin Ltd.), the wells I*': !
filled either with 0.45 ml supplemented RPMI 1640 medium alone or medic -
containing 0.1 mg/ml ovalbumin. Six to eight wells were used for each antig*"1"
dose or for control cultures. After incubation at 37° C for 20 hours, migration ar>-j-!
were measured using a drawing tube attached to a dissecting microscope, I''
migration index was calculated as the mean area of migration in wells contain^
antigen divided by the mean area of migration in control wells.
Small Intestinal Epithelial Cell Kinetics
For measurements of intestinal mucosal architecture and mitotic activity -
the crypts of Lieberkilhn, villus length, crypt length, and crypt cell-products
rate were examined in groups of animals by a technique first described f''
Clarke,19 and previously used by our group in experiments on allograft rejects®
of gut.3 Briefly, on the day of killing, all animals were given 7.5 mg/kg colchici"*
(BDH Pharmaceuticals Ltd.) intraperitoneally (i.p.). to arrest mitosis in metaph-U*
Individual animals were then killed at intervals from 20 to 100 minutes thereaf!'''
Pieces of jejunum, 10 cm from the pylorus, were removed and fixed in ' >
ethanol/25% acetic acid for six hours, then stained with a modified Feulgen si." *
Villus length and crypt length were expressed in microns (/xm) and the cr>5r
cell-production rate (CCPR) expressed as net accumulation of motaphas*"1-
crypt/hour.
j Intraepithelial Lymphocyte Counts
(Pieces of jejunum were fixed in 10% buffered formal saline, paraffin"^bedded, 5 nm sections cut and stained with hematoxylin a d eosin. A
. "fferentia! count was made of cell types within the epithelium covering the
* ''Hi,20 and the intraepithelial lymphocyte (IEL) count was expressed as the
l!Wiber of IEL/100 epithelial cells.
Experiments and Results
Separate groups of animals were used for the measurements of lymph node
'^'1 migration, intestinal epithelial cell kinetics and IEL counts, studies of
??stemic immunization, and of systemic tolerance. Further groups of animals
'•fire used as positive controls having been systemically immunized with OVA in
,:otnplete Freund's adjuvant; specificity controls were also performed using
CLrnan serum albumin as an antigen.I7,21 Animals remained healthy throughout
experiments and the CY pretreated animals had no clinical side effects,
height gain being similar in all groups.
In general, four groups of animals were studied for each type of response,
ntreated controls received water i.p. on day -2 and a water feed on day one. CY
!-one: animals received CY on day —2 and water or no further treatment
"■•ereafter, OVA alone: animals received water i.p. on day -2 and OVA feeding
■n day one. CY/OVA: animals received 100 mg/kg CY i.p. on day -2, and a feed
"I OVA on day one.
Systemic Immunity
The validity of intradermal skin testing as a measure of systemic DTH was
confirmed by parenteral immunization of four mice that had received OVA in
•feund's complete adjuvant and 21 days later were skin tested with 100 ng OVA
Ticure 2). Similar skin testing was performed in orally immunized mice at 21 and
days after OVA feeding; no positive reactions were elicited in any of the orally
i0>munized groups, including the CY/OVA treated animals (Figure 2).,8,2i
Systemic Tolerance
The presence or absence of tolerance induction was examined in the various
s*perimental groups by immunizing all animals with 100 rig OVA in Freund's
complete adjuvant intradermally, with DTH responses being measured 21 days
wjer by a footpad swelling test. Results are summarized in Figure 3. both doses ofOVA used, 2 and 25 mg, suppressed a subsequent DTH response with 88% and
suppression (p - 0.05 in each case) in the fed mice when compared with
*ater fed controls. The mice that were treated with CY before the feeding of 2 mg
•'■■'A had completely normal systemic DTH responses with no residual tolerance,
J'0d those mice CY pretreated, fed 25 mg OVA, had systemic DTH responses
Widvvay between control and tolerant animals, the value not being significantly
different from either. Thus the tolerance for systemic DTH that was found after
be feeding of OVA was abrogated by CY pretreatment.
MeanSp cificIncr me t
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Intestinal Cell Mediated Immunity—Migration Inhibition of Mesenteric
Lymph Node Cells
Migration inhibition tests were performed with 0.1 mg/ml OVA and MLN
^lls taken at intervals from 1 to 22 days after oral immunization. Results are
rsimarized in Figure 4. Animals fed OVA alone had no migration inhibition at
-iv time, but animals given OVA preceded by CY had significant inhibition of
-ignition at 24 hours after the OVA feed. A similar degree ofmigration inhibition
- rsisted until 13 days after feeding. Two specificity controls were performed.18
there was no migration inhibition of MLN in cells from OVA-immunized
taimals when the cells were incubated in the presence of human serum albumin,







* p = 0.05
25mg OVA








24 hr Specific increment in Footpad Thickness (mm)
Figure 3. Effect of CY pretreatment on systemic tolerance induced by an OVA feed.
t,sSefflic DTH responses were measured by footpad swelling test three weeks after systemic
immunization of all animals with 100 ng OVA in complete Freund's adjuvant. Bars
..^resent mean specific increment in footpad thickness (millimetres) 24 hours after 100 fig
tVA in saline, plus 1 SE. The three experimental groups are as shown. Prior OVA feeding,
^both doses studied, induced systemic tolerance that was abrogated by CY pretreatment.
Intestinal Mucosal Architecture Changes after a Repeat Feed of Ovalbumin
Measurements of villus and crypt length, CCPR and IEL counts were made 10
pys after OVA was fed again to the four experimental groups. Our previous work
yj shown that these two features can be used as indirect measures of the
^ence of a mucosal CMI reaction.4'5 Although on conventional histology no
'-normality of the mucosa was detected in any of the groups, objective measure-
rants revealed minor but significant differences in the CY/OVA experimental
Results are illustrated in Figure 5. Villus length, crypt length, and CCPR
}ire similar for the exclusively CY and OVA mice and untreated controls.
-y/OVA animals, however, given a 10 day oral challenge with OVA, had
Irnificantly increased crypt length and CCPR compared with the other experi-
,'jntal groups. There were no significant differences between the groups with
aspect to villus length.
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DAYS AFTER 2mg OVALBUMIN ORALLY
Figure 4. Development of migration inhibition in the MI.N of mice fed OVA after ( -
presentment, and in mice fed exclusively OVA or given only CY. Where shown, h*.,
represent mean ± 1 SD of three experiments (OVA/CY groups versus others, p < or'
Other results are for one experiment, and statistical analysis between groups was tur
possible.
Intraepithelial Lymphocyte Counts
As illustrated in Figure 6, IEL counts were significantly higher in ft
CY/OVA animals (mean 25.9) than in the other experimental and control
(14.5, 15.9, and 14.1).
Discussion
The experiments described in this paper have shown that under certiui,
circumstances, oral immunization with the protein antigen OVA can indue* rlocal CMI response in the gut-associated lymphoreticular tissues. Mice pretrtsaipgwith 100 mg/kg CY before a feed of OVA had significant inhibition of migrate
in the presence of antigen and of MLN cells. They also had alterations in =ta
structure of the intestinal mucosa after a repeat feeding of ovalbumin. TW„
results suggest that CY pretreatment has induced intestinal cell-medifei!(i
immune responses.
The mechanism by which CY treatment has produced these effects in lh*
is likely to be analogous to that which has been established in experiments :(j
systemic immune responses—release of CMI reactions from suppressor tw»,
trol.'2"'5 Thus we postulate that all of the effects observed in CY/OVA treatyanimals could be due to the effect of CY on T-suppressor cells. Two other pn^i
actions of CY, however, should also be considered. The small intestine e;,.
lium is one of the principal target organs for the cytotoxicity of many
including CY. and so an increased permeability to proteins, or reduced'etuym,content of cells of the intestinal mucosa may also be present. Alterations ^
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antigen handling properties of the gastrointestinal tract may influence CMI
responses by leading to absorption of an unusually large amount of antigen, or
alterations in the immunochemical nature of absorbed antigens. The maximal
effect on the intestinal epithelium, however, of the dose of CY used occurs at
'.2-24 hours after drug administration,22 and in our experiments OVA was fed at
48 hours. In addition to this potential alteration in the villus epithelium, an effect
of CY on the lymphoid tissues of the gut, including Peyer's patches and surface
epithelium overlying Peyer's patches, also deserves consideration; however, we
live no information on this effect a! the moment.
Support for the hypothesis that in these experiments we have reversed a
background of homeostatic suppression of gut-associated CMI responses, comes
from the considerable body of work on regulation of systemic delayed type

















2m* OVA onUiy 3m* OVA orally
0. Iras OVA 0. Iras OVA orally
orally
ft-j re 5. Mucosal architecture in jejunum of BALB/c mice treated as shown. Mucosal
were measured after 10 days oral challenge with 0.1 mg OVA/day. Bars show
s t 1 SD for villus and crypt lengths, and arrows represent CCPR (six to eight mice per
A
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degree of inhibitory control operating on the induction phase of DTH response^
and although we cannot draw any firm conclusions from the work described 1q
this paper as to the nature of the postulated suppressor cells involved in
regulating intestinal CMI, it is probably significant that T-suppressor cells lot
antibody production have been detected in Peyer's patches of orally immunized
mice.112'"1 A similar system appears to exist for cell-mediated immune response!
following oral immunization.12 Future work on intestinal mucosal CMI respon&ei
and extension of this animal work into the clinical sphere, will require methods to
detect and measure such responses. Our previous research on allograft rejection
IEL/100 Epithelial Cells




Day -2 Nil lOOmg/kgCY Nil lOOmg/kg CY
Day 1 Nil Nil 2mg 0YAorally 2mg0YAorally
Days 28-37 Nil Nil 0.1 rng OVA orally 0.1 mg OVA orally
Figukk (i. Intraepithelial lymphocyte counts in jejunum of I3ALB/c mice trea'.eo'
shown. !EL counts measured after 10 days of oral challenge with 0.1 mg OVA/day. g,.,. ,,
are expressed as mean ± 1 SD for each group of six to eight mice.
and graft-versus-host reaction identified the CCPR and IEL counts as relup,
indices of mucosal CMI,2'5 and these two parameters are sensitive, if ...f
necessarily specific, indicators of a mucosal CMI reaction in experinv -
animals. These indices can now be supplemented by lymphocyte migrai.-i
inhibition tests on MLN cells, and these tests should allow more deta'h,.
investigation of the effects on the intestinal mucosa and its lymphoid tissues of *<„
manipulation of cell-rnediated immune responses to fed antigens.
There is a growing body of evidence that says that mucosal T-cells reprev-'
separate pool of lymphocytes from the systemic T-cell system, and have unj- •••
origins, routes of migration, and functions.26 In theory, activation of the pj
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associated lymphoreticular tissues with subsequent migration and differentiation
pf gut-associated lymphocytes need not involve activation of systemic-immune
responses. Our findings of enhanced CMI responses in the gut in the absence of
fysiemic DTH is further evidence supporting the segregation of mucosal and
jystemic T-cell populations.
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Discussion of the Paper
). R. McGhee (University of Alabama in Birmingham): How do you know tQ
a suppressor cell is involved in systemic tolerance in vivo? Could you summary
the CM I test that you used?
A. Ferguson (University of Edinburgh, Edinburgh, Scotland): We transfers,•
serum from animals fed with OVA, into the recipients, or sera from CY pretreat«,»
and OVA-fed donors. The abrogation of tolerance occurs if the recipients of p ,
serum from OVA-fed animals are given cyclophosphamide. It is a CY-sensim,
mechanism.
j. A. Mattingly (Ohio State University, Columbus, Ohio j: Perhaps I f.
confirmed your results in an antibody system. Cyclophosphamide eliminated P,.
suppressor cells from the spleen, but left the suppressor-inducer in the Pey« ,
patches. 1 was wondering whether the suppressor in the Peyer's patches can U 1
suppressor-effector for DTH rather than a suppressor-inducer for antibody.
J. M. Piiillips-Quagliata (New York University Medical Center, New y< •,
N.Y.): 1 lave you tried to induce GVH reactions with peripheral node T-celU?
so, do they have the same effect on crypt length? Do mixed lymphocyte reach;,)
(MLR) supernates have a similar effect?
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Ferguson: We have tried supernatants without any significant success. With
*e$grd to different cell types that induce GVH, we have used only spleen cells.
Changes observed are really quite mild compared to those that have been
^ported by others.'
[)r. J. Bienf.nstock (McMoster University, Hamilton, Ontario, Canada): What
i, she time scale of induction of mucosal CMI, and do you know whether your
pujenteric lymph nodes contain functional suppressor cells? If so, when do they
.,;,;*'ar? Suppressor cells have been shown to appear first in Peyer's patches and
■ ,-n in mesenteric lymph nodes.
Ferguson: Surprisingly, we found positive MIF tests from day 1 to day 21.
«hen animals were refed, positive responses reappeared after 10 days. I am
i^rjid we have no information on functional suppressor cells. Cells from Peyer's
jutches would be very difficult to use in the migration inhibition test.
